University of Memphis

University of Memphis Digital Commons
Electronic Theses and Dissertations
8-24-2017

Towards Accurate Automated MRI Based R2* Measurements of
Hepatic Iron Content
Aaryani Sajja

Follow this and additional works at: https://digitalcommons.memphis.edu/etd

Recommended Citation
Sajja, Aaryani, "Towards Accurate Automated MRI Based R2* Measurements of Hepatic Iron Content"
(2017). Electronic Theses and Dissertations. 1723.
https://digitalcommons.memphis.edu/etd/1723

This Dissertation is brought to you for free and open access by University of Memphis Digital Commons. It has
been accepted for inclusion in Electronic Theses and Dissertations by an authorized administrator of University of
Memphis Digital Commons. For more information, please contact khggerty@memphis.edu.

TOWARDS ACCURATE AUTOMATED MRI BASED R2* MEASUREMENTS OF
HEPATIC IRON CONTENT

by
Aaryani Tipirneni-Sajja

A Dissertation
Submitted in Partial Fulfillment of the
Requirements for the Degree of
Doctor of Philosophy

Major: Biomedical Engineering

The University of Memphis
December 2017

To my family

ii

Acknowledgements
First and foremost I want to extend my sincerest gratitude to my supervisor, Dr. Claudia
Hillenbrand, who has given me the opportunity to pursue doctoral degree and supported me
throughout my dissertation with her knowledge whilst allowing me the room to work in my own
way. I also owe my deepest gratitude to my department chair, Dr. Eugene Eckstein for being a
great advisor and for supporting me throughout my doctoral studies. I would also like to thank
Dr. Amy Curry and Dr. Esra Roan for their very helpful recommendations and suggestions
during my dissertation preparation.
I would like to thank my lab members for their support and guidance throughout my
doctoral research. Personally, I would like to thank Dr. Ray Song and Dr. Ralf Loeffler for
providing me all the technical and practical knowledge on MRI and making my dissertation
research so productive. My sincere thanks goes to our former lab member, Dr. Axel Krafft for
getting me started with my dissertation project and giving me training and guidance throughout
my dissertation and being a true inspiration. I would like to thank Dr. Joseph Holtrop for taking
time to review my dissertation and providing helpful suggestions during my dissertation
preparation. I would also like to thank Chris Goode for gathering all the clinical data necessary
for my dissertation and assisting me in acquiring patient and volunteer MRI scans. I am grateful
for the possibility to work at St. Jude Children’s Research Hospital, which has helped me fulfill
my career ambition to pursue doctoral research in MR imaging.
I would like to thank my father, Achyuta Prasad Tipirneni, for giving me the inspiration
and my mother Sarada Tipirneni, for her enormous help and support in achieving this major
milestone in my life. Finally, this dissertation would not have been possible without the endless
love, support and cooperation of my dearest husband, Kalyan Sajja and my most precious in the
world, my son, Arush Prasad Sajja. This dissertation is dedicated to both of them.
iii

Preface
Chapter 5, Radial UTE Imaging Removes the Need for Breath-holding in Hepatic Iron Overload
Quantification by R2*-MRI, is published in the American Journal of Roentgenology. July 2017.
Chapter 7, Automated Vessel Exclusion Technique for Quantitative Assessment of Hepatic Iron
Overload by R2*-MRI, has been submitted to JMRI.

iv

Abstract
Tipirneni-Sajja, Aaryani PhD. The University of Memphis. August 2017. Towards
Accurate Automated MRI Based R2* Measurements of Hepatic Iron Content. Major Professor:
Claudia M. Hillenbrand, PhD.
Hepatic iron overload is a severe complication in patients receiving chronic blood transfusions
for sickle cell disease, beta-thalassemia, and myelosuppression during chemotherapy. Accurate
assessment of hepatic iron content (HIC) is thus paramount to quantify excessive iron
accumulation and to monitor response to iron removal treatment. Needle biopsies are considered
the reference standard to measure HIC. Magnetic resonance imaging (MRI) methods based on
the effective transverse relaxation rate (R2*) have become a noninvasive alternative to measure
HIC. R2* estimation typically involves 3 major steps - acquiring multiecho gradient echo (GRE)
images of the liver under breath-hold, fitting a mono-exponential signal model to quantify R2*,
and manually excluding the blood vessels from liver tissue via T2*-thresholding to estimate
mean liver R2*. However, there are challenges such as respiratory motion, presence of fat, and
manual extraction of liver parenchyma that affect each of these steps respectively, and eventually
affect the accuracy, precision, and clinical workflow of R2*/HIC measurements. This
dissertation addresses these challenges by evaluating a radial free-breathing multiecho ultra-short
echo time (UTE) acquisition technique, a signal model based on Auto regressive moving average
(ARMA) modeling that incorporates fat-water separation and R2* quantification, and an
automated vessel exclusion technique for extraction of liver parenchyma to provide accurate
automated methods for MRI based R2* measurements for the assessment of hepatic iron
overload.
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Chapter 1
Introduction

1.1

Motivation

Iron overload is a severe complication in patients with increased gastrointestinal absorption of
dietary iron or on chronic blood transfusions.1-5 The body has no physiologic mechanism for
clearing excess iron, and hence, extra iron accumulates in organs, primarily the liver, and
ultimately leads to organ damage if not treated. Accurate assessment of hepatic iron content (HIC)
is paramount to quantify excessive iron accumulation and to monitor response to iron chelation
therapy. Traditionally, needle biopsy was considered the gold standard to measure HIC.6 However,
biopsies are invasive, painful, subject to sampling variation,7 and have associated risks such as
bleeding and infection.8 Alternatively, magnetic resonance imaging (MRI) methods based on the
effective transverse relaxation rate (R2*) have been used to noninvasively measure HIC. Previous
studies have shown that R2* measurements by MRI and HIC measured by biopsy are linearly
correlated, and thus HIC can be estimated from R2* using published biopsy HIC/R2* calibration
curves.9-12 Accurate assessment of R2* is therefore crucial for calculating precise HIC that guides
the iron removal therapy in iron overloaded patients.
R2* is typically measured by acquiring liver images at multiple echo times, fitting a signal
model to calculate R2*, and then extracting the liver parenchyma to estimate the mean liver R2*.
The first step for accurate R2* quantification is to use an acquisition technique that produces
diagnostic quality images and captures the true signal decay of the tissue of interest. The standard
acquisition technique for estimating liver R2* is using a multiecho gradient echo (GRE) sequence
done in a breath-hold. However, breath-holding is not possible in sedated patients especially
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children, and is problematic in patients who have difficulty holding their breath for the scan
duration. Problems in breath-holding can lead to poor image quality because of respiratory motion
artifacts and may eventually introduce errors in R2* quantification.
The second step in R2* quantification is choosing the appropriate model to fit the signal
decay. R2* is typically calculated by fitting a pure mono-exponential model to the signal decay.
However, the signal decay is not a simple mono-exponential in patients with other co-morbidities
such as hepatic steatosis, i.e. presence of fat in the liver. This is because the presence of fat
introduces oscillations in the multiecho GRE signal and using a mono-exponential model will
confound R2* measurements.
The final step in R2* quantification is extracting the liver parenchyma to calculate the mean
liver R2* that is used to estimate mean MRI based HIC. Currently, radiologists report mean liver
R2*/HIC values obtained by drawing a region of interest (ROI) outlining the whole liver area in
the acquired cross-section and then manually excluding the blood vessels from liver tissue via
T2*(=1/R2*) histogram based thresholding. Blood has higher T2* compared to iron overloaded
liver, and hence, exclusion of blood vessels from the ROI is important in producing accurate R2*
estimates of the actual liver tissue. However, T2*-thresholding is an iterative, time consuming
process that may take radiologists several minutes to complete and is susceptible to inter-rater
variability.
All the above mentioned issues with respect to image acquisition, signal model selection,
and extraction of liver parenchyma will affect the accuracy and precision, and slow down the
clinical workflow of R2* measurements. These issues will thus, lead to either inaccurate or
delayed R2*-MRI based HIC predictions that might have considerable effects on the
management of patients with iron overload.
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1.2

Objectives

This proposed research will focus on addressing the above three issues, i.e., respiratory motion
artifacts in image acquisition, signal modeling in the presence of fat, and operator dependence in
extracting the liver parenchyma, in order to improve the accuracy and optimize the current
clinical workflow of R2*-MRI based HIC assessments. The specific aims of this research are:
Aim 1: To evaluate if radial ultra-short echo time (UTE) imaging removes the need for breathholding in quantification of hepatic iron content.
Aim 2: To evaluate the performance of an Auto Regressive Moving Average (ARMA) signal
model for accurate quantification of hepatic iron content in the presence of fat.
Aim 3: To develop and evaluate an automatic vessel exclusion and parenchyma extraction
technique for assessment of hepatic iron content.

1.3

Organization of the Dissertation

The remainder of this dissertation is organized as follows:


Chapter 2 gives a general background on iron overload including the pathophysiology,
consequences, affected organs, treatment for iron removal, and various monitoring
techniques for assessment of iron overload.



Chapter 3 provides a general description of the basic concepts of MRI and presents an
overview of current MRI techniques for assessment of hepatic iron overload. This chapter
reviews the most relevant and previously proposed methods including the data acquisition,
and signal modeling algorithms for estimating R2*-MRI based HIC.



Chapter 4 provides a greater in-depth knowledge regarding the background and clinical
motivation for the specific aims of this dissertation. This chapter presents a framework
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related to how each of the specific aims addressed in Chapters 5, 6 and 7 with respect to
image acquisition, signal model selection, and extraction of liver parenchyma will improve
the accuracy and optimize the current clinical workflow of R2*-MRI based HIC assessments.


Chapter 5 illustrates the impact of motion artifacts on R2* quantification using the standard
Cartesian free-breathing GRE sequence and evaluates an alternative acquisition technique
based on radial UTE imaging to improve the image quality and subsequently the R2*
quantification under free-breathing conditions. The work in this chapter is published in the
American Journal of Roentgenology.13



Chapter 6 evaluates the performance of an ARMA signal model to provide accurate R2*
measurements in the presence of fat. This chapter presents the theoretical description of the
ARMA model, and validation of the model in constructed fat-iron phantoms and in-vivo
cases.



Chapter 7 presents the development and validation of an automatic vessel exclusion
technique for extraction of liver parenchyma, to improve the current clinical workflow in
R2*-MRI based HIC quantification by reducing interpretation time and operator input.



Chapter 8 identifies the limitations of the work presented in this dissertation and provides
insights or ideas for further development for future research.



Chapter 9 provides a summary of the work presented in this dissertation with a list of
significant findings.
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Chapter 2
Iron Overload

2.1

Normal Iron Metabolism

Iron is one of the most important elements in human metabolism. It is a transition metal that is
essential for the functioning of proteins involved in oxidative energy production, oxygen
transport and storage, mitochondrial respiration, inactivation of harmful oxygen radicals, and
DNA synthesis. Iron is bound to larger molecules, mainly hemoglobin, transferrin, and ferritin
because of the toxicity and precipitation of free iron. The total human body iron content is
approximately 3–4 grams.14 Under physiological conditions, about 80% of total iron content is
incorporated into the hemoglobin of red blood cells, myoglobin and iron-containing enzymes.
The remainder is stored in the liver, spleen and muscles, in hepatocytes and reticuloendothelial
system (RES) macrophages as ferritin.14 The daily loss of iron is small, only 1–2 mg in adults
(<0.1% of total body iron), and is replaced from dietary sources to maintain iron balance.14, 15
Figure 2.1 is a schematic of iron homeostasis, which has been redrawn from a previous
review paper.15 Iron enters the body from the diet through absorption in the proximal small
intestine. Only about 10% of available dietary iron content (~1–2 mg), corresponding to the daily
loss is absorbed every day in the duodenum and delivered through the ferroportin channel to the
blood plasma.16 Although some plasma iron is derived from dietary iron absorption, most is
derived from the recirculation of hemoglobin-derived iron from senescent red blood cells. This
process is carried out by RES macrophages in the liver, bone marrow, and spleen.15 Iron that
enters the plasma will bind to circulating protein transferrin and is mainly delivered to the bone
marrow for erythropoiesis, i.e., to build new red blood cells. Almost all cells are able to take up
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iron from transferrin via an interaction with transferrin receptor-1 found on the plasma
membrane but in a much smaller amount than red blood cells.17 Nevertheless, this small amount
of iron is essential to serve in many enzymatic reactions, particularly within the respiratory
chain. The circulating proportion of iron, bound to transferrin, is only about 0.05% of total body
iron; however, it plays an essential role in iron metabolism.16 Transferrin is involved in
transporting iron between absorption, utilization, excretion, recovery, and storage areas.18 Of
note, the human body has mechanisms to absorb, transfer and store iron but none to excrete it.

Figure 2-1. Distribution of Iron in Adults. In the balanced state, 1 to 2 mg of iron enters and
leaves the body each day. Dietary iron is absorbed by duodenal enterocytes. It circulates in
plasma bound to transferrin. Most of the iron in the body is incorporated into hemoglobin in
erythroid precursors and mature red cells. Approximately 10% – 15% is present in muscle fibers
(in myoglobin) and other tissues (in enzymes and cytochromes). Iron is stored in parenchymal
cells of the liver and reticuloendothelial macrophages. These macrophages provide most of the
usable iron by degrading hemoglobin in senescent erythrocytes and reloading ferric iron onto
transferrin for delivery to cells. Adapted and redrawn from Andrews NC. N Engl J Med 1999.
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2.2

Pathophysiology of Iron Overload

Iron overload is a serious condition in which excess iron is accumulated in the body. Iron
overload is caused by primary and/or secondary hemochromatosis. Primary (hereditary)
hemochromatosis is caused by a defect in the genes that control intestinal iron absorption from
food; the most common is the HFE gene.19 Affected patients absorb iron at 5–10 times the
normal rate (up to 10mg/day),20 leading to iron overload condition.
Secondary hemochromatosis usually is the result of another disease or condition that
causes iron overload, e.g. severe chronic hemolysis, chronic blood transfusions. Chronic blood
transfusions are used in many hematologic diseases to either supply red blood cells when there is
ineffective bone marrow erythropoiesis (e.g., thalassemia major, myelodysplastic syndromes,
Diamond-Blackfan anemia, congenital dyserythropoietic anemia) or to prevent complications of
the disease (e.g., sickle cell disease (SCD)), by suppressing the bone marrow’s production of red
blood cells or supplying functionally normal ones.21, 22 Survivors of cancer, especially those
undergoing bone marrow transplantation, may also receive numerous transfusions as part of their
treatment.23, 24 Each milliliter of transfused blood has approximately 1 mg of iron. Patients
undergoing chronic transfusions have an iron excess of 0.3–0.4 mg/kg/day, and laboratory signs
of iron overload such as high serum ferritin levels can be detected after 15–20 transfusions.2

2.3

Consequences of Iron Overload

Under normal iron conditions, apotransferrin (transferrin without bound iron) exists in excess,
with only 30% of the binding sites carrying iron to the bone marrow, liver, and other tissues.
With iron overload, transferrin saturation increases and may even reach 100%. Elevated
transferrin saturation is detected by the liver, which secretes a counter-regulatory hormone called
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hepcidin. Hepcidin acts by inhibiting intestinal iron absorption and iron release from hepatic
stores and from macrophages recycling senescent erythrocytes.25 Hepcidin production is also
suppressed in some patients with hereditary hemochromatosis leading to increased iron
absorption and iron overload.25 With chronic transfusions, RES (primarily in the liver) can no
longer retain all the extra iron. Iron then enters plasma in amounts that exceed the transport
capacity of circulating transferrin. As a consequence, non-transferrin-bound iron (NTBI) appears
in the plasma, and eventually leads to uncontrolled loading of organs, primarily liver, heart and
endocrine organs.26

Figure 2-2. The pathways of iron uptake and distribution in parenchymal cells that load
nontransferrin bound iron (NTBI) (e.g. hepatocytes or cardiac myocytes) under conditions of
iron overload are shown in red, together with potential targets for chelation therapy. In the
absence of iron overload, iron is taken into cells by transferrin. Under conditions of iron
overload, plasma NTBI species are taken into cells that express voltage-dependent calcium
channels (VDCC). Iron from either uptake mechanism enters a labile pool that, if too large, can
generate free radicals and damage organelles or load into ferritin molecules. If ferritin levels are
high over a sufficiently long period of time, the ferritin molecules will be converted into ironinsoluble aggregates of hemosiderin deposits leading to tissue damage. Adapted from Porter JB,
et al. Am J Hematol. 2007.
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NTBI is highly toxic as it can enter the cells via unregulated pathways, increasing the
labile cell iron (LCI) content. High levels of LCI can lead to organ damage by two mechanisms
as shown in Figure 2-2.27 First, LCI (Fe3+ and Fe2+) can react with reactive oxygen intermediates
(𝑂2−̇ and H2O2) produced by respiration or by other incomplete reductions of O2 and form
noxious HO· radicals (Haber-Weiss cycle) by Fenton reaction:28
𝐹𝑒 3+ + 𝑂2−̇ → 𝐹𝑒 2+ + 𝑂2

(2.1)

𝐹𝑒 2+ + 𝐻2 𝑂2 → 𝐹𝑒 3+ + 𝑂𝐻 − + 𝐻𝑂 .

(2.2)

Sustained levels of LCI lead to the generation of reactive oxygen species (i.e., HO· radicals)
resulting in damage to lipids, proteins, DNA, and subcellular organelles, including lysosomes
and mitochondria. The damage, if sustained, leads to progressive fibrosis and organ dysfunction.
Second, excess LCI can load into ferritin molecules for storage within cells, primarily
hepatocytes and RES macrophages. Ferritin is the principal iron storage molecule found in cells.
It is a globular protein complex about 10 nm in diameter composed of 24 subunits arranged as a
hollow shell (apoferritin) in which iron atoms can be packed. A typical ferritin molecule contains
about 2000 iron atoms at its core, but potentially may hold up to 4500.29 Pores are present on the
surface of the complex allowing iron atoms to enter and be released from the core. In this
manner, ferritin is able to regulate levels of intracellular iron. The iron in ferritin is readily
available to meet physiologic needs. Ferritin is typically not visible on Perls iron stain, but
occasionally ferritin is seen as a diffuse blue blush in the hepatocyte cytoplasm. However, if
ferritin levels are high over a sufficiently long period of time, hemosiderin deposits can develop.
Hemosiderin consists of conglomerates of clumped ferritin particles, denatured proteins, and
lipids. In contrast to the iron stored as ferritin, the iron in hemosiderin deposits is insoluble and
not readily available for biologic needs. Hemosiderin appears as granular, golden brown
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cytoplasmic deposits on hematoxylin and eosin (H&E) stain and as blue deposits on Perls iron
stain as shown in Figure 2-3. During iron overload, aggregates of hemosiderin molecules are
deposited in body tissues reaching sizes as large as 1-2 μm eventually causing tissue damage and
dysregulation of function.

Figure 2-3. Hemosiderin deposits shown in the liver biopsy samples using H&E stain (A) and
Perls iron stain (B) in a severely iron overloaded patient with biopsy iron content of 16.5 mg
Fe/g. Iron deposits are seen as brown granules in the cytoplasm of the Kupffer cells (i.e., RES
macrophages of liver) and hepatocytes on the H&E stain and as blue pigment on Perls iron stain.

2.4

Target Organs

Excess iron accumulates in nearly all tissues, but most notably in the liver, heart, thyroid,
kidneys, spleen, pituitary gland, and pancreas. Clinical manifestations depend on the pattern and
severity of organ involvement, which in turn depend on the route and cause of the iron
overload.30 Frequent manifestations include liver damage, cardiac disease, and endocrine
dysfunction. Iron overload can also result in arthropathy, neurodegenerative disorders,
hyperpigmentation, pulmonary hypertension, and carcinogenesis.26
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2.4.1 Liver
The liver is a central organ in regulating iron homeostasis. The liver performs three essential
functions in maintaining systemic iron homeostasis: 1) It is the major site for production of
proteins that maintain systemic iron balance such as transferrin, ferritin and hepcidin, 2) It is a
major storage site for excess iron, and 3) It mobilizes iron from hepatocytes to the circulation to
meet metabolic requirements.31 Dysregulation of the liver's ability to maintain balance of these
three functions leads to iron-related disorders.
Liver is also one of the main target organs in iron overload. During conditions of excess
iron, the liver increases iron storage and protects other tissues, namely the heart and pancreas
from iron-induced cellular damage. The liver stores excess iron in hepatocytes and
reticuloendothelial Kupffer cells, as ferritin and hemosiderin, in order to keep iron more soluble
and in a non-toxic form. However, a chronic increase in liver iron stores results in excess
reactive oxygen species production and liver injury. The degree of liver dysfunction is directly
dependent on the amount of hepatic iron deposition. Progressive iron accumulation eventually
leads to hepatomegaly, liver synthetic abnormalities, fibrosis, and finally, cirrhosis and liver
failure.32-35 Also, the risk of developing hepatocellular carcinoma increases significantly in
patients with cirrhosis secondary to iron overload.36

Iron storage
The distribution of iron in the liver within hepatocytes or reticuloendothelial storage areas
depends on different pathophysiologic mechanisms of iron accumulation and has relevant
implications for organ damage. In fact, it is well documented that organ damage is related to the
amount of iron present in the parenchymal cells (i.e., hepatocytes), whereas iron within RES
cells appears to be relatively innocuous.37 In transfusional iron overload, most liver iron is
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initially deposited in hepatic RES, particularly the Kupffer cells, while the hepatocyte
compartment is largely spared.37 With continued transfusions, iron eventually accumulates in
hepatocytes, increasing the risk of liver injury with hepatocyte damage, synthetic dysfunction,
fibrosis, and eventually cirrhosis.2, 34 In contrast, for hereditary hemochromatosis, the iron
deposition first occurs in hepatocytes, and Kupffer cells are typically spared until later stages.20

Liver Histology and Vasculature
The liver is the largest internal organ, in adults averaging about 1.5 kg or 2% of the body
weight.38 Anatomically, the liver is divided into a larger right lobe and a smaller left lobe by the
falciform ligament. Functionally, the liver is divided into eight independent functional segments
based on the distribution of blood supply, with each segment having its own independent
vascular and biliary branches. Each segment of the liver is further divided into lobules as shown
in Figure 2-4. Lobules are the basic functional units of liver and consists of discrete hexagonal
aggregations of hepatocytes, and sinusoids. The hepatocytes are the functional liver cells and are
assembled as plates which radiate from a central vein within each lobule. Sinusoids are vascular
channels (acting as capillaries) between plates of hepatocytes. Sinusoids receive blood from
portal triads, which comprise of branches of portal vein, hepatic artery and bile duct (Figure 2-4).
The blood mixes, passes through the sinusoids, bathes the hepatocytes and drains into the central
vein.
Kupffer cells are reticuloendothelial cells that reside in the liver sinusoids and scavenge
damaged RBCs and bacteria as they pass through. Kupffer cells, like other reticuloendothelial
macrophages, lyse RBCs into heme and globin. Globin is further catabolized into polypeptide
components for reuse. Heme is broken into biliverdin and iron. Biliverdin is converted to
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bilirubin. Iron is transported by transferrin to the liver and spleen for storage and to the bone for
hematopoiesis.

Figure 2-4. Liver Structure and Histology. The liver is composed of thousands of polygonal
structures called hepatic lobules, which are the basic functional units of the organ. (a) Diagram
showing a small central vein in the center of a hepatic lobule and several sets of blood vessels at
its periphery. The peripheral vessels are grouped in connective tissue of the portal tracts and
include a branch of the portal vein, a branch of the hepatic artery, and a branch of the bile duct
(the portal triad). (b) Both blood vessels in this triad branch as sinusoids, which run between
plates of hepatocytes and drain into the central vein. (c) Micrograph of a lobule shows plates of
hepatocytes, and components of the portal triad: a portal venule, hepatic arteriole, and bile
ductule. (X220; H&E). Source: Mescher AL. Junqueira's Basic Histology, 14e; 2016.38

The liver is a very vascular organ and at rest receives about 25% of total cardiac output.
The liver has a unique dual blood supply; it receives blood both from the proper hepatic artery,
which contributes 25% to 30% of the blood supply, and from the portal vein, which is
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responsible for the remaining 70% to 75%. The arterial and portal blood ultimately mixes within
the hepatic sinusoids before draining into the systemic circulation via the hepatic venous system.
Figure 2-5 shows the vasculature of the liver with vessels comprising of different sizes.
The normal mean diameter of the portal vein is 11 ± 2 mm,39 and the diameter typically increases
in patients with portal hypertension. The mean diameter of the proper hepatic artery ranges
between 2 – 4.5 mm.40 The proper hepatic artery bifurcates into right and left hepatic arteries
with mean diameters ranging from 2 – 3.6 mm.40 The hepatic vein is composed of three major
tributaries: right, middle and left, each again having several intrahepatic branches. The mean
diameter of the right hepatic vein ranges from 15 – 25 mm.41 The mean diameters of the middle
and left hepatic veins were usually smaller than the right, ranging from 10 – 15 mm and 10 – 20
mm, respectively.41 In adults, the mean diameter of the normal common hepatic duct, as
measured by ultrasound, is less than 5 mm.42

Figure 2-5. Liver vasculature. The liver receives blood supply from two sources. The first is the
hepatic artery which delivers oxygenated blood from the general circulation. The second is the
hepatic portal vein delivering deoxygenated blood from the small intestine containing nutrients.
14

The blood from both the sources mix in the sinusoids, and flow to the hepatocytes. The
exchanged blood drains into the central vein and finally leaves the liver via the hepatic vein. The
common hepatic duct is part of the biliary tract that transports bile from the liver into the
intestines. Source: http://humananatomychart.us/category/human-body/

2.4.2 Heart
The loading of iron in the heart is slower than in the liver, and cardiac dysfunction related to iron
overload usually appears after years of exposure.26 Cardiac disease caused by transfusional iron
overload remains the principal cause of death in patients with thalassemia major.43 Myocardial
hemosiderosis can also occur in other hematologic diseases treated with repeated blood
transfusions, such as Diamond-Blackfan anemia, and less frequently in SCD. The severity of
cardiac disease depends on the amount of iron deposited in individual myocardial fibers and the
number of fibers affected. Persistently increased intracellular labile iron in cardiac tissue
diminishes the contractility of cardiomyocytes and can lead to myocarditis, pericarditis, and
atrial/ventricular arrhythmias.26

2.4.3 Endocrine organs
Endocrine dysfunction is common in thalassemia major patients with iron overload. Patients
younger than 10 years of age often experience growth failure. Diabetes mellitus can develop
when iron deposition in the interstitial pancreatic cells affects the microcirculation, leading to
insulin deficiency. Pituitary dysfunction results in a plethora of conditions, including
hypogonadism, and reduced parathyroid activity.26
Hence, iron overload, if not treated effectively, has serious clinical consequences resulting
in significant morbidity and mortality.
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2.5

Treatment of Iron Overload

The treatment of iron overload is based on its cause, severity, and organ involvement. The
primary treatment for patients with hereditary hemochromatosis is life-long therapeutic
phlebotomy (regular extractions of about 500 ml of blood), which aims to remove excess iron
and prevent iron mediated tissue damage.30, 44 Phlebotomy is initially performed weekly, with
longer intervals between sessions once hemoglobin levels decrease or an acceptable body iron
content is achieved. Liver fibrosis may regress in response to therapy, and life expectancy may
return to that of a normal person.30, 45, 46
Iron overload in patients with transfusion-dependent anemias cannot be treated by
phlebotomy. Instead, these patients are treated with chelation therapy.47, 48 In chelation therapy,
patients are treated with chelators that bind to excess iron and facilitate its removal from the
body. Currently, two chelating agents are approved for use in North America: parenteral
deferoxamine mesylate (Desferal, Novartis) and oral deferasirox (Exjade, Novartis).49 The aim of
therapy is to maintain total body iron at a level sufficiently low to prevent or even reverse iron
toxicity while simultaneously minimizing treatment side effects.30 Hence, close monitoring of
iron levels is crucial for both phlebotomy and chelation therapy to maintain sufficiently low body
iron levels while minimizing treatment side effects.

2.6

Monitoring Iron Overload

Monitoring of body iron loading and unloading is therefore obligatory in the management of
iron-overloaded patients for initiating and guiding the response to therapy and also for adjusting
the dose and intensity of chelation.50-52 Hepatic iron content (HIC) correlates significantly with
total body iron stores and is considered to be a reliable marker for assessment of iron
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overload.44,53 The liver accounts for more than 70% of somatic iron stores (even more in
splenectomized patients). HIC tracks net iron balance in both chelated and non-chelated patients.
Body iron stores are predicted from HIC using the formula:44
𝑇𝑜𝑡𝑎𝑙 𝑏𝑜𝑑𝑦 𝑖𝑟𝑜𝑛 (𝑚𝑔⁄𝑘𝑔) = 10.6 × 𝐻𝐼𝐶(𝑚𝑔 𝐹𝑒 ⁄𝑔 𝑑𝑟𝑦 𝑤𝑒𝑖𝑔ℎ𝑡)

(2.3)

Normal HIC values are up to 1.2 mg Fe/g dry weight, and levels up to 7 mg/g dry weight (mild
iron overload) are seen in some patient populations without apparent adverse effects.54 Patients
with HIC levels >7 mg Fe/g (moderate iron overload) are associated with increased risk of
hepatic fibrosis and diabetes mellitus and >15 mg Fe/g (severe iron overload) have greatly
increased risk for cardiac disease and death in unchelated patients. Chelation therapy effectively
maintains or reduces liver iron levels. The dose of the chelating agent is primarily determined by
the HIC levels and the daily transfusion intake and an optimal maintenance level for chelation
therapy is HIC<3 mg Fe/g.49 Hence, monitoring HIC is very essential for initiating and guiding
the response to therapy and also for adjusting the dose and intensity of chelation to avoid the
deleterious effects associated with excess chelation.50-52 Various tools have been defined for
assessment of iron overload and are described below.

2.6.1 Monitoring transfusion burden
Each unit of blood transfusion contains about 250 mg of iron. Based on this, the transfusional
iron intake can be calculated from hematocrit (Hct) using the following relationship:
𝑇𝑟𝑎𝑛𝑠𝑓𝑢𝑠𝑖𝑜𝑛𝑎𝑙 𝑖𝑟𝑜𝑛 𝑖𝑛𝑡𝑎𝑘𝑒 (

𝑚𝑔
𝑚𝑙
𝑚𝑔
) = 𝐵𝑙𝑜𝑜𝑑 𝑣𝑜𝑙𝑢𝑚𝑒 ( ) × 𝐻𝑐𝑡 × 1.08 ( )
𝑘𝑔
𝑘𝑔
𝑚𝑙

(2.4)

where Hct is calculated from the transfusion units provided by the blood bank.55 If no chelation
is taken, this transfusional iron intake in 1 year can be converted into predicted HIC change
using the following equation:44
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∆𝐻𝐼𝐶 (

𝑚𝑔
) = 𝑇𝑟𝑎𝑛𝑠𝑓𝑢𝑠𝑖𝑜𝑛𝑎𝑙 𝑖𝑟𝑜𝑛 𝑖𝑛𝑡𝑎𝑘𝑒/10.6
𝑔

(2.5)

Thus, patients placed on chronic transfusions accumulate iron at very predictable rates.56 As a
rule of thumb, each transfusion of 15 ml/kg (assuming Hct of ~70%) will raise HIC by
approximately 1 mg/g dry weight.55, 57 Therefore, tracking transfusional iron exposure is clearly
useful in deciding when to initiate chelation therapy.58 However, once iron chelation has started,
intersubject variability in chelator efficacy and patient compliance limit the usefulness of
monitoring transfusion burden.55

2.6.2 Serum markers
Serum ferritin
Serum ferritin (SF) is considered as an indirect measure of iron overload. Ferritin is primarily an
intracellular protein produced to protect cells from labile intracellular iron.59 Most ferritin is
present in liver, spleen, and bone marrow, and only a trace amount is found in the blood as serum
ferritin. Although the biological role of SF is still not clear, it is the most convenient and widely
used laboratory test to estimate body iron stores across the world.57
The normal range for SF levels is 10 – 220 µg/L in males and 10 – 85 µg/L in females.14
Patients with low SF values less than 12 µg/L are usually representative of one condition; i.e.,
body iron deficiency. On the other hand, patients with SF levels that are higher than the normal
range may be indicative of several conditions such as iron overload, inflammation, infection,
collagen disease, and malignancy (Table 2-1).14 Further, as the liver is the major source of
circulating SF, even minor liver insults will sharply increase SF levels.57, 60 It is found that
ascorbate deficiency, in contrast, leads to inappropriately low SF values relative to iron stores.61
Because of these reasons, the relationship between SF and total body iron stores is complicated.
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SF levels correlate poorly with HIC measurements, and hence, important therapeutic decisions
should not be based solely on SF levels.62, 63 Serial SF measurements may provide a general idea
of the degree of iron overload. However, there is also evidence that SF trends can under- or
overestimate the total iron body content, significantly and dangerously compromising adequate
medical management of iron overload.64-66 Despite these limitations, SF remains the primary
means of diagnosis for iron overload because of its low cost and universal availability.57

Table 2-1: Considerations needed to use serum ferritin as a biological marker for the evaluation
of body iron store. (Adapted from Kohgo et al. 2008)14
Serum ferritin levels
Disease conditions
Slight elevation (250 – 500 µg/L)

Malignancies, chronic liver damage, chronic
inflammation, mild iron overload

Mild elevation (500 – 1000 µg/L)

Early stage of iron overload, ineffective
erythropoiesis (thalassemia, etc)

Moderate elevation (1000 – 5000 µg/L)

Iron overload, Adult Still’s disease,
hemophagocytic syndrome

Severe elevation (> 5000 µg/L)

Iron overload (hemochromatosis)

Transferrin saturation
Transferrin saturation (TSAT) is also an important and widely available serologic marker of iron
balance. TSAT is the percentage of transferrin that is saturated with serum iron. Two
components are needed to estimate TSAT: serum iron and total iron-binding capacity (TIBC)
and is calculated as follows:67
𝑇𝑟𝑎𝑛𝑠𝑓𝑒𝑟𝑟𝑖𝑛 𝑠𝑎𝑡𝑢𝑟𝑎𝑡𝑖𝑜𝑛 (𝑇𝑆𝐴𝑇) =

𝑆𝑒𝑟𝑢𝑚 𝑖𝑟𝑜𝑛
× 100
𝑇𝑜𝑡𝑎𝑙 𝑖𝑟𝑜𝑛 − 𝑏𝑖𝑛𝑑𝑖𝑛𝑔 𝑐𝑎𝑝𝑎𝑐𝑖𝑡𝑦 (𝑇𝐼𝐵𝐶)

TSAT is mainly used in the recognition and risk stratification of primary
hemochromatosis disorders.68 It is also a useful metric for deciding when to initiate iron
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(2.6)

chelation therapy in patients on chronic transfusions.58 However, this technique has several
limitations. Firstly, transferrin saturation cannot be accurately assessed in the presence of
circulating chelator, so patients must hold their iron chelation for 24 hours before their blood
draw, limiting the practicality of frequent monitoring by this method.57 Secondly, many
chronically transfused patients have fully saturated transferrin, making it uninformative for shortterm and mid-term assessment of chelation efficiency.57 The presence of circulating NTBI
increases dramatically once TSAT exceeds 85%.69 Thus, desaturating transferrin to less than
85% is a reasonable long-term target for iron chelation therapy in transfusional iron overload.
Thirdly, several other conditions such as infection, inflammation, malignancy, and chronic
disease may affect TSAT through modulating the rate of transferrin synthesis.67 Transferrin
levels are also altered in diseases with hepatocellular damage. Therefore, care must be taken
when interpreting TSAT results if concomitant liver diseases such as alcoholic liver disease and
liver cirrhosis are present.67

NTBI
NTBI is a potential biomarker of iron overload assessments because it is directly responsible for
parenchymal iron loading and toxicity. It can be directly measured using high-pressure liquid
chromatography.70 Alternatively, labile plasma iron (LPI) which is the redox active component
of NTBI, can be measured using fluorescent labels.71 However, both these measurements suffer
from three important limitations. Firstly, the assays are incompletely validated and the results
differ considerably between assay methods.56, 72 Secondly, there is only limited data supporting
elevated NTBI or LPI levels with adverse clinical outcomes.56 Lastly, all labile iron metrics
reflect a short time horizon, making them vulnerable to dietary iron, acute inflammation and

20

recent chelator administration.56 Thus, more clinical evidence is needed before these metrics can
be recommended for routine monitoring purposes.

2.6.3 Liver biopsy
The current gold standard to quantify iron overload is by measuring HIC directly in liver biopsy
specimens using atomic absorption spectrophotometry.73 However, atomic absorption
spectrophotometry for HIC quantification is available only at specialized centers. Moreover, the
specimens treated with this technique cannot be used for histologic evaluation.30
Iron deposition in biopsy specimens can also be evaluated histologically on a semiquantitative scale based on Prussian Blue staining of iron granules. The most commonly used
scoring system is described in Rowe et al,74 which is based on detection of iron granules and the
magnifications at which discrete granules are resolved. The method uses a 5 point grading scale:
grade 0 = granules absent/barely discernible at ×400 power, grade 1+ = iron granules barely
discernible (×250); grade 2+ = discrete iron granules resolved (×100); grade 3+ = discrete
granules resolved (×25); grade 4+ =masses visible (×10 or grossly visible). This method has been
shown to correlate with quantitative HIC measurements.
Liver biopsy suffers from two major limitations, regardless of whether biopsy specimens
are analyzed quantitatively by spectrophotometry or semiquantitatively by histology. Firstly, the
small size of the biopsy core lacks information on spatial distribution and causes high sampling
variability in liver biopsy measurements at 12-15% overall, and up to 40% among patients with
cirrhosis and heterogeneous iron deposition.75, 76 Secondly, the invasiveness of biopsy is a
limitation for all patients due to pain, bleeding, and infection,6 in turn leading to suboptimal
patient adherence. Further, annual or more frequent assessments of iron overload are necessary
to guide iron removal therapy, making biopsy impractical. Thus, there is a clinical need for
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accurate, precise and noninvasive techniques for proper medical management of iron overloaded
patients.

2.6.4 Non-invasive techniques
SQUID
Magnetic susceptibility of the liver can be measured noninvasively using a superconducting
quantum interference device (SQUID), which was among the first non-invasive techniques to
quantify liver iron.77, 78 Magnetic susceptibility is a fundamental property of tissues, and is
determined by the induced magnetic field generated by the tissue in response to an externally
applied magnetic field. Normal liver tissue is diamagnetic and has susceptibility close to that of
the water; but in the presence of iron, the susceptibility of liver tissue is modified. This is
because iron clusters in the form of ferritin and hemosiderin are paramagnetic, producing an
induced magnetic field in the same direction as the applied field, and with strength about four
orders of magnitude smaller than the applied field. This paramagnetic change in susceptibility
introduced by the presence of iron can be modeled as a linear function of the iron
concentration.79, 80 Thus, measurement of liver susceptibility can enable quantification of liver
iron.
Previous studies have demonstrated that SQUID measurements show excellent
correlation with biopsy-determined HIC.81 However, its complexity, high cost, limited
availability (only four instruments in the whole world), and challenges of measuring liver
susceptibility in obese patients with large amount of subcutaneous fat have precluded the
widespread clinical implementation of SQUID.77, 82
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Ultrasound
Iron deposition is not detectable on ultrasound and thus ultrasound has no clinical role in the
measurement of hepatic iron overload. However, ultrasound can be used to assess the sequelae of
liver injury related to iron overload, such as cirrhosis, hepatic cell carcinoma, and portal
hypertension.30

Computed Tomography (CT)
Hepatic iron overload increases the overall attenuation of liver on CT images because iron
increases the absorption of X-rays. Previous studies have shown that CT can detect iron
overload qualitatively.83, 84 However, it was found that increased attenuation in the liver is not
specific to iron overload. Several confounding factors, including steatosis, glycogen deposition,
Wilson’s disease, as well as certain drugs (eg, amioradone or gold) may alter liver attenuation.82
Recent studies have shown that dual-energy CT may be able to provide improved assessment of
liver iron even in the presence of steatosis.82, 85 However, limited validation studies in humans,
poor sensitivity in patients with low iron loads, and exposure to ionizing radiation makes CT not
a good choice for frequent monitoring of iron overload.

Because of the limitations of above mentioned techniques, and due to the radiation-free
nature and widespread availability of magnetic resonance imaging (MRI) scanners, significant
efforts have been made to assess liver iron overload using MRI based methods, which are
explained in detail in the next chapter.
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Chapter 3
Magnetic Resonance Imaging for Assessment of Hepatic Iron Content

3.1

Basic MRI Concepts

Magnetic resonance imaging (MRI) is a noninvasive diagnostic method used to investigate the
internal anatomy and the physiology of living organisms. MRI is based on the phenomenon of
nuclear magnetic resonance (NMR), whereby atomic nuclei exposed to a strong magnetic field
absorb and reemit electromagnetic waves at a characteristic or ‘resonant’ frequency, which falls
in the radio frequency (RF) range. This NMR phenomenon was first described by Felix Bloch 86
and Edward Purcell,87 who both received the Nobel Prize in Physics in 1952 for their discovery.
The first MR image using linear magnetic field gradients was reported by Paul Lauterbur in
1973.88, 89 This section contains a brief introduction to the basic principles necessary for
understanding MRI.

3.1.1 Nuclear Magnetic Resonance
Nuclear Magnetization
All matter, including the human body, is made up of atoms. Atoms consist of a central nucleus
and orbiting electrons. The atomic nucleus is made up of positively charged, protons and
electrically neutral, neutrons. Nuclei with unpaired protons or neutrons exhibit net spin or
angular momentum. According to the laws of electromagnetic induction, nuclei with net charge
and spin acquire a magnetic moment and align with an external magnetic field. These nuclei act
similarly to tiny magnets and are considered as MR active nuclei. Some examples of MR active
nuclei are 1H, 13C, 15N, 17O, 19F, 23Na and 31P. 1Hydrogen is the (stable) isotope with the largest
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magnetic moment and is the most abundant isotope in the human body. 1H atoms are, therefore
the principal MR active nuclei used in clinical MRI.
In the absence of an external magnetic field, the magnetic moments of the 1H nuclei are
randomly oriented. However, when a sample containing 1H atoms is placed in an external
magnetic field (B0), the magnetic moments align parallel or anti-parallel to the magnetic field.
Nuclei aligned parallel to the field are in a low energy state and nuclei aligned anti-parallel are in
a high energy state. The relative distribution between the two levels depends on the thermal
energy level of the nuclei (i.e. temperature) and the strength of the external magnetic field. In
thermal equilibrium, there are always more low-energy nuclei (Nup) than high-energy nuclei
(Ndown) and hence they produce a net nuclear magnetization (M0) in the direction of B0 as shown
in Figure 3-1.The resultant distribution between these two energy levels is given by the
Boltzmann distribution:
𝑁𝑢𝑝
= 𝑒 −(∆𝐸⁄𝑘𝑇)
𝑁𝑑𝑜𝑤𝑛

(3.1)

where ΔE is the energy difference between the two levels (ΔE = h × ω; h (Planck’s constant) =
6.62 × 10-34 J s; ω is the Larmor frequency); k is the Boltzmann constant (k = 1.3181 × 10-23 J K1

); and T is the absolute temperature (Kelvin).

Larmor Frequency
The hydrogen nuclei will precess around B0 at the Larmor frequency ω0 , given by the Larmor
equation:
𝜔0 = 𝛾𝐵0
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(3.2)

where γ is the gyromagnetic ratio expressed in MHz/T and B0 is the external magnetic field
expressed in Tesla (T). Each isotope has a unique gyromagnetic ratio (e.g. 1H: 42.57 MHz/T) and
so has a distinct precessional frequency at the same field strength.

Figure 3-1. Nuclear Magnetization. In thermal equilibrium, slightly more spins are aligned
parallel to B0 and form the macroscopic nuclear magnetization M0 along B0.

Magnetic Resonance
Resonance is a phenomenon that occurs when an object is exposed to an oscillating perturbation
that has a frequency close to its natural frequency or harmonics of its natural frequency of
oscillation. This phenomenon is important in MRI for producing a detectable MR signal.
At equilibrium, the net nuclear magnetization M0, is aligned with the direction of the
external magnetic field B0, which is usually taken as the z-axis as shown in Figure 3-1. So, at
equilibrium, no torque, and hence no rotation of the magnetization vector occurs. If, however,
M0 is rotated into the x-y, or “transverse” plane, it will precess about the external magnetic field
B0 and produce an oscillating magnetic field. According to Faraday’s laws of induction, if any
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receiver coil is placed near such oscillating magnetic field, a voltage is induced in this receiver
coil that can give rise to an MR signal. The frequency of this signal is the same as the Larmor
frequency and the magnitude of the signal depends on the amount of transverse magnetization.
Thus, in order to produce a detectable MR signal, the nuclear magnetization M0 must be
tipped away from the longitudinal axis, so that it produces a finite component in the transverse
plane. This tipping is done with a resonant RF pulse, one that is applied at exactly the Larmor
frequency of hydrogen.

RF Excitation
The application of an RF pulse that causes resonance is termed RF excitation. The angle to
which the magnetization vector M0 is tipped away by applying a rectangular RF pulse B1 for the
duration Δt as illustrated in Figure 3-2 is called flip angle (α) given by:
𝛼 = 𝛾 𝐵1 ∆𝑡

(3.3)

The longer the pulse duration Δt or the stronger the applied field B1 the greater is the flip angle.
For example, a 90o flip angle transfers the longitudinal magnetization Mz= M0 completely into
the transverse plane and hence produces the largest transverse magnetization Mxy= M0.
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Figure 3-2. RF excitation. (A) In presence of the main magnetic field B0, the magnetization
vector M0 is aligned parallel along the z axis and contains a longitudinal magnetization
component (MZ) only. (B) When a radio frequency (RF) pulse with a flip angle α is applied, it
tips M0 at an angle α into the xy plane producing a transverse magnetization component Mxy.

Bloch Equations
The Bloch equations, introduced by Felix Bloch,86 are a set of coupled differential equations
which can be used to describe the behavior of a magnetization vector under any conditions.
These macroscopic equations are used to calculate the nuclear magnetization M = (Mx, My, Mz)
as a function of time when relaxation times T1 and T2 (described in next section) are present.
These equations when properly integrated will yield the x, y, and z components of magnetization
as a function of time.

𝑑𝑀𝑥
𝑀
⃗⃗ × 𝐵
⃗) − 𝑥
= 𝛾(𝑀
𝑥
𝑑𝑡
𝑇2
𝑑𝑀𝑦
𝑀
⃗⃗ × 𝐵
⃗) − 𝑦
= 𝛾(𝑀
𝑦
𝑑𝑡
𝑇2
𝑑𝑀𝑧
𝑀 − 𝑀0
⃗⃗ × 𝐵
⃗) − 𝑧
= 𝛾(𝑀
𝑧
𝑑𝑡
𝑇1
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(3.4)

Relaxation Mechanisms
When the RF pulse is switched off, the perturbed magnetic moments try to retain their thermal
equilibrium, i.e. the magnetization vector MZ realigns with B0 by losing energy given to the
atoms, by the RF pulse. The process by which the spin system loses this energy to return to the
low energy state is called relaxation. Two processes occur during relaxation (Figure 3-3): (i) T1
recovery: recovery of the longitudinal magnetization, (ii) T2 decay: decay of the transverse
magnetization.

M
ω

xy

0

Figure 3-3. Relaxation. When the excitation field B1 is turned off, the transverse magnetization,
Mxy, continues to rotate about B0 at the Larmor frequency, producing an oscillating magnetic
field that can be detected with a radio frequency coil. However, simultaneously the spins
undergo longitudinal relaxation and realign again towards B0.90

T1 recovery
T1 recovery is caused by the spins giving up their energy to the surrounding environment or
crystal lattice to recover their longitudinal magnetization Mz. This process is also called spinlattice relaxation or longitudinal relaxation and is illustrated in Figure 3-4. The rate of T1
recovery can be derived as a solution to the Bloch equation as:
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𝑀𝑧 (𝑡) = 𝑀𝑜 (1 − 𝑒 −𝑡⁄𝑇1 )

(3.5)

where T1 is the recovery time constant called the T1 relaxation time. This is the time it takes for
63% (= (1- e-1)) of the longitudinal magnetization Mz to recover.

Figure 3-4. T1 recovery: After the 90º RF pulse, the transverse magnetization is at its maximum,
the longitudinal magnetization is zero. Through spin-lattice relaxation, the longitudinal
magnetization begins to recover. The time it takes for 63% of the maximum longitudinal
magnetization to recover is known as the T1 relaxation time. Figure adapted from Bushberg et al.
2002.91

T2 decay
T2 decay is caused by loss of coherent transverse magnetization due to interaction of spins with
each other. This spin interaction induces intrinsic (microscopic) field fluctuations that result in
decay of transverse magnetization. So, this process is also called spin-spin relaxation or
transverse relaxation and is illustrated in Figure 3-5. The rate of T2 decay can also be derived
as a solution to the Bloch equation as:
𝑡

𝑀𝑥𝑦 (𝑡) = 𝑀𝑜 𝑒 − ⁄𝑇2
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(3.6)

where T2 is the decay time constant called the T2 relaxation time. This is the time it takes for the
signal to decay to 37% (=1/e) of the maximum transverse magnetization Mxy.

Figure 3-5. T2 decay. Spin-spin interactions create a loss of phase coherence resulting in a faster
decay of the transverse magnetization (solid line). Additional external field inhomogeneities
cause an even faster loss of phase coherence and a faster signal decay. This is refered to as T2*
relaxation (dashed line). Figure adapted from Bushberg et al. 2002.91

In addition to intrinsic inhomogeneities, dephasing also occurs due to external
(macroscopic) field (Bo) inhomogeneities and due to differences in magnetic susceptibility
among the tissues, which is characterized by T2’. This further shortens the coherence time of the
transverse magnetization T2 to a value denoted by T2*, called the T2* relaxation time as shown
in Figure 3-5 and the equation:
1
1
1
=
+
∗
𝑇2
𝑇2 𝑇2′

(3.7)

MR Imaging
The basis for MR imaging is the MR signal emanated from a probe due to the induction of
transverse magnetization by applying an external RF signal. Once the RF signal is switched off,
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the nuclei undergo the relaxation process as explained above. During relaxation, the nuclei lose
energy by emitting their own RF signal. This signal is referred to as the free-induction decay
(FID) signal and is measured using a receiver coil (Figure 3-6).

Figure 3-6. Free induction decay. When the RF pulse is turned off, the nuclei undergo transverse
relaxation, causing a gradual attenuation of the signal in the receiver coil, known as free
induction decay.90

The initial amplitude of the FID signal is determined by the portion of the magnetization
vector (M0) that has been tipped onto the XY plane. This, in turn, is determined by the flip angle,
α and is given by:
𝑀𝑥𝑦 = 𝑀0 sin𝛼

(3.8)

The rate of signal decay is determined by the T2* relaxation time as shown in Figure 3-6.

3.1.2 Spatial localization
In MRI, spatial localization is necessary in order to incorporate positional information to the
measured volume. The spatial localization is accomplished in MRI by applying spatially varying
linear magnetic fields.88 Based on the Larmor equation, a spatially variant magnetic field will
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lead to a spatially variant distribution of resonant frequencies. Since magnetization from the
entire object induces signal changes in the receiver coil, the received signal now contains a
spectrum of signals. Frequency analysis can then be used to discriminate between different
spatial locations based on the spatial distribution of magnetic field strength. Typically, specially
designed gradient coils are used to induce an additional magnetic field that varies linearly with
spatial location. Three gradient coils, as described below are used to spatially localize the points
along three arbitrary axes in space (Figure 3-7).

Slice Selection
In a 2D acquisition, the first step is the slice selection. Slice selection is performed by turning on
a linear magnetic field gradient in any desired slice direction, e.g., in z-direction (Gz), such that
the field in the z direction has the form:
𝐵(𝑧) = 𝐵0 + 𝐺𝑧 ∗ 𝑧

(3.9)

The slice selection gradient is applied simultaneously with an RF pulse of a certain bandwidth
(BW) so that the resonance frequency of the protons along the z-axis differs depending on the
field gradient and the BW of the RF pulse. For a slice perpendicular to the z-axis, the slice of
thickness Δz is given by:
𝐵𝑊 = 𝛾𝐺𝑧 ∆𝑧

(3.10)

So, only the spins within the slice of thickness Δz are rotated into the transverse plane and hence
can generate signal.
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Figure 3-7. Spatial localization in x, y and z directions is showed using a simple pulse sequence.
RF line illustrates the radio frequency pulses produced by the transmitter. The lines marked Gz,
Gy, and Gx indicate the magnetic field gradients in the slice-select, phase-encoding, and
frequency-encoding directions, respectively. TR and TE are the repetition and echo times
respectively. Figure adapted from Prasad et al. 2006.90

2D Spatial Encoding
Once the signal from the slice has been isolated, the remaining two in-plane dimensions need to
be encoded (i.e., along x and y directions in our example). The following details are for
performing 2D spatial encoding using Cartesian sampling, described in 3.1.5. To encode in one
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direction, e.g., the x-direction, a frequency encoding gradient (Gx) is applied during signal
reception and hence it is also called a readout gradient. The readout gradient causes the spins at
different positions along x to generate signal at different frequencies and is given by:
𝐵(𝑥) = 𝐵0 + 𝐺𝑥 ∗ 𝑥

(3.11)

If a Fourier transformation is applied to the resulting signal, individual frequency components
can be decomposed corresponding to their positions along the x-axis.92
To encode in the remaining y-direction, a so-called phase encoding gradient is applied for
a short period of time between the RF excitation and the signal readout, and is of the form:
𝐵(𝑦) = 𝐵0 + 𝐺𝑦 ∗ 𝑦

(3.12)

During the time that the phase encoding gradient Gy is on, spins in different rows precess at
different frequencies and accumulate phase differences, which correspond to their locations in ydirection. After Gy is switched off, the precession frequency will be the same as before, but the
phase difference remains. So, the signal cannot be spatially resolved by simply one phase
encoding step, because the superimposed signal will contain no different frequencies in ydirection. To overcome this, the phase encoding has to be repeated many times by changing Gy
in small steps, which also changes the phase and amplitude of the superimposed signal. The
number of phase encoding steps (NPE) required depends on the resolution desired along the ydirection. If Fourier transformation is done along the y direction, it gives the different frequency
components along y and hence their position.92
Applied magnetic field gradients 𝐺 = (𝐺𝑥 , 𝐺𝑦 , 𝐺𝑧 ) along the 3 directions will yield the
following spatially dependent precession frequency at position 𝑟 = (𝑥, 𝑦, 𝑧) :
𝜔(𝑟, 𝑡) = 𝛾(𝐵0 + 𝐺 (𝑡). 𝑟)
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(3.13)

Thus, by exploiting magnetic field gradients in all three spatial dimensions, one is able to fully
spatially encode the object under investigation. In this explanation, although the directions of
frequency-encoding, phase-encoding and slice-selection gradients were chosen along the x, y and
z directions, the directions can be completely arbitrary and need not be related to the physical
axes of the scanner. In fact, any oblique plane can be imaged by using a proper combination of
the gradient fields.

3.1.3 Basic Pulse Sequences
Spin Echo Sequence
A single RF pulse generates an FID signal (Figure 3-6) that dephases quickly as a result of both
magnetic field inhomogeneities and intrinsic T2 mechanisms, which cause phase dispersion
among the spin isochromats. Erwin Hahn discovered the spin echo (SE) sequence to generate an
echo signal by refocusing the dispersing spin isochromats with the addition of a 180° refocusing
RF pulse so that the magnetization vectors of the spin isochromats will rephase at a later time.93
The additional 180° refocusing pulse compensates for the inhomogeneity of the main magnetic
field and removes the T2’ component from the measured signal. Hence, SE signals are weighted
by the factor of T2 instead of T2*. The sequence diagram of a SE sequence is shown in Figure
3-8. The echo time of the signal (TE) is twice the time between the initial 90° excitation pulse
and the 180° refocusing pulse (TE/2). By adjusting the TE and TR, a SE sequence can produce
either T1, T2, or proton density weighted images. The signal magnitude (S) of a SE sequences is
dependent on TE, TR, and T1 of the tissue.
𝑆 = 𝑀0 (1 − 𝑒

−𝑇𝑅⁄
−𝑇𝐸⁄
𝑇1 ) 𝑒
𝑇2
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(3.14)

Figure 3-8. Pulse sequence diagram of a spin echo (SE) sequence. The SE sequence consists of
two radiofrequency pulses, typically a 90o pulse for excitation and a 180o refocusing pulse
applied at half the echo time (TE) to rephase the dispersing spin isochromats and produce an
echo signal at TE. The repetition time (TR) is the time between two 90 o RF excitations with
different phase encoding steps. Figure based on Bernstein MA et al. 2004.94

SE sequences typically use flip angles of 90° for RF excitation and 180° for refocusing
pulses. At these flip angles, a maximum transverse magnetization can be achieved and optimally
refocused to produce the largest SE signal. Pulses with flip angles other than 180° are also
capable of refocusing the transverse magnetization vectors, although the refocusing is only
partial.
Gradient Echo Sequence
Gradient echo (GRE) pulse sequences do not use the 180o RF refocusing pulse to form an echo.
Instead, gradient reversal on the frequency-encoded axis forms the echo. First, a readout
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prephasing gradient lobe dephases the spin isochromats, and then they are rephased with a
readout gradient that has opposite polarity.95, 96 Figure 3-9 shows a typical pulse diagram for a
GRE sequence. The area under the prephasing gradient lobe determines the time at which the
echo peak forms. The echo signal reaches its maximum when the area under the readout lobe is
equal to the area of the prephasing lobe.94 A GRE sequence has several distinct advantages.
First, without the refocusing pulse, a GRE is faster than a SE and requires less RF power.
Second, GRE sequences are also quicker because spins can be excited at a smaller flip angle. A
smaller flip angle creates a shorter T1 recovery period, which allows for a shorter TR and hence,
allows rapid scanning.
Residual transverse magnetization may remain at the end of any pulse sequence. To
avoid potential echoes from the residual transverse magnetization from previous RF excitations,
the remaining transverse magnetization is destroyed by applying large spoiling gradients to
dephase any remaining signal.97 In Figure 3-9, the phase encoding direction is reversed and
large spoiling gradients are added on the slice-selection direction at the end of the readout
gradient. This addition is known as a spoiled GRE sequence. The signal magnitude (S) of a
spoiled GRE sequences is dependent on flip angle (θ), TR, and the T1 value of the tissue.

𝑆=

𝑀0 sin 𝜃 (1 − 𝑒
(1 − cos 𝜃 𝑒

−𝑇𝑅⁄
𝑇1 )

−𝑇𝑅⁄
𝑇1 )

∙𝑒

−𝑇𝑅⁄ ∗
𝑇2

(3.15)

The signal from (3.13) is maximized at a flip angle known as the Ernst angle, which is dependent
on TR and T1 of the tissue.98
𝐸𝑟𝑛𝑠𝑡 𝐴𝑛𝑔𝑙𝑒(𝜃) = cos −1 (𝑒

38

−𝑇𝑅⁄
𝑇1 )

(3.16)

Figure 3-9. Pulse sequence diagram of a gradient echo (GRE) sequence. A slice is excited at
flip angle α. The combination of a short negative readout pre-phasing gradient and a positive
readout gradient will generate a gradient refocused echo. Figure based on Bernstein MA et al.
2004.94

3.1.4 K-Space and Image Formation
In the presence of gradients, the signal S(t) picked up by the receiver is composed of the sum of
all spins in the object under investigation with spin density 𝜌(𝑟) (neglecting relaxation effects) at
position 𝑟 = (𝑥, 𝑦, 𝑧):
𝑡

𝑆(𝑡) ∝ ∫ 𝜌 (𝑟). 𝑒 𝑖 ∫0 𝜔(𝑟,𝑡
𝑡

′ )𝑑𝑡 ′

𝑆(𝑡) ∝ 𝑒 𝑖𝜔0 𝑡 ∫ 𝜌 (𝑟). 𝑒 𝑖𝛾 ∫0 𝐺(𝑡
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𝑑𝑟

′ )𝑑𝑡 ′ 𝑟

(3.17)
𝑑𝑟

(3.18)

The received signal represents the spatial frequency spectrum of the object, which is commonly
⃗ is the wave number representing the spatial frequency.99, 100
referred to as k-space data, where 𝑘
In other words, a value in k-space (Eq. 3.18) represents the integral of the spin density modulated
⃗ given by:
by a complex sinusoid of spatial frequency 𝑘
𝑡

⃗ = 𝛾 ∫ 𝐺 (𝑡′)𝑑𝑡 ′
𝑘

(3.19)

𝑜

where t denotes the time the magnetic field gradient is applied. Omitting the exponential term
with spatially independent modulation frequency 𝜔0 , the relation in Eq. 3.16 yields:
⃗⃗⃗ 𝑟
⃗ ) ∝ ∫ 𝜌 (𝑟). 𝑒 𝑖𝑘.
𝑆(𝑘
𝑑𝑟

(3.20)

In this form, the received signal S can be recognized as the Fourier transformation of the spin
density 𝜌(𝑟) at position 𝑟. Therefore, the spin density (or the image) can be determined by
simply applying the inverse Fourier transformation to the received signal (Figure 3-10).
⃗⃗⃗ 𝑟 ⃗
⃗ ). 𝑒 −𝑖𝑘.
𝜌(𝑟) ∝ ∫ 𝑆(𝑘
𝑑𝑘

(3.21)

With 𝑘𝑥 = 𝛾𝐺𝑥 𝑡𝑥 and 𝑘𝑦 = 𝛾𝐺𝑦 𝑡𝑦 , where Gx and Gy denote the magnetic field gradients
applied in the frequency- and phase-encoding directions for durations of tx and ty, respectively,
the two-dimensional signal originating from the excited slice can be written as:
𝑆(𝑘𝑥 , 𝑘𝑦 ) = ∫ 𝜌 (𝑥, 𝑦). 𝑒 𝑖2𝜋(𝑘𝑥 𝑥+𝑘𝑦 𝑦) 𝑑𝑥𝑑𝑦

(3.22)

In k-space, low spatial frequencies are located at the center and have the highest
amplitude. They contain most of the MR image information: about contrast and general shape.
On the other hand, high spatial frequencies are located at the edges of k-space and have lower
amplitude. They do not have an effect on contrast or general shape but sharpen the image as they
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encode the edges. Thus, the farther from the center of k-space the data are collected, the higher
the spatial resolution is.

Figure 3-10. Relation between k-space and image formation. The k-space on the left is a matrix
that contains the raw data of spatial frequencies where low spatial frequencies are located close
to the center and high spatial frequencies are away from the center. A 2D inverse Fourier
Transform of k-space results in the MR image on the right.

3.1.5 K-Space Trajectories
⃗ (t). This path illustrates the acquisition strategy,
The k-space trajectory is the path traced out by 𝑘
influences which types of artifacts can result, and determines the image reconstruction algorithm
to be employed. The position in k-space at time t depends on all gradient fields on after the RF
excitation. Hence, for a given time-course of gradient fields, Eq. (3.17) can be used to calculate
the k-space trajectory, i.e. the path along which the object’s Fourier transform, Eq. (3.18) is
sampled during the experiment. The k-space trajectories can basically be divided into 2 types:
Cartesian and non-Cartesian sampling trajectories. Radial and spiral trajectories are the most
common among non-Cartesian sampling methods. The following section discusses only about
Cartesian and radial sampling methods which are relevant to this dissertation work.
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Cartesian Sampling
Conventional MRI sequences acquire the k-space data by sampling using a line-by-line scheme,
which is often referred to as Cartesian sampling. A single row (or line) of k-space is sampled
after one RF excitation and for each repetition a different row is acquired. For example, a total of
128 repetitions is required for an image with a size of 128 × 128 pixels. Figure 3-11 shows the kspace trajectory for a GRE sequence together with the sequence timing diagram, which indicates
the required time-course of gradient fields. The sequence starts with a slice-selective RF
excitation in the z-direction (1), which includes a rewinder gradient to compensate for the
undesired phase evolution caused by the slice-selection gradient during the second half of the
excitation pulse. Because the excitation is spatially limited in the z-direction, the received signal
corresponds to the two-dimensional Fourier transform of the slice in the xy-plane. Directly after
the RF excitation, the phase of all proton spins is equal, which relates to the center position in kspace. The starting point for the read-out procedure is set by applying a negative gradient in the
x-direction and (normally at the same time) a phase encoding gradient in the y-direction (2),
followed by the actual read-out procedure (3). This corresponds to moving to a certain ky
position in k-space and then moving in the kx-direction from left (−kxmax) to right (+kxmax) by
sampling at Nx discrete points in intervals of Δtx while a constant gradient Gx is on. This
procedure must be repeated with multiple phase encoding gradients running from −Gymax to
+Gymax in Ny equidistant steps to cover the entire k-space from –kymax to +kymax in the ky-direction.
The distance between the sample points in k-space is given by:
2𝐺𝑦𝑚𝑎𝑥 𝑡𝑦
𝐺𝑥 𝑡𝑥
∆𝑘𝑥 = 𝛾
= 𝛾𝐺𝑥 ∆𝑡𝑥 𝑎𝑛𝑑 ∆𝑘𝑦 = 𝛾
= 𝛾∆𝐺𝑦 𝑡𝑦
𝑁𝑥
𝑁𝑦

(3.23)

During the data acquisition, the continuous Fourier transform of the object can only be
sampled discretely at a certain sampling rate. The sampling can be seen as multiplication of the
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Fourier transform with a comb function in k-space. In image space, this corresponds to a
convolution with the Fourier transform of the comb-function, which is a comb-function with
reciprocal interval width. Hence, the discrete sampling leads to occurrence of periodic object
copies, where the distance between the copies is the reciprocal to the sample distance in k-space.
If the sample distance is chosen too large, then neighboring copies overlap in the image space,
which makes it impossible to recover the object properly. Hence, the k-space sampling distance
Δk with respect to a given field of view (FOV), which describes the extent of the object to be
imaged is given by:
∆𝑘 =

1
𝐹𝑂𝑉

(3.24)

After the acquisition of all rows is finished, the object can be reconstructed from the
samples by inverse Fourier transformation. A major advantage of the Cartesian sampling scheme
is that all sample points lie directly on an equidistant grid. Therefore, it is possible to perform a
simple reconstruction with the use of an inverse fast Fourier transformation (FFT). In the two
dimensional case, the FFT has to be performed for each row of the matrix and then for each
column, which yields an image of the object with identical extent, i.e. same number of entries as
the raw data matrix.
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Figure 3-11. Schematic description of Cartesian sampling in MRI. On the left, a typical GRE
sequence is displayed, and on the right, the corresponding k-space trajectory. In step (1), the slice
selection is carried out by an RF excitation applied during a normally constant gradient in zdirection. In step (2), the rephase lobe of the slice select gradient is applied. Normally at the
same time, a negative gradient lobe in x is switched, moving the trajectory in k-space to −kxmax.
Simultaneously, a phase encoding gradient applied in the y-direction moves the trajectory to a
specific ky-value. The actual read-out procedure (3) follows, which corresponds to travelling in
the kx-direction in k-space from left to right.

Radial Sampling
In a radial acquisition scheme, the k-space signal is sampled along rotated spokes instead
of parallel rows as illustrated in Figure 3-12. The spoke with an angle of zero degrees
corresponds to the central row in the Cartesian scheme and is achieved with a pre-phasing
gradient in the negative x-direction and a readout gradient in the opposite direction. Other spokes
are acquired with a combination of respective gradients in the x- and y-directions, which
produces a rotation of the spoke around the k-space center. Usually, the same gradient
waveforms are used for all spokes, while the gradient amplitudes in the x- and y-direction are
varied according to
𝐺𝑥 = 𝐺0 . cos(∅);

𝐺𝑦 = 𝐺0 . sin(∅)
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(3.25)

where ∅ is the desired angle of the spoke, and G0 denotes the amplitude required for sampling
the central k-space row. As in the Cartesian case, the distance between two samples along a
spoke is conveniently selected for a given FOV size,
∆𝑘 =

1
𝐹𝑂𝑉

(3.26)

and the number of samples per spoke determines the base resolution n. In the radial case, the
spatial resolution depends additionally on the number of spokes (ns) and from the literature it is
usually suggested to select the number of spokes according to:94
𝑛𝑠 =

𝜋
.𝑛
2

(3.27)

which ensures that the distance between samples on neighboring spokes (Δq in Figure 3-12) is
less or equal to Δk. In contrast to Cartesian sampling, the sampling positions in radial sampling
are neither on a grid nor equidistant, which precludes a straightforward use of the FFT. Hence,
radial sampling requires an extra step called regridding where the measured spokes are
interpolated onto a Cartesian grid, and then a normal FFT based reconstruction of the gridded
data is performed.94
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Figure 3-12. Pulse sequence diagram and associated k-space coverage for radial sampling. In
radial sampling, the data is sampled along rotated spokes, each spoke passing through the center
of k-space. After the slice selection gradient, pre-phasing gradients are applied along the phaseencoding and frequency-encoding directions moving the k-space trajectory to the outermost
point of the k-space, and followed by readout gradients to acquire the data along each spoke.

The most prominent advantage of the radial sampling scheme is lower sensitivity to
object motion during the data acquisition, which can be explained by two main reasons. First and
foremost, the superior robustness is a consequence of the fact that conventional Cartesian
sampling is rather vulnerable to motion. Any motion in the image space translates into a phase
modulation in the Fourier space according to the shift property of Fourier transformation:
⃗ ) = 𝑆𝑠 (𝑘
⃗ )𝑒 𝑖2𝜋𝑘⃗.𝐷⃗(𝑡)
𝑆𝑚 (𝑘

(3.28)

⃗ ) is the motion-corrupted signal, 𝑆𝑠 (𝑘
⃗ ) is the signal for a stationary object and 𝐷
⃗ (𝑡)
where 𝑆𝑚 (𝑘
is the displacement vector. The phase modulation can be either random or periodic depending on
the motion type and occurs primarily in the phase-encoding direction. This is because normally
patient motion is much slower than the fast sampling process along the frequency encoding
direction which is in the order of milliseconds. So motion artifacts along the frequency encoding
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direction can occur, but they are only detected as slight blurring. On the other hand, sampling
along the phase encoding direction needs all phase encoding steps and thus it is in the order of
seconds. In this longer period in time, the amount of motion can be large enough to result in
disturbing artifacts. These random or periodic phase offsets in the phase encoding direction
create gaps in the k-space coverage, and hence lead to blurring or ghosting artifacts,101, 102 which
usually overlap with the main object of interest, causing diagnostic misinterpretations. Note that
in Cartesian sampling, motion in all three planes, not only in phase encoding direction, leads to
ghosts or blurring in the phase encoding direction.102 In contrast, any signal inconsistencies
among different spokes in radial sampling, translate into blurring or streaking artifacts which
emanate tangentially from the moving objects and thus spread the artifact energy in all
directions. The streaks usually appear at a certain distance from the moving entity if a large FOV
is used, and thus do not obscure the main object of interest.94, 101
Oversampling the k-space center is the second reason for the improved motion robustness
of radial sampling. Typically, the phase offsets that arise from bulk motion of entire organs
affect the low spatial frequencies. In radial sampling, the low spatial frequencies are sampled in
every spoke, which provides intrinsic signal averaging of low frequency components, which are
responsible for gross features and contrast in the image. However, in Cartesian sampling, each
spatial frequency component is sampled uniformly and only once. Hence, the oversampling
property together with the general absence of ghosting artifacts makes radial sampling to have
high potential for examinations of moving organs or uncooperative patients.101
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3.1.6 Image Contrast
A great advantage of MRI is that there are many adjustable imaging parameters that can have an
effect on the image appearance (i.e. contrast). Out of these, repetition time (TR) and echo time
(TE) are the two most important parameters in producing the intrinsic image contrast in MRI.

Repetition Time (TR)
TR is the time between successive RF excitations of a given slice as shown in Figure 3-7. TR
usually determines the amount of longitudinal relaxation that is allowed to occur between the end
of one RF pulse and the application of the next. Thus, TR determines the amount of T1
relaxation that has occurred when the signal is read.

Echo time (TE)
TE is the time delay between the RF excitation and the acquisition of the signal as shown in
Figure 3-7. TE determines how much decay of transverse magnetization is allowed to occur.
Thus, TE can be used to control the amount of T2 relaxation that has occurred when the signal is
read.

Contrast Mechanisms
Contrast is one of the major concerns in medical imaging, and determines the ability to
distinguish and characterize certain structures with sharpness and accuracy from one another.
MRI provides excellent soft tissue contrast based on the differences in proton densities, and T1
and T2 relaxation times between different tissues. The basic contrast mechanisms are: proton
density (PD) weighted, T1-weighted, and T2-weighted contrasts. The degree of PD-, T1-, and
T2-weighting can be controlled via the values of TR and TE.
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PD-weighted contrast
The PD contrast depends on the differences in the proton density (i.e., the number of protons per
unit volume) between different tissue types. In order to achieve PD weighting, the effects of T1and T2-weighting contrast must be diminished so that PD weighting is dominant.
Figure 3-13 shows the recovery of longitudinal magnetization and the decay of transverse
magnetization for three tissue types. A long TR allows all tissue types to recover to equilibrium
and therefore diminishes T1 weighting. A short TE does not give time for the different tissues to
decay, and therefore diminishes T2 weighting. Therefore, to achieve proper PD weighting
imaging, the necessary parameters are a long TR and a short TE. PD weighting is not very
important as it does not give strong contrast since the proton density does not vary much between
the different tissues as all the tissues are basically made of water molecules.

Figure 3-13. Proton density (PD) weighted contrast. The graphs show the longitudinal relaxation
(left) and transverse relaxation (right) for three types of tissues: 1, 2 and 3. PD weighting is
achieved with long TR and short TE.
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T1-weighted contrast
The T1-weighted tissue contrast depends predominately on the differences in the T1 times
between different tissues. Effective T1 weighting can be achieved by minimizing the effects of
proton density and T2 differences between the tissue types.
As illustrated in Figure 3-14, a short TR cancels the effect of the proton densities and a
short TE cancels the effect of T2 relaxation. So, the difference in signal strengths depends
largely on the previous longitudinal magnetizations that is from the T1 relaxation of the tissue.
Thus, to achieve successful T1-weighted imaging, the parameters would be a short TR and a
short TE.

Figure 3-14. T1-weighted contrast. The graphs show the longitudinal relaxation (left) and
transverse relaxation (right) for three types of tissues: 1, 2 and 3. T1 weighting is achieved with
short TR and short TE.

T2-weighted contrast
The T2-weighted tissue contrast depends on the differences in the transverse decay
characteristics for different tissue types. So, TE is the parameter that controls the amount of T2
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weighting. In order to achieve effective T2 weighting, the effects of proton density and T1
weighting must be minimized.
As illustrated in Figure 3-15, a long TR cancels the effect of the T1 relaxation and a long
TE cancels the effect of proton densities. So, at longer TE and longer TR, the contrast is
controlled only by the T2 relaxation and thus a T2-weighted image can be obtained. However,
TE cannot be made too long as the signal may vanish and hence cannot be detected.

Figure 3-15. T2-weighted contrast. The graphs show the longitudinal relaxation (left) and
transverse relaxation (right) for three types of tissues: 1, 2 and 3. T2 weighting is achieved with
long TR and long TE.

3.2

MRI Techniques for HIC measurement

MRI does not image iron directly but instead detects the effect of iron on water protons in the
tissue of interest.103 Iron acts as little magnets, disrupting the homogeneity of the magnetic field
in tissues and causing the water protons to dephase faster. Thus, iron accelerates T2 and T2*
relaxations, thereby causing signal loss on T2-weighted spin-echo and T2*-weighted gradient
echo images. The degree of signal loss depends on the amount of iron and the echo time; in
general, the longer the echo time, the higher the signal loss.
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While detection of liver iron using qualitative MRI is possible, qualitative MRI methods
do not reliably assess the degree of iron overload and hence do not provide reliable guides for
treatment initiation or therapy monitoring. The requirement is quantitative methods that can
predict the exact HIC based on MRI data. An ideal technique would measure HIC accurately
over its entire clinical range from 2 mg Fe/g dry weight to over 40 mg Fe/g dry weight104 in a
manner that is reproducible across most clinical MRI platforms. In general, there are two MRIbased techniques for quantitatively measuring HIC: (a) Signal intensity ratio, and (b)
Relaxometry.

3.2.1 Signal intensity ratio (SIR)
In SIR methods, the signal intensity of the liver on spin-echo or gradient echo sequences is
divided by the signal intensity of a reference tissue that does not accumulate iron such as fat or
skeletal muscle.105 Images are obtained using a body coil to avoid signal inhomogeneities arising
from surface coils. Signal intensity measurements are performed by placing large regions-ofinterest (ROIs) in the liver and reference tissue in the same slice while avoiding artifacts, vessels,
and boundaries, and the ratio of the mean signals is calculated. As the absolute signal intensity
measured by MRI is arbitrary and depends on acquisition parameters and instrumentation, a
comparison to a reference tissue is necessary. The skeletal muscle is the most commonly used
reference because the normal liver usually has higher signal intensity than muscle, and any
decline in relative liver signal intensity can be visually compared.
SIR methods use more than one sequence in order to be able to quantify all levels of iron
overload. The most widely recognized SIR method is that developed by Gandon et al.105 at the
University of Rennes, France. In this method, five breath-hold GRE sequences are obtained with
fixed TR and different flip angles to alter T1-weighting, and different TEs to alter T2*
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weighting. This method is optimized for 0.5, 1.0 and 1.5 T field strengths and the acquisition
parameters are given in Gandon et al.105
On each sequence, the mean liver and muscle signal intensities are measured at 3 ROIs in
the right lobe of the liver and at 2 ROIs in the right and left paraspinal muscles, respectively.105
The authors evaluated this technique in a group of 139 patients and estimated HIC with high
accuracy, with a mean difference of 0.8 μmol Fe/g and 95% confidence interval of -6.3 – 7.9
μmol Fe/g for HICs ranging from 3 – 375 μmol Fe/g (i.e., 0.2 – 20.9 mg Fe/g dry weight). Based
on this data, the authors designed a computer-based algorithm (available at www.radio.univrennes1.fr) that automatically estimates HIC by combining the SIR data from the five sequences.
The authors also validated this algorithm in a validation group of 35 patients.105
The Gandon method has some important limitations despite being used clinically. The
liver-to-muscle ratio varies based on the choice of sequence (spin-echo or gradient echo), scan
parameters (field strength, repetition time, echo time, flip angle), and type of coil (surface or
body) used, and hence standardization of parameters is necessary. However, even with
standardization of parameters, the HIC estimates calculated by Gandon method depend on the
scanner type,106 suggesting that results may not be reproducible across platforms or sites.
Initially, the liver-muscle ratio declines linearly with increasing HIC, but all sequences
eventually saturate as the ratio reaches the noise floor.105 Due to this limitation, the Gandon
method cannot quantify HIC values greater than 375 μmol Fe/g (20.9 mg Fe/g) and hence does
not capture the entire clinically relevant range of liver iron levels.107 Other underlying
conditions, such as hepatic steatosis and fat within muscle fascial planes, may confound the
results because these conditions are known to affect the signal intensity of the liver and muscle,
respectively. Finally, this method requires multiple breath-hold sequences and the total
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acquisition time is about 10 minutes including inter-breath-hold intervals.30, 108

3.2.2 Relaxometry
Relaxometry is considered to be a more robust approach for estimating HIC compared to SIR
methods because the measured relaxation parameters are potentially independent of scanner type
and coil configuration. In relaxometry, a series of images are acquired with increasing TEs, the
signal intensity of the tissue of interest is modeled as a function of TE, and the signal decay
constants (i.e., relaxation times: T2 or T2*) are calculated.109 While SIR methods compare the
signal intensity of two tissues (e.g., liver and reference tissue) at a given TE, relaxometry models
the signal intensity of a single tissue (e.g., liver) across multiple TEs.
Relaxation times T2 or T2* values can be calculated depending on whether a spin-echo
or gradient-echo based sequence is used. These relaxation times are inversely related to the iron
concentration, i.e., the greater the iron content, the faster is the signal decay and the lower are the
T2 or T2* times. In recent years, investigators report relaxation rates, R2 (=1000/T2) or R2* (=
1000/T2*) instead of relaxation times, as the iron content and R2 or R2* are linearly related; i.e.,
the higher the iron content and the higher is the R2*. Typically, T2 and T2* are expressed in
milliseconds (ms), while R2 and R2* are expressed in 1/second (s-1). Both R2 and R2* are
suitable for calculating HIC estimates in clinical practice when performed using validated
acquisition and analysis protocols as described in below sub-sections.

R2-MRI
R2 can be measured using a series of single spin-echoes, each acquired after a separate
excitation,110 or with a train of spin-echoes, each acquired after a single excitation using a CarrPurcell-Meiboom-Gill (CPMG) sequence.109, 111, 112 However, R2 measurements made with a
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CPMG sequence will be lower compared to those made with a series of single spin echoes due to
more frequent application of refocusing pulses and will also depend strongly on the spacing
between refocusing pulses.113, 114

Existing R2-Based Calibrations
Early correlation studies showed a linear relationship between R2 and biopsy HIC.115-118
However, these studies had small cohort sizes, limited dynamic range and inter-study calibration
variability, which are factors that may have obscured the detection of nonlinear relationship
between R2 and HIC. In a study of over 100 patients, St Pierre et al. found a curvilinear
relationship between R2 and biopsy HIC over the entire clinically relevant range.110 Moreover,
the study also demonstrated measurement stability among different imaging platforms.
The St Pierre method uses five T2-weighted single spin-echo free-breathing sequences
with constant TR and increasing TEs of 6, 9, 12, 15 and 18 ms. The method requires placement
of an external calibration phantom with very long T2 within the field of view to correct for
instrumental gain drift between sequences acquired at different TEs. This method involves
several post processing steps that include gain drift correction, respiratory motion correction,
background noise subtraction, estimation of effective initial signal intensity at TE = 0, and
performing pixel-by-pixel bi-exponential modeling to generate quantitative liver R2 maps. The
bi-exponential model estimates two R2 values corresponding to short T2 and long T2
components, respectively. At each pixel, a composite R2 value is calculated as the average of the
two R2 values, weighted by their respective population densities. The mean liver R2 is measured
by choosing the largest axial slice of the liver and by placing a large ROI in the liver parenchyma
excluding vessels and artifacts.110
In this study of over 100 patients, the HIC values ranged from 0.3 – 42.7 mg Fe/g dry
55

weight. Liver R2 demonstrated a curvilinear relationship with HIC over the entire HIC range
with a correlation coefficient of 0.98 and exhibited limits of agreement between -56% and
50%.110 An empirical formula for R2 in terms of HIC describing the curvilinear behavior was
derived by St. Pierre et al:110
𝑅2 = 6.88 + 26.06[𝐹𝑒]0.701 − 0.438[𝐹𝑒]1.402

(3.29)

Wood et al. inverted this equation to predict iron concentration from a given R2 measurement as
follows:10
[𝐹𝑒] = ( 29.75 − √900.7 − 2.283 𝑅2 )1.424

(3.30)

However, this expression was derived at 1.5T for a specific set of imaging parameters and
analysis method described by St. Pierre et al. and may not be directly applicable to other
sequences that measure R2. Nevertheless, another independent study by Wood et al.10 was able
to reproduce St. Pierre’s calibration curve using different imaging parameters (e.g., using 120o 120o echo rather than conventional 90o - 180o spin-echo; TE range of 3.5 – 30 ms rather than 6 –
18 ms) and fitting the data with mono-exponential model with constant offset rather than a biexponential model.
An important advantage of the St. Pierre method is that it is approved by the Food and
Drug Administration (FDA), and is commercially available as FerriScan®, marketed by
ResonanceHealth (http://www.resonancehealth.com/). The reproducibility of the St. Pierre
method has been validated in a recently published multicenter study conducted in 233 ironoverloaded thalassemia patients.119 The study demonstrated that the calibration curve was
independent of scanner platform, patient age, liver fibrosis stage, inflammation grade, and use of
chelator therapy, although the limits of agreement between R2-based HIC and biopsy-based HIC
were very broad (between 74% and -71%).
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The St. Pierre method has some practical limitations. First, the method requires a long
acquisition time of 10-20 minutes due to the multiple free-breathing sequences. Second, the
image analysis is centralized and the company charges a fee around $500-$700 for HIC analysis,
which is not covered under standard insurance.120 Third, the method requires an external
calibration phantom to be placed within the field of view. Last, as the relationship between R2
and HIC is curvilinear, the method is relatively insensitive to longitudinal changes in HIC in
patients with extreme iron overload, which may limit the suitability of the technique for
monitoring severe iron overloaded patients.30
The curvilinear relationship between R2 and HIC demonstrates that R2 values plateau at
high HIC values. In theory, R2 should rise linearly with iron only if the size and cellular
distribution of liver iron deposits are independent of HIC.10 But in patients with severe iron
overload, iron particles cluster to form large aggregates of hemosiderin. These aggregates cause
large magnetic inhomogeneities that have greater influence than the diffusion-dependent
movement of water molecules.10, 30, 110 In presence of such large inhomogeneities, diffusing
water molecules experience a relatively constant magnetic field between excitation and
refocusing pulses and hence there is relatively little diffusion-dependent dephasing and signal
decay.30 Thus, R2 changes very slowly and exhibits a plateau behavior for high HIC values.

R2*-MRI
R2* relaxometry, based on gradient echo (GRE) acquisitions, has major advantages over R2based methods due to its ability to provide full liver coverage without motion artifacts within a
single breath-hold. Also compared to the R2 approach, R2*-MRI is relatively less sensitive to
variations in the size and distribution of iron particles as the severity of iron overload increases.10
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Pulse sequence
R2* is measured using GRE sequences that can acquire multiple echoes in each TR using an
echo train obtained with either unipolar or bipolar readout gradient (multiecho GRE),11, 121, 122 a
single echo per TR,10 or a combination of the two, e.g. multiple interleaved echo trains. Figure
3-16 shows multiecho GRE images of the liver in patients with normal, moderate, and high HICs
and their respective signal decays. As seen, the higher the iron content, the darker the liver
appears and the faster the signal decays.

Figure 3-16. Transverse liver slices of patients with normal (A), moderate (B), and high (C) HICs
and corresponding T2* decay curves (D) obtained from small circular region-of-interests (blue:
normal, green: moderate, and red: high HIC).
The TEs of the GRE sequence should be selected in such a way to maximize the ability
of fitting algorithms to reliably measure the expected clinically relevant values of R2* (e.g., 33–
2000 s-1 at 1.5T).123 Optimally, the first echo (TEmin) should be as short as possible (1 ms or
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less) and the echo spacing (ΔTE) should be short enough to capture the signal decay in cases of
severe iron overload (e.g., 1 ms or less). However, the lowest possible values for these 2
parameters are limited by the gradient hardware of the MRI scanners. A contrasting need occurs
for low iron cases, in which the choice of last echo time (TEmax) is important to capture the
entire signal decay and typically 15–20 msec is sufficient.11, 123 The optimal number of echoes
has not been determined, but acquiring as many echoes as possible between first and last echoes
is recommended to cover the entire clinically relevant R2*/HIC range observed in patients with
iron overload. Reduced ΔTE can be achieved utilizing small frequency matrix, fractional echo
sampling and high receiver bandwidth (>100 kHz).82 Figure 3-17 shows the pulse diagram of a
multiecho GRE with bipolar readout gradient acquiring echoes with both positive and negative
readout gradients, thereby allowing shorter ΔTE compared to unipolar GRE acquisition.

Figure 3-17. Pulse sequence diagram of a multiecho GRE with bipolar readout gradient. Gz
represents slice selection gradient, Gy represents phase-encoding gradient, and Gx represents
frequency or readout gradient. Odd echoes are acquired with positive readout gradient polarities
while even echoes have negative readout gradient polarities. This bipolar acquisition scheme
allows shorter echo spacing compared to unipolar GRE acquisition where echoes are acquired only
with positive readout gradient polarities.
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Signal model
R2* can be calculated from the rate of exponential signal decay of the multiecho GRE signal.
The simplest model for R2* fitting is a mono-exponential model given by,
∗

𝑆(𝑇𝐸) = 𝐴𝑒 −𝑇𝐸×𝑅2

(3.31)

where S is measured signal intensity and A is the signal intensity expected at TE = 0. But this
model has 2 major limitations. First, the model neglects the confounding effect of image noise.
The signal intensity measurements are usually derived from magnitude MR images. An
important disadvantage of magnitude-based methods is that the noise in the magnitude data has a
Rician distribution with non-zero mean at low SNR. This creates a noise floor in the magnitude
images, prevents the observed signal intensity from decaying to zero,111 prolongs the apparent
decay curve and hence causes R2* underestimation.124 Second, the model assumes uniform iron
concentration within each tissue voxel. However, this assumption might be incorrect as voxels
can contain both iron-dense and iron-sparse components (bile or blood).123 The iron-dense
component generates rapidly decaying signal, while the iron-sparse component generates slowly
decaying signal. If the combined curve from a voxel is fitted to a simple exponential function,
the “tail” contributed by the low-iron tissues will distort the fit from the iron-rich tissues. Failure
to account for this effect will lead to severe systematic overestimation of T2* values.124
Several data-fitting models have been proposed to address the limitations of the monoexponential model and some of them are listed below.
(1) Mono-exponential with truncation: In this model, echoes with low signal intensity are
excluded until a good fit to mono-exponential decay is achieved.9
(2) Mono-exponential model with weighting: In this model, signal decay is assumed to be
exponential but progressively less weight is given to echoes with decreasing signal intensity.
(3) Mono-exponential model with offset: In this model, a constant offset is added to account
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for noise and long T2* components:10
𝑆(𝑇𝐸) = 𝐴𝑒 −𝑇𝐸×𝑅2∗ + 𝐶

(3.32)

(4) Mono-exponential model with baseline subtraction: In this model, measured image noise
is subtracted directly from the tissue signal intensity at each echo time and the corrected signal
intensity of the tissue is then entered into a mono-exponential model.11, 125
∗

2
𝑆𝑐𝑜𝑟𝑟 = √𝑆𝑚𝑒𝑎𝑠
− 𝑁 2 , 𝑆𝑐𝑜𝑟𝑟 (𝑇𝐸) = 𝑆0 𝑒 −𝑇𝐸∙𝑅2

(3.33)

(5) Quadratic mono-exponential model: This model has been presented recently as an
improved fitting approach for accurate and precise R2* quantification in low SNR conditions
and is given by:126
∗

2

𝑆 2 (𝑇𝐸) = (𝑆0 𝑒 −𝑇𝐸∙𝑅2 ) + 𝑁 2

(3.34)

(6) Bi-exponential model: In this model, two components are modeled- (a) an iron-dense, shortT2* component, and (b) an iron-sparse, long-T2* component.127 The model is given by,
𝑆(𝑇𝐸) = 𝐴𝑒 −𝑇𝐸×𝑅2∗|𝐴 + 𝐵𝑒 −𝑇𝐸×𝑅2∗|𝐵

(3.35)

where A and B are the iron-dense, short-T2*and iron-sparse, long-T2* components, respectively.
Each of the above models has advantages and disadvantages, and a consensus has not yet
been reached regarding which model is optimal. For example, while the bi-exponential model
provides a more complete description of the multi-component nature of liver tissue, it has four
degrees of statistical freedom.127 This makes the fitting process unstable unless mathematical
constraints are imposed. Further research is needed to identify the most accurate fitting model.
Pixel-wise or Region-based R2*
R2* fitting can be performed in 2 ways: (a) pixel-by-pixel basis where the signal model is
applied to the acquired signal in each pixel followed by averaging the estimated pixel-wise R2*
over an ROI,10, 11 and (b) first averaging the measured signal within an ROI and then applying
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the signal model to estimate the mean R2*.126 Each way has advantages and limitations. One
important advantage of pixel-wise R2* measurements is the ability to provide parametric maps
depicting the spatial distribution of iron within liver and also exposing areas of artifact or
pathology that might be missed using a region-based approach. On the other hand, it is shown
that the pixel-wise fitting skews relaxation rate estimates and increases variance, particularly in
livers with high iron contents when compared to region-based fitting.128
Field strength
Most R2* and biopsy HIC calibration studies have been performed at 1.5T.9-11 Recently, clinical
use of 3T magnet strength has increased as it has twice the SNR of 1.5T magnet strength. As
both R2 and R2* rise proportionally to field strength,129, 130 calibration curves developed at 1.5T
do not apply to 3T. Fortunately, recent studies have demonstrated that liver R2* values measured
at 3T were approximately 2-fold higher than those obtained at 1.5T; indicating that R2* values at
3T can be converted to 1.5T, and hence estimate the HIC by applying the 1.5T calibration
curves.131, 132 But there are two key limitations for R2*-based iron quantification at 3T. Firstly,
susceptibility artifacts at 3T are significantly worse than at 1.5T, requiring good shimming of
gradient coils to provide a homogenous magnetic field. Secondly, the increasing signal decay at
3T cuts the maximum detectable iron by a factor of two compared to 1.5T and hence, limiting
the dynamic range for accurate R2*-based iron quantification at 3T.
Existing R2*-Based Calibrations
Several studies have performed calibration of liver R2* (in s-1) at 1.5T to biopsy-measured HIC
(in mg Fe/g dry tissue).9-12, 133 Preliminary liver R2* calibration data was published by Anderson
et al.,9 but their accuracy were limited by some technical and patient selection difficulties.123
Wood et al. published a study in 2005 that calibrated R2* to biopsy HIC in 20 patients with
transfusion-dependent thalassemia or sickle cell disease.10 This study acquired single-echo GRE
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sequences within a single breath-hold with short TE1 and ΔTE, stepping TE from 0.8 to 4.8 ms in
0.25 ms intervals, for a total of 17 acquisitions. Other acquisition parameters were FOV of 480
mm x 240 mm, flip angle = 20o, TR = 25 ms, imaging matrix 64 x 64, and slice thickness = 15
mm. Data were fitted to a mono-exponential decay curve with constant offset on a pixel-by-pixel
basis, and quantitative R2* maps were obtained. This study demonstrated the following linear
relationship between R2* and HIC, with a correlation coefficient of 0.97 and limits of agreement
of -46% to 44%:10
[𝐹𝑒] = 0.0254 × 𝑅2∗ + 0.202

(3.36)

Another study by Hankins et al. calibrated R2* to biopsy HIC in a larger cohort of 43
patients with transfusional iron overload.11 This study used a multiecho GRE sequence to acquire
20 images with increasing TEs from 1.1 to 17.3 ms, TR = 200 ms, flip angle = , matrix = 128 x
104, slice thickness = 10 mm. Quantitative T2* maps were calculated by subtracting background
noise from the liver signal intensity and fitting a truncated mono-exponential signal decay on a
pixel-by-pixel basis. This study also demonstrated a linear relationship between R2* and biopsy
HIC with a correlation coefficient of 0.98 and derived the following regression line (Figure
3-18):
[𝐹𝑒] = 0.028 × 𝑅2∗ − 0.454

(3.37)

The study also shows that Wood et al. calibration curve falls within the 95% predicted intervals
of Hankins et al. analysis across the entire range of HIC values, hence showing good agreement
between both studies (Figure 3-18). But the regression line from Anderson et al. has a
substantially lower slope, probably reflecting differences in instrumentation and biopsy iron
quantification technique.11
Garbowski et al. published a study in 2014 that calibrated R2* measurements against 50
liver biopsy samples on 25 patients with transfusional hemosiderosis.133 They also found a near63

linearity correlation between R2* and HIC (Pearson r = 0.94). Recently, Henninger et al.
performed a comprehensive analysis by comparing the agreement between these several
published R2* and biopsy HIC calibration studies described above, by pooling all the available
data to investigate the transferability of these published calibration curves.12 The study also
found no significant differences between Wood, Hankins, Garbowski and their calibration
curves; with all studies using a scanning sequence that had an initial TE of around 1 ms. Slight
differences in calibration curves between studies might be because of different sequence
parameters and post-processing methods.
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Figure 3-18 R2*-MRI versus HIC. (A) Plot of R2*-MRI measurements versus HIC values
obtained by liver biopsy with linear regression lines and 95% prediction limits. The intercept was
-454.85 (P = .31), the slope was 28.02 (P < .001), and R2 was 0.72. The correlation coefficient
for R2*-MRI and HIC was 0.98 (P < .001). (B) Standard Bland-Altman plot shows the
difference versus the average of HIC (R2*) and HIC (biopsy), that is, (HIC [R2*] - HIC
[biopsy]) versus (HIC [R2*] + HIC [biopsy])/2. The solid line represents the mean difference
between HIC (R2*) and HIC (biopsy); dashed lines, upper and lower 95% limits of agreement
between the 2 measurements. (C) R2*-MRI versus HIC regression line overlaid with regression
lines from 2 other published methods of R2*-MRI showing that the Wood et al regression line
falls well within our 95% predicted interval across the entire range of values, but the regression
line from Anderson et al1 (extrapolated from a published log-transformed plot) has a
substantially lower slope, probably reflecting differences in instrumentation and biopsy iron
quantification technique. Reprinted from Hankins et al. Blood 2009.
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Limitations
Although different groups have successfully calibrated R2*-MRI techniques with liver biopsyproven HIC,9-11 no previously developed technique has been able to accurately quantify HIC in
patients with massive iron overload because of the exceedingly fast signal decay produced by
high concentrations of tissue iron, which cannot be captured with the current GRE techniques.
The prediction accuracy that can be achieved with a GRE sequence deteriorates when signal
decay (1/R2*) is about the TE of the first echo and the signal of the first echo falls near the noise
level.10 In other words at 1.5T, the error in predicting iron values for R2* > 500 s-1 (~15 mg
Fe/g) is significant, but even higher for R2* > 900 s-1 (~25 mg Fe/g) as shown in the BlandAltman plot in Figure 3-18.11 The key factor is the minimum TE of conventional MR sequences,
which cannot be much shorter than 1 ms for technical reasons. This limitation of conventional
GRE imaging is even more restrictive for the current, clinically accessible HIC range with 3T,
which is about 12.5 mg Fe/g (R2* at 3T > 900 s-1) or even lower as the signal decay rate is twice
as fast as at 1.5T.
Multiecho UTE
The limitations on the shortest possible TE achievable with GRE based HIC estimation can be
overcomed by using ultra-short echo time (UTE) imaging.134 UTE imaging allows for very short
delays (≤ 100 µs) between signal excitation and data acquisition and enables the detection of
tissues with very short transverse relaxation times as for example demonstrated in pulmonary
and musculo-skeletal applications.134-138 Slice-selective 2D UTE imaging is achieved via half
pulse RF excitation and center-out radial sampling.134 Half pulse excitation requires two
acquisitions with respectively inverted slice selection gradients, but otherwise identical scan
parameters which are combined in the complex domain to obtain the desired slice profile. This
type of acquisition avoids the need for a rephasing gradient lobe, hence making the TE as short
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as possible, e.g., in the range of 0.05 – 0.2 ms.134 Data acquisition can begin as soon as each of
the slice selection and RF switching are completed . Radial mapping is performed from the
center of k-space without phase encoding pulses including acquisition during the ramping up of
the gradient. The radial data are then gridded onto rectangular coordinates and are reconstructed
using 2D Fourier Transformation.134
UTE sequences have not only been used for visualization of short T2* tissues but also to
quantitatively characterize the short T2* properties of tissues such as lung parenchyma, cortical
bone, and the ultrashort T2 components in white matter.136, 139-141 A study by Chappell et al.
showed the general applicability of UTE-based T2* measurements in hepatic iron overload.142
However, this study did not aim at a specific investigation of UTE imaging in massive HIC
settings as the reported mean T2* is 7.0±2.7 ms, reflecting only mild iron overload patients
(HIC< 7mg Fe/g), where standard GRE techniques still work.
Most recently, Krafft et al.143 described the technical implementation of a 2D multiecho
UTE sequence (Figure 3-19) that is specifically applicable for hepatic R2* quantitation whenever
conventional GRE techniques become imprecise due to T2* shortening, i.e. in patients with high
or massive HIC and at higher field strengths. The sequence employed spatial saturation bands to
reduce unwanted out-of-slice signal contributions. This was because the combination of two
half-pulse acquisitions with inverted slice selection gradients should theoretically lead to a full
cancellation of signals from out-of-slice locations.134, 144 Unfortunately, this mechanism was
sensitive to any system imperfections affecting the slice selection gradient such as eddy currents
or gradient delays.145 Such imperfections can manifest in insufficient cancellation of unwanted
out-of-slice signals,146, 147 which hampers quantitative imaging needed for R2*-based HIC
assessment. The acquisition scheme proposed by Krafft et al. also incorporated fat suppression

67

pulses to reduce the streaking artifacts arising from high signal intensities of the subcutaneous
fat, and achieved dense temporal sampling of the rapidly decaying signal via acquisition of
interleaved echo trains.143 This study tested and validated the multiecho UTE sequence in
phantom experiments and 5 massive HIC (> 25 mg Fe/g) patients in vivo and demonstrated that
the UTE can precisely measure R2* in massive hepatic iron overload at both 1.5T and 3T, where
current GRE techniques failed.

Figure 3-19. Schematic excitation and acquisition diagram of the free-breathing interleaved
multi-echo UTE sequence; only important elements are shown: Prior to each half-pulse
excitation, CHESS pulses for fat suppression and sSAT pulses for out-of-slice signal suppression
are applied. CHESS and sSAT pulses are followed by spoiler gradients (not shown) to dephase
transverse magnetization. The sSAT bands are oriented parallel to the imaging slice. The slice
selection gradient GSL (light gray; dotted line indicates alternating polarity of slice-selection
gradients) and readout gradient GRO (dark gray) are illustrated for the first echo train only. Each
echo of the multi-echo readout train is acquired via center-out radial sampling including data
acquisition during ramp-up of the readout gradients. The sequence acquires additional echo
trains, which are shifted relative to the previous echo train by a small echo-time increment ΔTE
to achieve dense temporal sampling even for fast T2* decay. ADC, analog-to-digital converter;
CHESS, chemically selective saturation pulses; GRO, readout gradient; GSL, slice selection
gradient; HP, half-pulse; RF, radiofrequency; sSAT, spatial saturation; TE, echo time. Reprinted
from Krafft et al. Magn Reson Med. 2017.
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Chapter 4
Development of an Accurate and Automated R2*-MRI Based HIC Estimation Framework

Accurate assessment of R2* is crucial for calculating sufficiently precise HIC to guide
physicians prescribing iron removal therapy for iron overloaded patients. There are 3 major steps
involved in the estimation of R2*: (a) the acquisition technique used to produce diagnostic
quality images and capture the true signal decay of the tissue of interest and, (b) the signal model
used to accurately quantify R2*, and (c) extraction of liver parenchyma to estimate mean R2*.
Figure 4-1 shows the current R2* estimation framework used at our institution to report mean
R2*-based HIC measurements, and is described below in detail.

Figure 4-1. Current R2* estimation framework. Data acquired from a breath-hold multiecho
GRE is processed by fitting a mono-exponential signal model to produce quantitative R2* maps,
and finally the liver parenchyma is extracted by excluding the vessels using T2*-thresholding
technique in order to estimate the mean liver R2*.
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The standard acquisition technique for estimating liver R2* is using a multiecho GRE
sequence typically done in a breath-hold. However, breath-holding is a challenge in sedated
children or in patients who have difficulty holding their breath for the scan duration. Failure to
breath-hold causes artifacts due to respiratory motion that degrade the image quality and may
eventually introduce errors in R2*-HIC quantification. Our first study (Chapter 5) illustrates the
impact of motion artifacts on R2* quantification using the free-breathing multiecho GRE
sequence and evaluates an alternative acquisition technique to improve the image quality and
subsequently the R2* quantification under free-breathing conditions.
Once the images are acquired, R2* is typically calculated using magnitude images and
one of the mono-exponential signal model described in Chapter 3 (3.2.2). However, the presence
of fat introduces oscillations in the multiecho GRE signal and using a mono-exponential model
will confound R2* measurements. Our second study (Chapter 6) evaluates an Auto Regressive
Moving Average (ARMA) signal model that performs fat-water separation and simultaneous
R2* quantification to provide accurate iron measurements in presence of fat.
After calculating the pixel-wise R2* maps using the appropriate signal model, mean liver
R2* values are estimated by drawing an ROI outlining the whole liver and then manually
excluding the blood vessels from liver tissue via T2* histogram based thresholding. However,
this manual T2* thresholding process is time consuming and operator dependent. Our third study
(Chapter 7) presents a robust and automated vessel exclusion technique to extract the liver
parenchyma and thereby optimize the current clinical workflow in R2*-MRI based HIC
quantification.
Each section below (4.1 – 4.3) provides a detailed description of how each of the above
challenges will affect the accuracy and clinical workflow of R2*-MRI based HIC measurements.
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4.1

Impact of Respiratory Motion on GRE Acquisition

R2* is typically measured by acquiring a series of multiecho GRE images of the liver over a
period of about 20 seconds during which the patient is asked to hold their breath to mitigate
respiratory motion related artifacts. But many young patients who receive an MRI for HIC
evaluation are sedated or incapable of holding their breath for ~21 sec. For example, at St. Jude
Children’s Research Hospital over 40% of iron overloaded patients scanned during the past 4
years received either sedation or were incapable to carry out breath-holds. Non-compliance in
breath-holding causes degraded image quality on GRE images due to respiratory motion
artifacts. The motion artifacts arise primarily due to the high intensity signal from the
subcutaneous abdominal fat that is folded over the low intensity signal of an iron loaded liver. As
the R2* value of fat is lower than the R2* value of iron overloaded liver, we hypothesize that the
motion artifacts will cause underestimation of R2* values. Consequently, R2*-MRI based HIC
will be underestimated as well, which is a problem that will impact patient care because the
calculated HIC value is guiding iron removal therapy. Chapter 5 demonstrates the use of radial
free-breathing ultra-short echo time (UTE) imaging as a potential solution for accurate R2*
quantification in sedated patients and subjects not able to perform breath-hold scans.

4.2

Signal Model in the Presence of Fat

Liver fat accumulation is a common condition, affecting about 20%-30% of the U.S.
population.148 But presence of fat is a major confounder for hepatic iron assessment by R2*MRI. Fat introduces additional modulations in the multiecho GRE signal as the water and fat
signals resonant at slightly different frequencies (i.e., differ by 220 Hz at 1.5T and 440 Hz at 3T)
and oscillate as they are in and out of phase.149 As shown in Figure 4-2A, the higher the fat

71

content, the higher is the amplitude of the oscillations. Also, fat has a complex MR spectrum
with multiple peaks,150 the largest of which is the main methylene fat peak (Fig. 4-1B, peak 5).
Hence, fitting a mono-exponential model to the signal decay without accounting for the multipeak fat spectrum will corrupt the R2* quantification. Chapter 6 investigates the performance of
an ARMA signal model that incorporates fat-water modeling and simultaneous R2*
quantification, in fat-iron phantoms and in-vivo cases.

Figure 4-2. (A) T2* decay curves in livers of patients with 0%, 9% and 30% fat fractions, and
(B) in vivo liver MR spectrum from a human subject with fatty liver.150 Of the six fat peaks (1–6)
resolved in vivo, peak 5 is the largest fat peak that contributes ~70% of the fat signal, peaks 1
and 2 are buried within the water peak, and peak 3 is small and is rarely seen in the human liver
clinically.

4.3

Extraction of Liver Parenchyma

Currently, the radiologists at our (St. Jude Children’s Research Hospital) and other institutions151,
152

compute reported R2*-MRI based HIC values by drawing a contour encompassing the entire

liver in the acquired cross-section (Figure 4-3, Step 1), and then manually excluding vessel
pixels above a certain T2* threshold value based on histogram analysis (Figure 4-3, Step 2).
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Exclusion of vessels is necessary because blood has higher T2* (=1/R2*) compared to iron
overloaded liver, and inclusion of blood vessels within the ROI will produce inaccurate R2*
estimates for the actual liver tissue. The radiologists must repeat Steps 2 and 3 multiple times by
re-adjusting the threshold value until they make a visual confirmation that all vessel pixels have
been excluded (Figure 4-3, Step 3). The red pixels represent the extracted parenchyma and the
mean R2* of these pixels gives the mean liver R2* value. This process of extracting the liver
parenchyma based on T2*-thresholding is however, iterative, time consuming and also
subjective as R2*/HIC measurement depends on the threshold chosen by the reviewer. Chapter 7
develops and validates an automatic vessel exclusion technique for extraction of liver
parenchyma, in order to improve the current clinical workflow in R2*-MRI based HIC
quantification by reducing interpretation time and operator input.

Figure 4-3. Extraction of liver parenchyma based on T2* thresholding. First, an ROI tracing the
liver border on the acquired slice is drawn (Step 1) and the blood vessels are excluded using a
certain threshold value based on histogram analysis (Step 2). Steps 2 and 3 are repeated by readjusting the T2* threshold until a visual confirmation is made that all vessel pixels were
excluded. The red pixels in Step 3 represent the extracted parenchyma and the mean R2* of these
pixels gives the mean liver R2* value.

4.4

Framework for Accurate Automated R2*-based HIC

This proposed research will thus focus on providing solutions for the above three issues, i.e., a)
respiratory motion artifacts in image acquisition, b) signal modeling in presence of fat, and c)
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operator dependence in extracting the liver parenchyma, in order to improve the accuracy and
optimize the current clinical workflow of R2*-MRI based HIC assessments. Based on these
solutions, the following R2*-MRI based HIC estimation framework (Figure 4-4) is proposed with
respect to, image acquisition, signal model selection and extraction of liver parenchyma, for
producing accurate and automated R2*-MRI based HIC assessments: Data acquired from a breathhold multiecho GRE or a free-breathing multiecho UTE will be processed by fitting either a monoexponential signal model in the absence of fat or via ARMA modeling in the presence of fat to
produce R2* maps, and finally the liver parenchyma will be automatically extracted using vessel
exclusion technique to estimate the mean R2*-MRI based HIC.

74

Figure 4-4. Framework for accurate automated R2*-MRI based HIC assessment. Data acquired
from a breath-hold multiecho GRE or a free-breathing multiecho UTE will be processed by
fitting either a mono-exponential signal model in the absence of fat or via ARMA modeling in
the presence of fat to produce R2* maps, and finally the liver parenchyma will be automatically
extracted using vessel exclusion technique to estimate the mean R2*-MRI based HIC.
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Chapter 5
Radial UTE Imaging Removes the Need for Breath-holding in Hepatic Iron Overload
Quantification by R2*-MRI

5.1

Introduction

Iron overload is a serious condition that usually arises from increased gastrointestinal absorption
of dietary iron (e.g., hereditary hemochromatosis) or from multiple blood transfusions (e.g., for
sickle cell disease, β-thalassemia, or myelosuppression during chemotherapy).1-5 Because the
body has no effective physiologic mechanism for excreting it, iron can accumulate in the liver
and other organs, eventually causing organ damage.26, 153 Iron overload can result in significant
morbidity and mortality if it is not effectively monitored and treated.49, 154
Hepatic iron content (HIC) is a reliable marker for total body iron accumulation.44 The
traditional reference standard for assessing HIC is liver biopsy,6 but this procedure is invasive
and painful, has sampling variability,7 and is associated with risks such as bleeding and
infection.8 In recent years, R2* MRI has been increasingly used as a non-invasive alternative to
liver biopsy for HIC quantification. R2* MRI is based on a linear correlation between HIC and
the tissue-specific MR relaxation parameter R2*.9-11 R2* is determined by quantifying the signal
decay of a Cartesian multiecho gradient-recalled echo (GRE) sequence typically measured in a
single breath-hold (BH). However, breath-holding is not possible for sedated patients and is
problematic for patients who have difficulty holding their breath for a short period. Problems
with breath-holding can lead to poor image quality caused by respiratory motion artifacts. The
artifact signal may introduce errors in the quantification of R2*-based HIC because calibration
equations have been established only for BH examinations of liver tissue void of artifacts.
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Several attempts have been made to overcome breathing artifacts in patients who are not
able to complete BH maneuvers. Respiratory gating based on external bellows or navigator
methods can mitigate breathing artifacts.155-157 However, such techniques add additional steps
and complexity to the clinical workflow, increase the total scan time, and can fail if patients have
irregular breathing patterns.158, 159 Signal averaging is an alternative to respiratory gating, and is
the most commonly used solution for sedated patients and for young children who cannot hold
their breath during thoracic and abdominal imaging.160 Signal averaging reduces motion artifacts
by decreasing the relative contribution of a motion-corrupted signal component compared with
the overall signal. However, increasing the number of averages also increases the scan time.
Radial sampling techniques are robust to respiratory motion because of oversampling of the
center of the k-space which is traversed with every radial projection.161, 162 Azevedo et al. 163 and
Chandarana et al. 164 demonstrated the clinical feasibility of using a free-breathing (FB) 3D T1weighted radial volumetric interpolated BH examination as a viable alternative to abdominal
imaging for sedated pediatric patients and patients who are unable to suspend respiration.
In the context of visceral iron quantification, ultrashort TE (UTE) imaging has been
proposed for imaging tissues with very short T2 or T2* components.134, 142 UTE imaging uses
half radiofrequency pulse excitations with radial center-out data sampling.134 Krafft et al. 143
showed the technical feasibility of multiecho UTE imaging for R2* quantification in patients
with massive hepatic iron overload (HIC > 25 mg Fe/g of dry liver weight). Because of the radial
sampling process, this sequence is relatively insensitive to respiratory motion and thus can
potentially overcome the limitations introduced by motion artifacts during R2*-based HIC
quantification.
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The purpose of this study is to evaluate R2* quantification by radial FB multiecho UTE
for sedated patients and for subjects who are not able to complete BH maneuvers. We compare
FB multiecho UTE imaging with a commonly used alternative technique: Cartesian FB
multiecho GRE imaging with multiple averages. We further compare the liver R2* values
obtained using the conventional Cartesian BH multiecho GRE technique in a control group of
patients undergoing R2* MRI for HIC quantification (the group consists only of patients who
could complete BH maneuvers).

5.2

Subjects and Methods

5.2.1 Participants
This retrospective study was approved by the institutional review board of St. Jude Children’s
Research Hospital. Data were collected from patients who underwent MRI for HIC assessment.
Patients were retrospectively assigned to either a test cohort or a control cohort. The cohorts
were differentiated on the basis of the imaging performed: patients who were unable to complete
BH maneuvers underwent FB multiecho GRE and FB multiecho UTE imaging, and patients who
were able to complete BH maneuvers underwent BH multiecho GRE, FB multiecho GRE, and
FB multiecho UTE imaging.
Test cohort (patients unable to complete BH maneuver) — All test subjects were consecutively
recruited from our ongoing institutional MIDAS (Massive Iron Deposit Assessment, National
Clinical Trials identifier 01572922 on ClinicalTrials.gov) study during the period from July 2012
to March 2016. A total of 130 patients underwent scanning performed in accordance with the
MIDAS protocol during this period. Of these 130 patients, 51 could not complete BH maneuvers
and had both FB examinations performed. One dataset could not be processed because of

78

technical issues; therefore, 50 patients (19 male patients and 31 female patients; median [± SD]
age, 6.6 ± 7.0 years; range, 1.6–33.1 years) were assigned to the test cohort.
Of the 50 participants, 40 (16 male patients and 24 female patients; median age, 5.9 ± 5.8
years; range, 1.6–33.1 years) received sedation and 10 (three male patients and seven female
patients; median age, 11.6 ± 8.2 years; range, 5.9–31.5 years) did not receive sedation but were
unable to complete BH maneuvers. Diagnoses included sickle cell disease (n = 28), βthalassemia major (n = 6), Diamond-Blackfan anemia (n = 3), acute myeloid leukemia (n = 2),
severe aplastic anemia (n = 1), acute lymphocytic leukemia (n = 5), Wilms tumor (n = 1),
adrenocorticocarcinoma (n = 1), Langerhans cell histiocytosis (n = 1), myelodysplastic syndrome
(n = 1), and severe combined immunodeficiency (n = 1).
The use of sedation is governed by institutional policies and is usually offered to patients
younger than 7 years. After the MRI procedure has been discussed, the decision to sedate is
made jointly by referring clinicians, child life specialists, and the patient, legal guardian, or both.
All nonsedated patients were asked to comply with the BH maneuvers during multiecho GRE
image acquisition. If the MRI technologists saw motion artifacts on the acquired BH images,
they repeated acquisition several times. If severe motion artifacts were still visible, then the
patient was asked to relax and take shallow breaths, and FB multiecho GRE imaging with
multiple averages was then performed. The reasons for BH failure were not documented by the
technologists; however, the patient group was frail and often had signs of sleepiness and
exhaustion, regardless of age.
Control cohort (patients able to complete BH maneuver)—From September 2015 to March 2016,
control data were consecutively collected from patients undergoing standard diagnostic MRI for
HIC assessment at St. Jude Children’s Research Hospital. A total of 16 consecutive patients (six
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male patients and 10 female patients; median age, 16.2 ± 5.8 years; range, 10.8–32.9 years) did
not receive sedation, were BH compliant (for approximately 21 seconds), and completed all three
examinations (one BH and two FB examinations), and they therefore qualified for inclusion in
this retrospective study. Diagnoses included sickle cell disease (n = 9), β-thalassemia major (n =
3), acute myeloid leukemia (n = 2), and acute lymphocytic leukemia (n = 2).

5.2.2 MRI Scans
MRI scans were obtained using a 1.5-T MRI scanner (Magnetom Avanto, Siemens Healthcare)
with body and spine array coils used for signal reception. All scans were obtained on a single
transverse slice at the location of the main portal vein of the liver. The sequence parameters used
for the acquisition of BH multiecho GRE images were as follows: TR/TE1, 200/1.1 ms; echo
spacing 0.8 ms; 20 echoes; bipolar readout gradient; matrix size, 128 × 104 (readout × phaseencoding direction); slice thickness, 10 mm; pixel bandwidth, 1950 Hz/pixel; flip angle, 35°; and
scan time, 21 seconds.
FB multiecho GRE image acquisitions were performed using the same imaging
parameters used for the acquisition of BH multiecho GRE images, but three to five averages
were used, resulting in a scan time of 63–105 seconds. The FB multiecho UTE sequence was
applied with three interleaved echo trains (shifted by a change in TE increment of 0.5 ms), in
accordance with the method described by Krafft et al.143 Sequence parameters used for the FB
multiecho UTE sequences were as follows: TR/TE1, 52.5/0.1 ms; echo spacing, 1.8 ms; 12
echoes per interleave; 192 radial lines; flip angle, 20°; slice thickness, 10 mm; pixel bandwidth,
780 Hz/pixel; and scan time, 60 seconds. For the FB multiecho UTE acquisition, two spatial
saturation bands were placed parallel to the imaging slice (gap between saturation band and
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imaging slice, 10 mm; saturation band thickness, 100 mm) to eliminate out-of-slice signal
contributions, and chemically selective saturation radiofrequency pulses were applied to reduce
radial streaking artifacts.143 The readout FOV for all acquisitions ranged from 250 to 500 mm
with phase FOV of 68–81%, depending on patient body size. The FOV for FB multiecho UTE
imaging was 100 mm larger than the readout FOV for FB multiecho GRE imaging, to match the
voxel sizes.
To test for the presence of fat in the liver, an additional multiecho GRE sequence
(obtained with the following parameters: TR/TE1, 200/1.1 ms; echo spacing, 1.4 ms; 20 echoes;
matrix size, 128 × 104; slice thickness, 5 mm; pixel bandwidth, 1950 Hz/pixel; flip angle, 45°;
and scan time, 21 seconds) with a monopolar readout gradient was also acquired at the same
slice location in both the control and test cohorts.

5.2.3 Presence of Hepatic Fat, R2* Mapping, and Image Analysis
The present study focused on quantifying R2*as a surrogate marker for HIC in patients with iron
overload. However, R2* quantification is affected by the presence of fat 30. Therefore, all
patients were tested for hepatic steatosis by applying a published auto-regressive movingaverage algorithm for fat-water quantification165, 166 to the acquired multiecho GRE data before
further R2* analysis was conducted. The algorithm was implemented using Matlab (version 8.1,
MathWorks). Cases with a fat fraction of 5% or more (i.e., steatosis grade 1 or higher167) were
excluded from R2* comparisons.
For all acquisitions across both cohorts, quantitative R2* maps were calculated using
Matlab. On a pixel-by-pixel basis, the signal decay was fitted to a monoexponential decay by use
of a nonlinear least-squares fit method, which accounts for bias caused by Rician noise.125, 168 To
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quantify mean liver R2* values, an ROI encompassing the whole liver in the acquired axial slice
was manually drawn, and blood vessels were excluded by histogram analysis for each patient, as
detailed elsewhere.151, 152 Because the FOV used for multiecho UTE imaging is larger than that
used for multiecho GRE imaging, the ROIs were drawn separately for multiecho GRE and
multiecho UTE images. However, outlining the whole liver is simple and straightforward
because it is guided by the outer borders of the liver; hence, the variability between the ROIs for
both acquisitions would be negligible.

5.2.4 Statistical Analyses
Statistical analysis was performed using a scientific data analysis and graphing software
(SigmaPlot, version 12.0, Systat Software) and Matlab. The mean (± SD) and range of R2*
values across different acquisitions and patient groups were determined. For the test cohort, the
mean R2* values between the two FB acquisitions were compared using the Wilcoxon signed
rank test for significant differences. For the control group, because there were three different
acquisitions, mean R2* values were first tested for statistically significant differences with the
use of repeated measures ANOVA, followed by the Tukey test for pairwise multiple
comparisons. No adjustment was made for age and sex between groups because the statistical
analysis focused on R2* accuracy and precision between acquisition methods, not between
groups, for individual patients.
Furthermore, for analysis of accuracy, linear regression and Bland-Altman analysis were
performed for R2* values obtained using different sequences in both cohorts, to quantitatively
test for R2* bias introduced by respiratory motion artifacts. For analysis of precision, the
coefficient of variation (CV), which was calculated by dividing the SD by the mean R2* value,
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was compared between different acquisitions in both cohorts to assess the dispersion of the R2*
measurements. This two-step approach eliminated the need for a qualitative assessment that
encompassed grading of image quality by a radiologist, thereby avoiding intra- and interobserver
variability. For all statistical tests, a statistical significance level of p = 0.05 was used.

5.3

Results

Of the 50 test patients who could not complete the BH maneuver, four (two were sedated and
two were not sedated) had grade 1 hepatic steatosis (fat fraction, 5.4–30.5%) and were excluded
from analysis. The final cohort consisted of 16 control patients who were able to complete the
BH maneuver and 46 test patients (17 male patients and 29 female patients; median age, 6.6 ±
5.6 years; range, 1.6–31.5 years) who were not able to complete the BH maneuver (38 were
sedated and eight were not sedated).
In both cohorts, FB multiecho GRE images showed motion artifacts and also quantitatively
showed poorer image quality (i.e., a larger SD of the R2* value) than did the FB multiecho UTE
images. As an example, Figure 5-1 shows magnitude images of the liver and the respective R2*
maps of BH multiecho GRE, FB multiecho GRE, and FB multiecho UTE acquisitions from a
control patient with mild iron overload (R2*-based HIC from BH multiecho GRE acquisition,
5.4 mg Fe/g of dry liver weight). FB multiecho GRE images showed substantial motion
(ghosting) artifacts that spanned the entire liver parenchyma, a lower mean liver R2* value, and
a higher SD compared with standard BH multiecho GRE images (R2*, 154 s−1 ± 38 s−1 vs 192
s−1 ± 19 s−1, respectively). In contrast, the FB multiecho UTE images had no motion artifacts and
only mild blurring, and the mean liver R2* and SD were close to those noted with the use of the
standard BH multiecho GRE sequence. Similarly, Figure 5-2 shows images and respective R2*
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maps from a sedated child with high iron overload (> 15 mg Fe/g of dry liver weight). FB
multiecho GRE images showed that breathing motion resulted in many arclike artifacts that
obscured the underlying anatomy and translated into an erroneous R2* map, whereas FB
multiecho UTE images showed only minimal streaking artifacts and thus produced a clean R2*
map. In this case, the mean liver R2* value calculated by FB multiecho GRE acquisition was
22% lower than that calculated by FB multiecho UTE acquisition, which would directly translate
to an underestimation of approximately 4 mg Fe/g of dry liver weight in the high R2* range,
according to linear R2* HIC conversions.11, 152

Table 5-1. Liver R2* Values for Different MRI Acquisitions and Patient Cohorts
Control Cohort
Test Cohort
Sedated
BH
Liver R2*
Value
Mean ± SD
(s-1)
Range (s-1)

FB

FB

FB

Nonsedated
FB

FB

FB

Multiecho Multiecho Multiecho Multiecho Multiecho Multiecho Multiecho
GRE

GRE

UTE

GRE

UTE

GRE

UTE

332 ± 243 284 ± 196a 319 ± 233 312 ± 244a 332 ± 254 44* ± 370a 488 ± 398
123 –1018 122 – 870 120 – 956 31 – 1004 34 – 1075 158 – 576 166 – 662

Note–The mean R2* values were compared for breath-hold (BH) multiecho gradient-recalled
echo (GRE), free-breathing (FB) multiecho GRE, and FB multiecho ultrashort TE (UTE)
acquisitions in the control cohort, by use of the repeated measures ANOVA, and for FB
multiecho GRE and FB multiecho UTE acquisitions in the test cohort, by use of the Wilcoxon
signed rank test. aR2* values for FB multiecho GRE imaging were significantly different from
those for standard BH multiecho GRE and FB multiecho UTE imaging in the control cohort and
from those for FB multiecho UTE imaging in the test cohort.

Table 5-1 summarizes the range and mean R2* values for different acquisitions and patient
groups. With the use of repeated measures ANOVA, the mean liver R2* values from FB
multiecho GRE imaging were statistically significantly lower in the control cohort than were
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those from standard BH multiecho GRE imaging and FB multiecho UTE imaging (p < 0.05),
whereas the mean liver R2* values from FB multiecho UTE imaging were not statistically
significantly different from the values from BH multiecho GRE imaging. Similarly, in the test
cohort, the mean liver R2* values from FB multiecho GRE imaging were significantly lower
than those from FB multiecho UTE imaging (p < 0.05), by use of the Wilcoxon rank test for both
the sedated and nonsedated subgroups of patients.

Figure 5-1. 13-year-old girl with sickle cell disease and mild iron overload who, as control
patient, had breath-hold (BH) and free-breathing (FB) MRI sequences compared.
A–F, First-echo magnitude MR images of liver (A, C, and E) and respective R2* maps (B, D,
and F) acquired by BH multiecho gradient-recalled echo (GRE) (A and B), FB multiecho GRE
(C and D), and FB multiecho ultrashort TE (UTE) (E and F) imaging. For each acquisition, mean
R2* (± SD) was calculated for whole-liver ROI (blue outline, A–F) after exclusion of blood
vessels by histogram analysis. BH multiecho GRE R2* MRI–based hepatic iron content (HIC) of
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5.4 mg Fe/g of dry liver weight (calculated using calibration equation in 152) served as reference
standard because existing calibration curves were derived from such examinations. Typical FB
multiecho GRE motion artifacts (arrows, C and D) are seen. For FB multiecho GRE acquisition,
R2* values are lower and SD is higher than values for BH multiecho GRE and FB multiecho
UTE acquisitions. Note that R2* value obtained using FB multiecho UTE imaging is in close
agreement with that obtained using BH multiecho GRE imaging, which suggests that FB
multiecho UTE acquisition provides accurate results under FB conditions. Applying BH
multiecho GRE R2* HIC calibration equation152 to respective R2* values results in apparent HIC
of 4.2 mg Fe/g of dry liver weight for FB multiecho GRE imaging and 5.1 mg Fe/g of dry liver
weight for FB multiecho UTE imaging.

Figure 5-2. 10-year-old girl with sickle cell disease and high iron overload who was sedated.
A–D, First-echo magnitude MR images of liver (A and C) and respective R2* (B and D) maps
acquired by free-breathing (FB) multiecho gradient-recalled echo (GRE) imaging (A and B) and
FB multiecho ultrashort TE (UTE) imaging (C and D) show comparison of FB sequences. Mean
R2* value (± SD) was calculated for whole-liver ROI (blue outline, A–D) after exclusion of
blood vessels by histogram analysis. Motion artifacts (arrows) are visible on magnitude image
(A) and R2* map (B) acquired using FB multiecho GRE imaging. Mean R2* value obtained by
FB multiecho GRE imaging was lower by 22% and SD was twofold higher, compared with FB
multiecho UTE imaging. In contrast, FB multiecho UTE (C and D) images were cleaner than FB
multiecho GRE images (A and B), with only minor residual streaking artifacts from radial
sampling. FB multiecho UTE R2* map (D) shows better representation of portal vein than does
FB multiecho GRE R2*map (B). Applying BH multiecho GRE R2* hepatic iron content (HIC)
calibration equation152 to calculated R2* values results in HIC of 17.9 mg Fe/g of dry liver
weight for FB multiecho UTE imaging and HIC of 13.9 mg Fe/g of dry liver weight for FB
multiecho GRE imaging, which may be indicative of HIC underestimation.
86

Figure 5-3 and Figure 5-4 show the results of linear regression and Bland-Altman analysis
of mean liver R2* values obtained by different acquisitions for the control and test cohorts. In
the control cohort, the mean liver R2* values from FB multiecho UTE imaging were in close
agreement with those from BH multiecho GRE imaging, with a slope of 0.96 and a mean bias of
−12.9 s−1. In contrast, R2* values from FB multiecho GRE imaging were underestimated, with a
slope of 0.8 and a mean bias of −48.2 s−1, compared with those of BH multiecho GRE imaging.
Similarly, in the test cohort, the mean R2* values measured by FB multiecho GRE imaging were
consistently lower than those measured by FB multiecho UTE imaging, with a mean bias of
−24.6 s−1. Within the test cohort, the underestimation of R2* values is greater for nonsedated
patients (slope, 0.83; mean bias, 45.4 s−1) than for sedated patients (slope, 0.96; mean bias, −20.2
s−1).

Figure 5-3. Mean liver R2* values obtained using different MRI acquisitions in control cohort.
A and B, In linear regression plot (A) and Bland-Altman plot (B), circles denote data for patients
who underwent FB multiecho gradient-recalled echo MRI, and triangles denote data for patients
who underwent FB multiecho ultrashort TE imaging. In regression plot (A), solid lines denote
regression lines for data points, and dashed line denotes unity line. In Bland-Altman plot (B),
solid lines denote mean bias, and dashed lines denote 95% CIs (± 2 SD). Regression equations,
correlation coefficients (R2), and mean biases for different comparisons are also included in
plots.
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Figure 5-4. Mean liver R2* values obtained using free-breathing (FB) multiecho gradientrecalled echo (GRE) and FB multiecho ultrashort TE (UTE) MRI acquisitions in test cohort.
A and B, In both linear regression plot (A) and Bland-Altman plot (B), gray circles denote
sedated patients, and black circles denote nonsedated patients. In regression plot (A), solid line
denotes regression line for entire test cohort (both sedated and nonsedated patients), and dashed
line denotes unity line. Regression plot (A) also includes regression equation and correlation
coefficient (R2) for regression analysis. In Bland-Altman plot (B), thick solid line denotes mean
bias and dashed lines represent 95% CIs (± 2 SD); mean bias value is also shown. Within test
cohort, regression equation was y = 0.96*x – 5.55, R2 = 0.99, and mean bias was −20.2 s−1 for
sedated group, whereas regression equation was y = 0.83*x + 37.62, R2 = 0.96, and mean bias
was –45.4 s−1 for nonsedated group.

Figure 5-5 shows scatterplots of the mean R2* values and CV R2* values measured using
different acquisition techniques in the control and test cohorts. For the control cohort, the mean
R2* CV for FB multiecho GRE imaging (25.9% ± 8.6%) was almost double that for BH
multiecho GRE imaging (15.4% ± 5.5%), whereas it is even lower for FB multiecho UTE
imaging (11.1% ± 3.1%). Likewise, for the test cohort, the mean R2* CV for FB multiecho GRE
imaging (18.7% ± 6.4%) was double that for FB multiecho UTE imaging (9.6% ± 2.7%). Also,
within the test cohort, the mean R2* CV for FB multiecho GRE imaging was higher for the
nonsedated subgroup than for the sedated subgroup. For both cohorts, the R2* CV for FB
multiecho UTE imaging was relatively constant over the entire range of R2* values, but the R2*
CV for FB multiecho GRE imaging increased with an increase in R2* values.
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Figure 5-5. Coefficients of variation (CVs) of R2* values obtained using different MRI
acquisitions in control and test cohorts. A, Scatterplot for control cohort shows that R2* CV
ranged from 10.0% to 26.2% (mean [± SD], 15.4% ± 5.5%) for breath-hold (BH) multiecho
gradient-recalled echo (GRE) (pink diamonds), 16.7–48.1% (mean, 25.9% ± 8.6%) for freebreathing (FB) multiecho GRE (red circles), and 6.0–18.9% (mean, 11.1% ± 3.1%) for FB
multiecho ultrashort TE (UTE) (blue triangles) imaging. B, Scatterplot for test cohort shows that
R2* CV ranged from 8.2% to 36.2% (mean, 18.7% ± 6.4%) for FB multiecho GRE imaging
(circles) and from 5.1% to 18.9% (mean, 9.6% ± 2.7%) for FB multiecho UTE imaging
(triangles). Red circles and blue triangles show data for sedated patients; black circles and black
triangles show data for nonsedated patients. Within test cohort, mean R2* CV for sedated and
nonsedated subgroups was 18.0% ± 6.4% and 22.1% ± 10.9%, respectively, for FB multiecho
GRE, and 9.8% ± 2.7% and 8.9% ± 5.6% respectively, for FB multiecho UTE. For both test and
control cohorts, R2* CV for FB multiecho UTE was relatively constant over entire range of R2*
values, whereas R2* CV for FB multiecho GRE increased with increase in R2*.

5.4

Discussion

The accurate quantification of hepatic R2* values is essential in guiding the management of
patients with iron overload. R2*-based HIC assessment was useful for deciding when to initiate
iron chelation therapy, and, more importantly, it enables the precise modification of ongoing
doses in patients with high HIC values. FB multiecho GRE imaging acquisitions are susceptible
to motion and exhibit artifacts in the phase-encoding direction that can appear within the liver
parenchyma and eventually hamper R2*-based HIC estimation. Our study shows that FB
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multiecho UTE imaging yields much better image quality and R2* maps than does
multiaveraged FB multiecho GRE imaging performed within the same scan time. Furthermore,
the R2* values from FB multiecho UTE imaging are in close agreement with those from
standard BH multiecho GRE imaging and provide superior accuracy (i.e., a lower CV) when
compared with FB multiecho GRE imaging. Hence, FB multiecho UTE imaging could replace
FB multiecho GRE imaging for potentially more accurate R2* quantification in patients who are
unable to hold their breath during the scan.
In both cohorts, Cartesian FB multiecho GRE images showed substantial motion
artifacts, compared with radial FB multiecho UTE images. The motion artifacts were primarily
introduced by overlap of the high signal from the subcutaneous abdominal fat and the smearing
of blood vessels. Because the R2* value of fat and blood is lower than the R2* value of ironoverloaded liver, the motion artifacts seen on FB multiecho GRE images resulted in significantly
lower R2* values than did standard BH multiecho GRE images and FB multiecho UTE images
in the control cohort and FB multiecho UTE images in the test cohort. Applying fat suppression
techniques such as STIR and chemically selective saturation can reduce the contamination of
liver tissue by the overlapped fat signal. However, motion artifacts from the skin, residual
subcutaneous fat, and smearing of blood vessels and other organs (e.g., kidneys) into the liver
tissue can still corrupt the true liver signal (Figure 5-6).
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Figure 5-6. 10-year-old girl with sickle cell disease and high iron overload who was sedated
(same patient as in Figure 5-2). A and B, First-echo magnitude MR image (A) and respective
R2* map (B) of liver acquired with fat-saturated free-breathing multiecho gradient-recalled echo
sequence. Fat was suppressed by applying chemically selective saturation radiofrequency pulses.
Although subcutaneous fat signal, which mainly contributed to motion artifacts and R2* bias,
was suppressed, motion-induced artifacts (arrows) from skin, blood vessels, and kidneys could
contaminate liver signal and thereby corrupt R2* quantification.

The mean R2* CV for FB multiecho GRE imaging was approximately twofold greater
than the mean R2* CVs for BH multiecho GRE imaging and FB multiecho UTE imaging in the
control cohort and the mean R2* CV for FB multiecho UTE imaging in the test cohort. This is
because of the motion artifacts that promote greater signal variation in the liver, causing
increased dispersion (SD) in the calculated R2* values and thus resulting in a higher CV. In the
control cohort, the mean R2* CV for FB multiecho UTE imaging is even smaller than that for
BH multiecho GRE imaging (especially for R2* > 200 s−1), which might be from shorter TEs
and a greater number of echoes for FB multiecho UTE imaging, compared with BH multiecho
GRE imaging, that increased the fit accuracy of FB multiecho UTE imaging. The R2* CV for FB
multiecho UTE imaging was less than 15% for all patients, with the exception of one patient in
each cohort, as a result of heterogeneous iron distribution between the liver lobes. The R2* CV
for the FB multiecho UTE acquisition was relatively constant over the entire range of R2*
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values, but the R2* CV for the FB multiecho GRE acquisition increased with an increase in R2*,
thus introducing a higher degree of uncertainty at high HIC values.
Between cohorts, underestimation of the R2* and the R2* CV by FB multiecho GRE
imaging was higher in the control cohort (slope, 0.80) than in the test cohort (slope, 0.94).
However, in the test cohort, underestimation of R2* for the few patients in the nonsedated
subgroup (slope, 0.83) was similar to that for the control cohort, whereas the sedated subgroup
showed relatively lower R2* bias (slope, 0.96). This might be for the reason that the patients in
the sedated group generally have a shallow breathing pattern because of the effects of sedation
and also because of their young age (median age, 5.9 years). In contrast, the nonsedated test subgroup and the control cohort comprised relatively older patients with wider chest excursions
during breathing and comparatively more subcutaneous fat; this might have led to more
pronounced artifacts, R2* underestimation, and a higher R2* CV.
Instead of contouring the entire liver ROI in a cross section, a small ROI in an area
devoid of blood vessels and artifacts could be drawn and used for R2* analysis. However, for
most patients in the present study, motion artifacts extended over the entire cross section of the
liver, so it would have been very difficult to identify an unaffected ROI that was free of artifacts.
Moreover, small ROI analysis is potentially more prone to interreviewer variability,152 and is
problematic in cases in which the iron distribution is heterogeneous.110, 169
FB multiecho UTE imaging was less sensitive to motion because of radial sampling.
Consequently, radial multiecho GRE techniques should also be useful in the context of
minimizing respiratory-induced artifacts under FB. However, apart from radial sampling, another
advantage of FB multiecho UTE imaging is that it has TEs shorter than those for standard
multiecho GRE acquisitions. Therefore, multiecho UTE imaging allows the measurement of
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higher R2* values in cases of massive iron overload143 for which standard Cartesian or radial
multiecho GRE acquisitions are unsuccessful.10, 11
Translation of findings from FB multiecho UTE imaging to clinical practice requires
good agreement of R2* values measured by FB multiecho UTE with those measured by the
reference BH multiecho GRE method. Our results for the small group of control patients who
were able to complete BH maneuvers showed that the mean liver R2* values from FB multiecho
UTE imaging were not significantly different from those from BH multiecho GRE imaging, with
a slope of 0.96 determined by linear regression. These findings are consistent with earlier
findings in phantoms.143
Our study has some limitations. Manual exclusion of the blood vessels152 could
potentially introduce bias in the R2* evaluation through thresholding for vessels that may present
differently in a subject for Cartesian and radial acquisition techniques. Also, to our knowledge,
no published calibration studies currently exist that compare multiecho UTE imaging–based
hepatic R2* values and HIC values determined from biopsy. However, our study showed that
mean liver R2* values acquired with biopsy-calibrated BH multiecho GRE and FB multiecho
UTE imaging were fairly similar in the 16 patients who could complete BH maneuvers. Clearly,
these findings need to be validated in a larger group of patients.
Furthermore, subtle streaking artifacts resulting from radial undersampling are still
visible on FB multiecho UTE images; however, their impact on quantification seems negligible,
as can be seen from the comparison with BH multiecho GRE images in the control cohort. There
is a small cost for artifact-free FB multiecho UTE imaging–based iron assessment, which has an
acquisition time (60 seconds) approximately three times longer than that of BH multiecho GRE
acquisition (approximately 21 seconds) because of an interleaved TE scheme for dense sampling
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of the T2* decay. However, preparation of the patient before the procedure (e.g., providing the
patient with breathing instructions) and recuperation after the BH multiecho GRE acquisition can
result in a total duration of approximately 1 minute, too. Nevertheless, for patients who can
complete the BH maneuver, we recommend the use of conventional BH multiecho GRE for R2*
quantification because the existing R2* HIC calibrations are based on equivalent BH multiecho
GRE acquisitions. However, for sedated children and for patients who have difficulties holding
their breath, FB multiecho UTE acquisitions can be an alternative for accurate R2* quantification
because they minimize the uncertainties associated with R2*-based HIC quantification that are
introduced by breathing motion. More importantly, FB multiecho UTE images can be acquired
within the same scan time required to acquire conventional multiaveraged FB multiecho GRE
images without increasing the time that the patients spend on the table.
In conclusion, the results of the present study show that FB multiecho GRE images are
susceptible to respiratory-induced motion artifacts. This can lead to lower R2* values and,
consequently, R2* HIC underestimation. This underestimation seems to be more prominent, in
general, for nonsedated patients who are unable to complete BH maneuvers, compared with
sedated patients. R2* HIC underestimation will have a clinical impact by delaying initiation of or
prematurely discontinuing iron overload therapy (e.g., iron chelation). FB multiecho UTE
acquisitions yield excellent image quality and accurate R2* estimates that are consistent with
reference BH multiecho GRE data. Hence, FB multiecho UTE acquisition appears to be a
reliable method for R2* HIC assessment in sedated patients or patients who cannot complete BH
maneuvers, without having the limitations of conventional FB multiecho GRE acquisitions. FB
multiecho UTE imaging may replace FB multiecho GRE imaging for quantitative ascertainment
of iron in the liver of patients unable to complete BH scans.
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Chapter 6
Evaluation of the Performance of an Auto Regressive Moving Average Signal Model for
Fat-Water Separation and Accurate R2* Quantification

6.1

Introduction

Accurate calculation of R2* is essential for the precise assessment of HIC, which guides the
management of iron overload. Measurement of hepatic R2* by fitting a mono-exponential model
to the signal decay obtained from the multiecho GRE images is considered as the reference
standard.10, 11 However, the signal decay is not simple mono-exponential in patients with
steatosis, i.e. presence of fat in the liver. This is because, the presence of fat introduces
oscillations in the multiecho GRE signal and using a mono-exponential model will confound
R2* measurements.
The oscillations in the signal decay are caused because fat and water signals resonate at
slightly different frequencies, i.e., they differ by 220 Hz at 1.5T and 440 Hz at 3T, and become in
and out of phase at 4.6 and 2.3 ms, respectively at 1.5T.149 Some simple solutions to estimate
R2* in the presence of fat are either to combine or suppress the fat signal. The fat and water
signals can be combined by acquiring images at in-phase TEs (e.g., 4.6 ms, 9.2 ms, etc. at 1.5T).
However, this acquisition uses a large echo spacing that causes bias in R2* due to sparse
sampling of the rapid signal decay. Another solution is to suppress the fat signal by applying
chemically selective fat saturation pulses. But recent studies have shown that applying fat
saturation pulses in iron overloaded cases, even without fat, leads to R2* underestimation.170, 171
Another limitation of both these methods is that they do not consider the spectral complexity of
fat, i.e., the fat signal comprises of not a single peak but multiple peaks; 6 peaks identified in the
in-vivo fatty liver with MR spectroscopy.150
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To avoid these limitations, signal modeling techniques based on Non-linear Least
SQuares (NLSQ) have been developed and validated to perform multi-spectral fat-water
modeling and to quantify R2*.172, 173 These methods require a priori information about the
frequencies and relative amplitudes of the multiple peaks in the fat spectrum. Further, these
methods fit only a single R2* value for both, fat and water peaks in order to reduce the model
complexity despite fat and water having different T2* decays.174 Moreover, these methods have
only been validated for fat fraction (FF) quantification in the presence of only fat, but have not
been systematically tested in the presence of both fat and iron.
Recently, another signal modeling technique based on autoregressive moving average
(ARMA) model,165 has been presented for fat-water modeling in the absence of iron and to
quantify hepatic R2* in the presence of iron alone.175, 176 ARMA represents the MR signal
evolution as a rational polynomial in the z-domain and when applied to the multiecho GRE
signal can determine the amplitudes, relative frequencies and R2* rates specific for water and
multiple fat species via an iterative Stieglitz-McBride algorithm.165 The major advantages are
that ARMA (i) does not require any prior information about the amplitudes and relative
frequencies of fat peaks, (ii) produces a B0 field map without making any assumptions, and (iii)
provides separate R2* for fat and water species.
However, the performance of ARMA has not been systematically tested in presence of
both iron and fat, which is the condition in some blood transfusion patients, especially cancer
survivors,177, 178 and some patients with nonalcoholic fatty liver disease (NAFLD).179, 180
Therefore, the purpose of this study is to develop and validate a robust algorithm based on
ARMA modeling for performing fat-water separation and simultaneous R2* estimation in
phantoms and show its applicability in some in-vivo biopsy cases. Further, ARMA results will be
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compared to the results obtained using the standard mono-exponential model and the NLSQ fatwater model in the literature.

6.2

Theory

In the presence of water and fat signal components, the signal acquired at a single voxel at the
individual echo times (TEn) can be modeled by the following signal equation,175 neglecting B0
inhomogeneities and noise:
𝑀

𝑆(𝑇𝐸𝑛 ) = (𝐶𝑊 𝑒

∗
−(𝑖2𝜋𝑓𝑊 + 𝑅2,𝑊
)𝑇𝐸𝑛

∗

+ 𝐶𝐹 ∑ 𝛼𝑚 𝑒 −(𝑖2𝜋𝑓𝐹,𝑚+ 𝑅2,𝐹,𝑚)𝑇𝐸𝑛 )

(6.1)

𝑚=1
∗
∗
where 𝐶𝑊 and 𝐶𝐹 are the amplitudes of water and fat signals, respectively, 𝑅2,𝑊
and 𝑅2,𝐹,𝑚
are

the R2* values for water and multiple fat peaks, M represents the number of fat peaks,
𝑓𝑊 and 𝑓𝐹,𝑚 are the relative frequencies for water and multiple fat peaks, 𝛼𝑚 represents the
relative amplitudes of multiple fat peaks such that ∑ 𝛼𝑚 = 1.
For the NLSQ approach, the values of 𝛼𝑚 and 𝑓𝐹,𝑚 are fixed and values from Hamilton et
al. will be used.150 For the NLSQ approach, the values of 𝛼𝑚 and 𝑓𝐹,𝑚 are fixed and will be used
from Hamilton et al. work.150,45 Also, the NLSQ method will be modeled assuming a single R2*
∗
∗
value for water and fat peaks,174 i.e., 𝑅2,𝑊
= 𝑅2,𝐹,𝑚
. The NLSQ approach utilizes a graphcut

algorithm for B0 field estimation and is available in the ISMRM Fat-Water Toolbox.181 In
∗
∗
contrast, ARMA modeling will be used to solve for 𝐶𝑊 , 𝐶𝐹 , 𝛼𝑚 , 𝑓𝑊 , 𝑓𝐹,𝑚 , 𝑅2,𝑊
and 𝑅2,𝐹,𝑚
by

representing the above signal equation as a rational polynomial in z-transform and then
calculating the poles (𝜌𝑘 ) via an iterative Stieglitz-McBride algorithm:165
𝑇𝐸1 +(𝑛−1)∆𝑇𝐸

𝑆(𝑡) = (𝐶𝑊 𝑒

∗
−(𝑖2𝜋𝑓𝑊 + 𝑅2,𝑊
)𝑡

+ 𝐶𝐹 𝑒

∗
−(𝑖2𝜋𝑓𝐹 + 𝑅2,𝐹
)𝑡

)∗

∑
𝑡𝑖 =𝑇𝐸1
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𝛿(𝑡 − 𝑡𝑖 ) (6.2)

Equation 6.2 represents the MR signal from a simple 2-peak model with the water and main fat
peaks convoluted with a comb function. By taking the z-transform, equation 6.2 can be represented
as
𝑇𝐸1 +(𝑛−1)∆𝑇𝐸

𝑆(𝑧) =

∑

𝑇𝐸1 +(𝑛−1)∆𝑇𝐸

𝐶𝑊 𝑒

∗
−(𝑖2𝜋𝑓𝑊 + 𝑅2,𝑊
)𝑡

𝑧 −𝑡 +

𝑡𝑖 =𝑇𝐸1

∗

𝐶𝐹 𝑒 −(𝑖2𝜋𝑓𝐹 + 𝑅2,𝐹)𝑡 𝑧 −𝑡 (6.3)

∑
𝑡𝑖 =𝑇𝐸1

By applying summation of geometric series, equation 6.3 can be represented as
𝑆(𝑧) =

𝐶𝑊
1−𝑒

∗ )∆𝑇𝐸
−(𝑖2𝜋𝑓𝑊 + 𝑅2,𝑊

𝑧 −1

+

𝐶𝐹
∗

1 − 𝑒 −(𝑖2𝜋𝑓𝐹 + 𝑅2,𝐹)∆𝑇𝐸 𝑧 −1

(6.4)

Equation 6.4 can be extended to N number of chemical species/peaks and the GRE signal can be
represented as an ARMA process described as
𝑃(𝑧) 𝛼0 + 𝛼1 𝑧 −1 + ⋯ + 𝛼𝑁−1 𝑧 −(𝑁−1)
𝑆(𝑧) =
=
𝑄(𝑧)
1 + 𝛽1 𝑧 −1 + ⋯ + 𝛽𝑁 𝑧 −𝑁

(6.5)

After calculating the coefficients α and β using an iterative Stieglitz-McBride algorithm, the
poles (𝜌𝑘 ) can be calculated as roots of the denominator in Equation 6.5. The frequencies (𝑓𝑘 , in
ppm), R2*s, and amplitudes of water and fat peaks can be calculated from the poles and
coefficients as follows:
𝑓𝑘 =

𝐼𝑚[ln(𝜌𝑘 )]
2𝜋. ∆𝑇𝐸. 𝛾𝐵0

∗
𝑅2,𝑘
=

𝐶𝑘 =

𝑅𝑒[ln(𝜌𝑘 )]
∆𝑇𝐸

(6.6)

𝑃(𝜌𝑘 )
𝑑𝑄(𝑧 −1 )
′ (𝑧 −1 )
𝑤ℎ𝑒𝑟𝑒
𝑄
=
𝑄 ′ (𝜌𝑘 )
𝑑𝑧 −1

where Re and Im represent real and imaginary parts, γ is the gyromagnetic ratio and B0 is the
main magnetic field strength.
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6.3

Materials and Methods

6.3.1 Phantom Experiments
Phantom preparation
Twenty cylindrical 140 ml fat-iron phantoms were constructed from 2% agar-water mixtures,
peanut oil and bionized nonferrites (BNF) iron particles.168, 182 Phantoms with a combination of
varying iron concentrations (0, 7.5, 15, 30, 60 μg/ml) and fat percentages (0, 10, 20, 40%) that
cover the clinically relevant R2* and fat fraction ranges were created.
The agar-water mixture was created by adding 2% agar by weight to the water solution
containing the following in distilled, deionized water: 43 mM sodium dodecyl sulfate, 43 mM
sodium chloride and 0.3 mM Gd-DTPA (Magnevist). The mixture was stirred and heated until
the solution was clear. While the mixture was cooling, appropriate volumes of peanut oil were
measured by weight assuming the density of peanut oil (0.94 g/cm3). Peanut oil was chosen
because it has a proton MR spectrum similar to that of triglyceride protons in adipose tissue.183
Appropriate volumes of BNF iron particles measured using micropipettes and pre-measured
peanut oil were added to proper volumes of the agar-water mixture and stirred in a beaker until
the solution turned milky. Then the solution was carefully poured into the phantom bottles
without creating any air bubbles and cooled to room temperature to form a solid gel. Caution was
exercised so that the agar-water mixture was at right temperature (~55-60 oC), when mixing with
the oil. If the mixture is too hot, then the oil and agar-water mixture do not mix well and will
form fat bubbles. In contrast, if the mixture cools down too much, then the agar-water mixture is
no longer in a liquid state and will not mix properly with the oil and iron particles.
MRI scans
All phantom bottles were stacked into a 4x5 rectangular array and scanned on 1.5T (Avanto,
Siemens Healthineers) and 3T (Skyra, Siemens Healthineers) scanners. The phantoms were
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scanned using a multiecho GRE sequence acquired with a monopolar readout gradient. The
following were the acquisition parameters for the first multiecho GRE acquisition (single-shot
GRE): TR = 200 ms, TE1 = 1.2 ms, ΔTE = 1.44 ms at 1.5T and 1.48 ms at 3T, flip angle = 25°,
10 echoes, matrix = 128x104, slice thickness = 10 mm. Then, a second multiecho GRE sequence
was acquired with the similar acquisition parameters but by incrementing the TEs of the first
acquisition by 0.72 ms at 1.5T and 0.74 ms at 3T. Combining the two GRE acquisitions (dualshot GRE) created dense sampling and reduced the combined ΔTE to 0.72 ms and 0.74 ms at
1.5T and 3T respectively.

6.3.2 In-vivo Data
In-vivo data was collected from two patients from our ongoing, institutional MIDAS (Massive
Iron Deposit Assessment, www.clinialtrails.gov NCT01572922) study who had both biopsy and
MRI scans for clinical monitoring of HIC. One patient with primary diagnosis of acute
lymphoblastic leukemia, had both iron overload and steatosis as confirmed by biopsy. Another
patient with primary diagnosis of sickle cell disease, had biopsy-confirmed severe iron overload
and no steatosis. Biopsy HIC was determined using atomic absorption spectrophotometry. Both
patients were scanned on a 1.5T (Avanto, Siemens Healthineers) MRI scanner using a breathhold multiecho GRE sequence with a monopolar readout gradient. The following were the
acquisition parameters: TR/TE1/ΔTE = 200/1.07/1.51ms, 20 echoes, flip angle = 45°, matrix =
128x104, slice thickness = 5 mm.
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6.3.3 Data Analysis
Quantitative R2* maps were calculated using the magnitude-based mono-exponential model,11,
125

and simultaneous R2* and FF maps were obtained using 2 complex-based fat-water modeling

techniques: NLSQ and ARMA described in the Theory section (6.2). All models were
implemented in Matlab (Mathworks, Natick, MA) to compute the R2* and FF maps in phantoms
and in-vivo data. In fat-iron phantoms, the performances of mono-exponential, NLSQ and
ARMA models were evaluated using single-shot and dual-shot GRE acquisitions. The mean R2*
values calculated using the mono-exponential model in pure iron phantoms were considered as
reference values for comparisons with other phantoms and methods. Mean (± standard deviation
(SD)) R2* results obtained with mono-exponential, NLSQ and ARMA methods were compared
to the reference R2* values in iron phantoms with varying FFs, and mean (±SD) FF results
obtained with NLSQ and ARMA methods were compared to the true FFs in fat phantoms with
varying iron concentrations using linear regression analysis. In patients, the R2* and FF maps
using each of the methods were compared with each other and to the biopsy results.

6.4

Results

6.4.1 Phantoms
Single-shot GRE
Figure 6-1 shows the mean (±SD) R2* values calculated using mono-exponential, NLSQ and
ARMA models plotted against reference R2* values for varying FFs using the single-shot GRE
acquisition at both 1.5T and 3T field strengths. For iron phantoms with no/low FF (0, 10%),
mono-exponential and ARMA models showed a linear relationship with reference R2* values
(Table 6-1, slopes: 0.89 – 1.06, R2> 0.99) whereas NLSQ slightly overestimated for the highest
R2* (slopes: 1.19 – 1.35, R2≥ 0.99) at both field strengths. In contrast, for iron phantoms with
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increasing FFs (i.e., 20, 40%), mono-exponential and ARMA models overestimated R2* values
at 1.5T (slopes: 1.24 – 1.99, R2> 0.99) and underestimated at 3T (slopes: 0.44 – 0.77, R2≥ 0.96)
for the highest R2*/iron concentration whereas NLSQ R2* values were getting close to reference
R2* values for higher FFs (slope: 1.08 – 1.25, R2> 0.99).
Figure 6-2 shows the mean (±SD) FF values calculated using the NLSQ and ARMA
models plotted against true FFs for varying iron concentrations using the single-shot GRE
acquisition at 1.5T and 3T field strengths. Both, NLSQ and ARMA FFs showed linear
relationship (Table 6-1, slopes: 0.99 – 1.19, R2≥ 0.99) with true FFs for no/low (0 – 15 μg/ml)
iron concentrations at 1.5T. However, at high iron concentrations (30, 60 μg/ml), NLSQ
overestimated and ARMA underestimated FFs and both produced high SDs. At 3T, ARMA
completely failed in fat-water separation and produced ~0% FFs whereas NLSQ overestimated
FFs for higher iron concentrations.
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Figure 6-1. R2* results for single-shot GRE acquisition. Mean (±SD, as error bars) R2* values
obtained by mono-exponential (first column), NLSQ (second column) and ARMA (last column)
methods plotted against reference R2* values in iron phantoms for varying FFs at 1.5T (top row)
and 3T (bottom row) using the single-shot GRE sequence. The black dotted line indicates the
unity line. For iron phantoms with increasing FFs, mono-exponential and ARMA fits showed a
linear relationship with reference R2* values for no/low FF (0, 10%) but overestimated R2*
values at 1.5T and underestimated at 3T for high FFs (20, 40%). In contrast, NLSQ showed only
slight R2* overestimation for the highest iron concentration. Results of linear regression analysis
(slope, intercept and R2) for each of the methods at different field strengths are shown in Table
6-1.
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Figure 6-2. FF results for single-shot GRE acquisition. Mean (±SD, as error bars) FF values
obtained by NLSQ (first column), and ARMA (second column) methods plotted against true FFs
in fat phantoms for varying iron concentrations at 1.5T (top row) and 3T (bottom row) using the
single-shot GRE sequence. The black dotted line indicates the unity line. At 1.5T, both NLSQ
and ARMA FFs showed linear relationship with true FFs at no/low (0 – 15 ug/ml) iron
concentrations. At high iron concentrations (30, 60 ug/ml), NLSQ overestimated and ARMA
underestimated FFs with high SDs. At 3T, ARMA completely failed in fat-water separation and
produced ~0% FFs whereas NLSQ overestimated FFs with increasing iron concentrations.
Results of linear regression analysis (slope, intercept and R2) for each of the methods at different
field strengths are shown in Table 1.
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Table 6-1. Results of linear regression between measured and reference R2* values (in s-1) for
varying fat fractions (FFs, in %), and between measured and true FFs for varying ironconcentrations using each of the models with a single-shot GRE acquisition.
Iron concentrations (μg/ml)

Fat fractions (FFs)
Field
strengths

Fits

Monoexponential

1.5T

NLSQ

ARMA

Monoexponential

3T

NLSQ

ARMA

Parameters

0%

10%

20%

40%

0

7.5

15

30

60

Slope

1.0

1.02

1.24

1.72

x

x

x

x

x

Intercept

0

-0.0

-35.6

-85.7

x

x

x

x

x

R2

1.0

>0.99

>0.99

0.99

x

x

x

x

x

Slope
Intercept
R2

1.35
-53.8
0.99

1.25
-35.9
>0.99

1.25
-41.7
>0.99

1.08
-15.5
0.99

1.04 1.19 1.17 1.19 0.80
1.6
-2.4 -0.10 3.2 11.8
>0.99 0.99 >0.99 >0.99 0.93

Slope

1.06

1.06

1.24

1.99

1.00

Intercept
R2
Slope

-9.0
>0.99
1.0

-3.9
>0.99
0.89

-36.6
>0.99
0.75

-65.5
0.99
0.44

1.5
-1.3 0.57 6.1 1.7
>0.99 >0.99 >0.99 0.51 0.09
x
x
x
x
x

Intercept

0

28.7

27.1

55.0

x

R2
Slope
Intercept

1.0
1.19
-31.3

>0.99
1.04
19.4

>0.99
1.08
4.9

0.99
1.20
-10.8

x
1.01
1.8

R2

>0.99

>0.99

>0.99 >0.99 >0.99 >0.99 >0.99 0.99 0.96

Slope
Intercept
R2

1.00
-0.40
>0.99

0.90
29.4
>0.99

0.77
30.0
>0.99

0.51
98.2
0.96

0.0
0.0
0.0

1.01 0.99 0.27 0.01

x

x

x

x

x
x
x
x
1.11 1.10 1.11 1.01
2.7 2.6 3.4 10.5

0.0
0.0
0.0

0.0
0.0
0.0

-0.0 0.1
0.1 -0.6
-0.7 0.92

Note: ‘x’ denotes not applicable as mono-exponential fit cannot estimate FFs. R2* values
calculated with the mono-exponential signal model in pure iron phantoms were considered as
reference.

Dual-shot GRE
A similar R2* and FF analysis using each of the mono-exponential, NLSQ and ARMA methods
as described above for single-shot GRE, was also performed using the dual-shot GRE acquisition
(Figure 6-3, Figure 6-4). Mono-exponential fits produced similar R2* values as single-shot GRE
at both field strengths, i.e., R2* was overestimated at 1.5T (slopes: 1.23 – 1.88, R2 ≥ 0.97) and
underestimated at 3T (slopes: 0.51 – 0.79, R2 ≥ 0.96) for highest iron concentrations with high
FFs (20, 40%). ARMA and NLSQ results improved at 1.5T but ARMA still overestimated R2*
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(slopes: 1.24 – 1.49, R2 ≥ 0.98) for the highest iron concentration and high FFs (20, 40%). At 3T,
both ARMA and NLSQ produced R2* results in excellent linear agreement (slopes: 0.93 – 1.04,
R2 > 0.99) with reference R2* values (Figure 6-3, Table 6-2).
With the dual-shot acquisition, both NLSQ and ARMA methods produced improved FF
results compared to single-shot GRE. However, for the fat-iron phantoms with the highest iron
concentration, NLSQ still overestimated for 0% FF (mean estimated FF: 12.5%) and produced
high SDs for 10 and 20% FFs at 1.5T and ARMA underestimated FFs with high SDs. But at 3T
both NLSQ and ARMA produced FFs in excellent linear agreement (slopes: 0.98 – 1.12, R2 >
0.98) with true FFs except ARMA still underestimated FF for 10% FF with highest iron
concentration and NLSQ slightly overestimated FF for 0% FF.

Figure 6-3. R2* results for dual-shot GRE acquisition. Mean (±SD, as error bars) R2* values
obtained by mono-exponential fit (first column), NLSQ (second column) and ARMA (last
column) methods plotted against reference R2* values in iron phantoms for varying FFs at 1.5T
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(top row) and 3T (bottom row) using the dual-shot GRE sequence. The black dotted line
indicates the unity line. At 1.5T, mono-exponential and ARMA fits showed a linear relationship
with reference R2* values for no/low FF (0, 10%) but overestimated R2* values for the highest
iron concentration at high FFs (20, 40%). In contrast, NLSQ only slightly overestimated R2* for
highest iron concentration at no/low FFs (0, 10%). At 3T, both NLSQ and ARMA R2* values
showed excellent linear agreement with reference R2* values for all FFs whereas monoexponential fit underestimated R2*s for high iron concentrations with increasing FFs. Results of
linear regression analysis (slope, intercept and R2) for each of the methods at different field
strengths are shown in Table 2.

Figure 6-4. FF results for dual-shot GRE acquisition. Mean (±SD, as error bars) FF values
obtained by NLSQ (first column), and ARMA (second column) methods plotted against true FFs
in fat phantoms for varying iron concentrations at 1.5T (top row) and 3T (bottom row) using the
dual-shot GRE sequence. The black dotted line indicates the unity line. At 1.5T, both NLSQ and
ARMA FFs showed linear relationship with true FFs at all iron concentrations except for the
highest iron concentration where NLSQ overestimated and ARMA underestimated FFs with high
SDs. At 3T, both NLSQ and ARMA produced FFs in agreement with true FFs even for the
highest iron concentration except that ARMA still underestimated FF for 10% FF and NLSQ
slightly overestimated FF for 0% FF. Results of linear regression analysis (slope, intercept and
R2) for each of the methods at different field strengths are shown in Table 2.
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Table 6-2. Results of linear regression between measured and reference R2* values (in s-1) for
varying fat fractions (FFs, in %), and between measured and true FFs for varying ironconcentrations (in μg/ml) using each of the models with a dual-shot GRE acquisition.
Fat fractions (FFs)
Field
strengths

Fits

Monoexponential

1.5T

NLSQ

ARMA

Monoexponential

3T

NLSQ

ARMA

Iron concentrations (μg/ml)
0
7.5
15
30
60

Parameters

0%

10%

20%

40%

Slope

1.0

1.02

1.23

1.88

x

x

x

x

x

Intercept

0

-2.5

-42.9

-144

x

x

x

x

x

R2

1.0

>0.99 >0.99

0.97

x

x

x

x

x

Slope
Intercept
R2

1.16
-23.5
>0.99

1.14
1.16
1.02 1.04 1.18 1.15 1.22 0.88
-16.8 -27.6 -5.1
1.6 -2.4 0.31 1.1 7.0
>0.99 >0.99 >0.99 >0.99 0.99 >0.99 >0.99 0.94

Slope

1.05

1.07

Intercept
R2
Slope

-6.8
>0.99
1.0

-3.5 -35.5
>0.99 >0.99
0.90
0.79

-48.6 1.2 -1.3 0.38 -0.02 -2.8
0.98 >0.99 >0.99 >0.99 >0.99 0.92
0.51
x
x
x
x
x

Intercept

0

30.9

32.4

67.4

x

R2
Slope
Intercept

1.0
1.04
-5.4

>0.99 >0.99
0.98
0.96
29.2
24.4

0.99
0.98
23.8

x
0.98
1.5

R2

>0.99

>0.99 >0.99 >0.99 >0.99 >0.99 >0.99 >0.99 0.99

Slope
Intercept
R2

1.01
-0.31
>0.99

0.93
0.99
0.98 1.07 1.07 1.06 1.12 1.05
40.8
22.8
52.0 -0.11 1.6 2.3 1.3 -2.5
>0.99 >0.99 >0.99 0.99 >0.99 0.99 >0.99 0.98

1.24

1.49

1.02

1.01 1.00 1.06

x

x

0.5

x

x

x
x
x
x
1.12 1.09 1.12 1.03
1.8 2.4 3.0 1.4

Note: ‘x’ denotes not applicable as mono-exponential fit cannot estimate FFs. R2* values
calculated with the mono-exponential signal model in pure iron phantoms were considered as
reference.

6.4.2 In-vivo
In both patients, R2* maps were calculated using mono-exponential, NLSQ, and ARMA models
and FF maps were obtained using NLSQ and ARMA models with the single-shot GRE sequence.
For the patient with mild hepatic iron and fat as confirmed by biopsy, the mean R2* values using
all 3 models were in good agreement (Figure 6-5A) and translated into an R2*-MRI based HIC
estimate of 7.7 – 7.9 mg Fe/g dry weight which is close to the biopsy HIC of 7.9 mg Fe/g. The
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iron deposition can be appreciated in blue on the histology slides using the Perl’s iron stain
(Figure 6-5B). The clear vacuoles on both H&E and Perl’s iron stains show the presence of fat
graded as macrovesicular steatosis by the pathologist, and no absolute fat quantification was
performed using the biopsy sample. Figure 6-5A shows the FF maps calculated with NLSQ and
ARMA methods, with ARMA mean FF slightly smaller (~13%) compared to NLSQ FF.

Figure 6-5. R2*-MRI and biopsy results obtained from a 13-year old acute lymphoblastic
leukemia patient with biopsy confirmed mild iron overload and steatosis. (A) Calculated R2*
maps obtained with mono-exponential, NLSQ and ARMA models and FF maps obtained with
NLSQ and ARMA models at 1.5T using a single-shot GRE sequence, and (B) histology slides of
the liver biopsy sample with H&E and Perl’s iron stains. The clear vacuoles (i.e., white bubbles)
on both stains depict the fat deposits and the blue color on Perl’s iron stain show the iron
deposits. Mean (±SD) R2* values and FFs in a small circular ROI drawn in the right lobe of the
liver were displayed for each of the methods. Mean R2*s using all 3 methods were in good
agreement but the FF calculated using ARMA was slightly lower compared to the NLSQ
method. R2*-based HIC calculated using a published calibration curve152 for mono-exponential,
NLSQ and ARMA methods are 7.8, 7.7 and 7.9 mg Fe/g respectively, which are all close to the
biopsy HIC of 7.9 mg Fe/g.

For the patient with severe HIC and no steatosis (Figure 6-6), ARMA produced a
homogeneous liver R2* map and the mean R2* (756 ± 121 s-1) was close to that obtained with
the reference mono-exponential signal model (724 ± 121 s-1). In contrast, the liver R2* map
calculated by NLSQ was not homogeneous and overestimated R2* compared to the reference
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R2* value. The golden brown deposits on H&E and blue deposits on Perl’s iron stains indicate
that the patient has severe iron overload. Figure 6-6A shows the FF maps calculated with ARMA
and NLSQ methods, with ARMA mean FF ~0% whereas NLSQ produced a false FF of ~11%
when the histology stains did not show any clear vacuoles (Figure 6-6B) suggesting the absence
of fat.

Figure 6-6. R2*-MRI and biopsy results obtained from a 9-year old sickle cell anemia patient
with biopsy confirmed iron overload and no steatosis. (A) Calculated R2* maps obtained with
mono-exponential, NLSQ and ARMA models and FF maps obtained with NLSQ and ARMA
models at 1.5T using a single-shot GRE sequence, and (B) histology slides of the liver biopsy
sample with H&E and Perl’s iron stains. Mean (±SD) R2* values and FFs measured in a small
circular ROI drawn in the right lobe of the liver were displayed for each of the models. ARMA
produced a homogeneous liver R2* map and the mean R2* was close to the R2* calculated using
the reference mono-exponential model and calculated FF was ~0%. In contrast, the liver R2*
map calculated by NLSQ was not homogeneous and overestimated R2* compared to reference
mono-exponential model. Further, NLSQ produced a mean FF ~11% where there is no fat
present as confirmed by biopsy (i.e., no white bubbles on histology slides). The golden brown
deposits on H&E and blue deposits on Perl’s iron stains indicate that the patient has severe iron
overload.

6.5

Discussion

The presence of fat introduces oscillations in the signal decay of the multiecho GRE acquisition
and hence, using standard mono-exponential signal models for R2* quantification will confound
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R2* measurements. Likewise, the presence of iron increases R2* causing rapid signal decay and
complicates fat quantification. Signal modeling techniques that perform multi-spectral fat-water
modeling will thus enable simultaneous quantification of R2* and FF. In this study, the
performance of ARMA in simultaneously quantifying R2* and FF was evaluated, and the results
were compared to a standard mono-exponential model and the NLSQ approach available in the
ISMRM Fat-Water Toolbox.181
First, this study investigated the performances of mono-exponential, NLSQ and ARMA
models in fat-iron phantoms with varying iron concentrations and fat percentages that cover the
clinically relevant R2* and FF ranges. The mono-exponential model produced mean R2* values
close to reference values in phantoms with low iron concentrations and any FFs. However, at the
highest iron concentrations (R2* ~750 s-1), R2* values were overestimated at 1.5T and
underestimated at 3T with higher FFs (20, 40%) likely depending upon the influence of in-phase
or out-phase TEs (~2.2 ms) on fitting the signal decay (e.g., the signal fit is affected by the first
out-phase TE at 1.5T and in-phase TE at 3T leading to R2* over- or under-estimations). Hence,
incorporating fat into the signal model is essential for accurate R2* quantification especially at
high iron concentrations and FFs.
All models were investigated using a single-shot GRE acquisition as used in the in-vivo
study and a dual-shot GRE acquisition that allowed denser sampling of the signal decay. Monoexponential R2* results were similar between single-shot and dual-shot acquisitions in all
phantoms at both field strengths. NLSQ and ARMA produced similar R2* and FFs in agreement
with reference values using either single-shot or dual-shot GRE for fat-iron phantoms with low
iron concentrations (R2* < 400) at 1.5T. At higher iron concentrations (R2* > 400), NLSQ and
ARMA R2* and FF results were improved by using the dual-shot GRE sequence compared to
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the single-shot sequence. Because higher iron concentrations lead to rapid signal decay, ΔTE
should be short enough to capture the signal decay in cases of severe iron overload. Similar
results were also observed at 3T except that ARMA failed to estimate the FF at 3T with singleshot GRE because the ΔTE used (~1.44 ms) does not fulfill the Nyquist criterion which is
essential to avoid spectral aliasing. As fat and water precession frequencies differ by ~440Hz at
3T, a ΔTE ≤ 1.1 ms is required to meet the Nyquist criterion. Hence, using dual-shot GRE
acquisition (ΔTE = 0.74 ms) enabled ARMA to perform fat-water separation at 3T and produce
R2* and FF results in agreement with the expected results. In contrast, the NLSQ approach could
still perform fat-water separation at 3T using single-shot GRE because it imposes constraints
such as spatial regularization in estimating B0 field map whereas ARMA does not.184
With dual-shot GRE, ARMA and NLSQ R2* results calculated at 1.5T produced
excellent linear correlation with true iron concentrations except that ARMA overestimated the
R2* with higher SD for the phantom with the highest iron (R2* ~ 750 s-1) and FF (~40%).
Similarly, phantom FFs estimated using ARMA and NLSQ at 1.5T are in excellent agreement to
the theoretical FFs for all iron concentrations except for the most extreme iron concentration
(R2* ~ 750 s-1). At 3T, both, ARMA and NLSQ produced improved R2* and FF results that are
in excellent linear agreement with reference R2* and true FFs respectively even for the highest
iron concentration, which may be due to the higher SNR at 3T, i.e., twice compared to 1.5T.
R2* and FF results at high iron concentrations using either ARMA or NLSQ will
improve with the use of high flip angles as the SNR of the images increase with the flip angle
and will thus enable accurate R2* and FF mapping. In theory, the SNR performance is maximal
for the Ernst angle, which is 45o in this study for a TR of 200 ms and assuming T1 of water is
586 ms at 1.5T.185 But the use of high flip angles such as 45o will result in overestimation of FF
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as demonstrated in previous studies185, 186 due to the T1 bias introduced because of the fact that
fat has a shorter T1 times compared to water. T1 bias introduced into water and fat signal
amplitudes can be calculated from the GRE signal equation using the imaging TR and the
assumed T1 values of water and fat, and can be corrected by dividing the respective signal
amplitudes with the correction factors.185, 186 For example, at 45o flip angle the T1 bias is ~14%
which translates into a ~14% overestimation in FF results. Instead, in our phantom study we used
a flip angle of 25o which will cause only ~5% overestimation in FF, which is considered
acceptable. However, our in-vivo data were obtained using a 45o Ernst angle and might show FF
overestimation using ARMA/NLSQ methods.
In in-vivo for the patient with mild hepatic iron and fat deposition, the mean R2* values
calculated using mono-exponential, NLSQ and ARMA methods were in good agreement.
However, the FF calculated using ARMA was slightly smaller compared to NLSQ method. The
reason might be that ARMA does not assume relative amplitudes of the multi-peak fat
spectrum11 whereas NLSQ method uses prior information about the relative fat amplitudes.
Therefore, any inability to detect the low amplitude fat peaks in the ARMA modeling might lead
to slight underestimation. Unfortunately, no gold-standard FF measurement from biopsy or
spectroscopy was available as a reference for comparison. Further, in phantoms, NLSQ also
showed slight overestimation in FF values compared to true FFs whereas ARMA FFs are in
agreement with true FFs when measurable.
For the patient with severe HIC and no steatosis, ARMA produced a homogeneous liver
R2* map and the mean R2* was in agreement with that obtained using the mono-exponential
model, which is considered as reference in cases of iron overload only. In contrast, the liver R2*
map calculated by the NLSQ method was not homogeneous and overestimated R2*. Further,
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ARMA produced a mean FF ~0% whereas NLSQ produced a mean FF ~11% when there is no
fat as confirmed by post-MRI liver biopsy. NLSQ produced similar R2* and FF overestimation
in phantom with similar R2* (i.e., at the highest iron concentration) and no fat at 1.5T using the
single-shot GRE. NLSQ R2* results improved with the dual-shot GRE for the highest iron
concentration and 0% FF phantom but there is still overestimation of FF.
There are some limitations in this study. The mono-exponential and fat-water modeling
methods were tested in only 2 patients at 1.5T. A more systematic investigation should be
performed in patients having both iron and fat using all 3 methods at both 1.5T and 3T. Our
phantom study has shown that dual-shot GRE produced better R2* and FF results using both,
NLSQ and ARMA methods compared to single-shot. However, both, NLSQ and ARMA
produced inaccurate FFs at 1.5T for the highest iron concentration even with the dual-shot GRE.
In the presence of high iron, the signal drops rapidly before the first TE with the current GRE
acquisition, limiting dephasing between water and fat components and causing fat quantification
to become less stable with either of the methods.187 In these high iron cases or even in
investigating massive iron cases, we believe ultra-short echo time (UTE) protocols could benefit
fat-water modeling methods to provide accurate R2* and FF results. Between fat-water modeling
methods, NLSQ seem to produce better results compared to ARMA in phantoms. This is because
the NLSQ model makes prior assumptions about the relative amplitudes and frequencies of fat
peaks and fits a single R2* to both water and fat species and thus has only 3 fitting parameters.
In contrast, ARMA considers all these assumptions as fitting parameters making it less stable. In
future, we will incorporate prior assumptions into ARMA as made in the NLSQ model and
investigate if it provides better R2* and FF results compared to NLSQ method. One of the
advantages of ARMA is that it estimates separate R2*s for fat and water species and thus helps
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in better understanding of how iron affects fat droplets sized ~20 μm and water molecules at 3Å
in-vivo.188 The effect of iron should be different for fat and water species in-vivo due to the
difference in molecular sizes and thus the R2* values of fat and water should be different. In
such cases, assuming a single, common R2* value for fat and water as is done in the NLSQ
model may bias the true R2* and therefore the HIC. In future, we will study the effect of iron on
fat R2* and how it may affect the single R2* measurements.

6.6

Conclusion

This study shows that the standard mono-exponential model, although it did not impact the R2*
quantification in fat phantoms with low iron concentrations, produced inaccurate R2* values at
high iron concentrations and high FFs. Fat-water modeling techniques such as NLSQ and
ARMA provide simultaneous R2* and FF quantification and thus can be used to diagnose both
hepatic iron overload and steatosis. This study demonstrates that ARMA seems to be superior in
R2* quantification for high iron and low fat cases whereas NLSQ appears to be superior in high
iron and high fat scenarios, and both failed in FF estimations for the highest iron concentration at
1.5T. Nevertheless, both methods produced improved R2* and FF results at 3T.
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Chapter 7
Automated Vessel Exclusion Technique for Quantitative Assessment of Hepatic Iron
Overload by R2*-MRI

7.1

Introduction

Hepatic iron overload is a severe complication in patients with increased gastrointestinal
absorption of dietary iron or receiving chronic blood transfusions for sickle cell disease, betathalassemia, and myelosuppression during chemotherapy.1-5 Accurate assessment of hepatic iron
content (HIC) is paramount to quantify excessive iron accumulation and monitor response to iron
chelation therapy. Needle biopsies are considered the reference standard to measure HIC.6
Magnetic resonance imaging (MRI) methods based on the effective transverse relaxation rate
(R2*) have been used to noninvasively measure HIC. R2* is typically measured by analyzing the
exponential signal decay of multi-echo gradient echo (GRE) images of the liver, and HIC is
estimated from R2* by using published biopsy HIC/R2* calibration curves.9-12 MRI-based HIC
quantification can therefore be used to guide iron overload management.
R2*-based HIC usually relies on mean R2* values calculated from manually outlined
regions of interest (ROIs). There are two approaches: One method involves drawing one or
multiple small (0.5–3 cm2) ROIs in a homogenous area of the liver devoid of vessels.106, 189
Although this approach shows excellent correlation between R2* values and biopsy-derived HIC
values, it is prone to inter-reviewer variability,152 and displays measurement errors in patients
with heterogeneous iron distribution.110, 169
The other approach involves drawing an ROI encompassing the entire liver area in the
acquired axial cross-section, followed by post-processing steps to exclude blood vessels, to
accurately estimate mean R2* of the segmented iron-loaded tissue. This whole-liver approach
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yields an overall R2*-based HIC estimate by maximizing the liver ROI area and minimizing the
inter-reviewer variability associated with ROI placement. In a comparative study of small and
whole-liver ROI with biopsy HIC for R2* measurements,152 whole-liver ROI analysis had higher
reproducibility and yielded smaller standard errors in R2* measurements than small ROI
analysis. Moreover, the whole-liver ROI approach lends itself more readily to automation
compared to the small ROI approach, with liver boundaries being for example automatically
detected based on contrast intensity changes.
Blood vessel exclusion for the whole-liver ROI approach can be achieved by T2*thresholding151, 152 or vessel segmentation based on fuzzy c-means (FCM) clustering
techniques.190-192 T2*-thresholding is based on the fact that T2* of blood (approximately 30 ms
at 1.5 T) is higher than that of iron-overloaded liver tissue (< 20 ms at 1.5 T). Then, on a T2*
histogram a patient-specific T2* threshold value is chosen that separates the blood pixel
distribution from the parenchyma distribution; pixels beyond that value are eliminated.151, 152
However, this process is iterative, time consuming, and subjective, because mean T2*/R2*
results depend on the chosen threshold.
FCM clustering techniques provide automatic vessel segmentation by assigning
membership to each data point corresponding to each cluster center by distance between the
cluster center and data point. They have been applied to segment the liver parenchyma and
vessels by using either a single image at a given TE or R2* map or their combination.190-192
However, FCM-based methods are computationally expensive, sensitive to initialization, easily
trapped in local optima,193 and segment tissue based on differences in pixel values, without
considering spatial or structural information.
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Frangi et al.194 introduced a multi-scale vessel enhancement filter to accurately visualize
and quantify blood vessels. This filter has been primarily used in brain,194-196 and has so far
limited body applications.197, 198 The filter computes the likeliness of an image region to contain
vessels by analyzing structural information and enhancing only tubular structures regarded as
blood vessels. In this study, we developed a vessel enhancement filter based on Frangi’s
technique for automatic segmentation of hepatic vessels and parenchyma extraction to assess
hepatic iron overload by R2*-MRI. Such a technique will improve the clinical workflow in
estimating R2*-based HIC by reducing the operator time and dependence. The purpose of this
study was therefore, to validate the proposed automated vessel exclusion technique by
comparing with the manual T2*-thresholding performed by an experienced radiologist for R2*based HIC assessment in a large cohort of patients covering the full clinical spectrum of HIC
values.

7.2

Theory

The multi-scale vesselness filter introduced by Frangi et al.194 provides a measure of
“vesselness” based on the eigenvalues (λ1, λ2, λ3) of the Hessian matrix.194 The Hessian matrix is
a square matrix consisting of second-order partial derivatives of a scalar-valued function. The
eigenvalues of the Hessian matrix describe the degree of curvature of the image. The eigenvalues
will have the largest absolute value in the direction of the greatest curvature and smallest
absolute value in the direction of the least curvature.
The idea behind eigenvalue analysis of the Hessian is to extract the principal directions in
which the local second order structure of the image can be decomposed. The magnitude or ratio
of these eigenvalues depends on the structure of interest as shown in Figure 7-1. The sign of the
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eigenvalues is an indicator of brightness or darkness of the structure of interest. Based on this
information, Frangi has derived various patterns based on the eigenvalues as shown in Table
7-1.194

Figure 7-1. Schematic of Frangi's filter detection principle. The filter can detect plate-like, tubelike and sphere-like objects by comparing the relative sizes of the eigenvalues (λ1, λ2, λ3) of the
Hessian matrix of an image dataset. Larger eigenvalues suggest that local image brightness is not
aligned in the direction of the corresponding eigenvector. Adapted from Campbell IC et al. J R
Soc Interface 2015.199
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Table 7-1. Possible patterns in 2D and 3D, depending on the value of the eigenvalues
2D

3D
Orientation pattern

λ1

λ2

λ1

λ2

λ3

N

N

N

N

N

Noisy, no preferred direction

L

L

H-

Plate-like structure (bright)

L

L

H+

Plate-like structure (dark)

L

H-

L

H-

H-

Tubular structure (bright)

L

H+

L

H+

H+

Tubular structure (dark)

H-

H-

H-

H-

H-

Blob-like structure (bright)

H+

H+

H+

H+

H+

Blob-like structure (dark)

Note: *H=high, L=low, N=noisy, usually small, +/- indicate the sign of the eigenvalue.

For 2D images, the vesselness response (V) proposed by Frangi et al.194 for detecting
bright vessels is given by:
0
𝑉(𝜎) = {

exp (−

2
𝑅𝛽
2𝛽 2

𝜆2 ≥ 0
𝑆2

) (1 − exp(− 2𝑐 2 ))

𝜆2 < 0

(7.1)

where
𝑅𝛽 = 𝜆1 ⁄𝜆2 ,

(7.2)

𝑆 = √𝜆12 + 𝜆22

(7.3)

Here, Rβ discriminates tube-like structures from blob-like structures and S differentiates between
vessel and background noise. Rβ attains its maximum value for blob-like structure and is 0
whenever λ1 ≈ 0, i.e., tube-like structures or λ1 and λ2 tend to vanish. S is calculated as the
Frobenius matrix norm square and is low for background pixels which have no structure because
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all eigenvalues will have small magnitude. In regions with high contrast, the norm will become
high since at least one of the eigenvalues will be large. Based on these 2 criteria, Frangi et al.
derived the above vesselness expression in equation 7.1. The idea behind this expression is to
map the features in equations 7.2-7.3 into probability-like estimates of vesselness for each
criterion. We combine the probability-like estimates using their product to ensure that the
response of the filter is maximal only if all criteria are fulfilled. The parameters β and c are the
thresholds which control the sensitivity of Rβ and S to measure vesselness. The vesselness
response is calculated at multiple scales (σ) by computing the Hessian with Gaussian derivatives
at multiple scales. The response will be maximum at a scale that approximately matches the size
of the vessel to detect. Thus, at every voxel location, the vesselness output with the highest
response is selected. This vesselness filter can enhance either bright vessels on a dark
background as in GRE imaging or MR angiography or dark vessels on a bright background as in
susceptibility-weighted imaging, except that the polarity of λ2 for which the above equation
holds good is reversed in the latter case. It is because for bright lines, the sign of the Gaussian
derivative is negative so eigenvalues are negative for bright structures and positive for dark
structures.

7.3

Materials and Methods

7.3.1 Numerical Simulations
Digital phantoms were created by simulations to determine appropriate filter parameters and
evaluate the efficiency of the vesselness filter for a wide range of R2* values and SNR scenarios
under known conditions. The phantoms were created as follows (Figure 7-2):

121

1. A liver mask was created by segmenting the parenchyma and vessels from a representative
patient.
2. A range of reference R2* maps were generated by assigning the liver parenchyma to R2*
values ranging from 50 s-1 to 1000 s-1 incremented in steps of 50 s-1 and the vessel to an R2*
value of 33 s-1.
3. From the R2* maps, magnitude images were created at 20 echoes (TEs: 1.07–18.17 ms,
ΔTE=0.9 ms) based on the equation
∗

𝑆(𝑇𝐸) = 𝑆0 𝑒 −𝑅2 ∗𝑇𝐸

(7.4)

where S0 is the signal intensity at the start of decay.
4. Partial volume effects were added by convolving the magnitude images with a Gaussian
kernel of size 3 × 3.
5. Images were simulated under different signal-to-noise ratio (SNR) conditions (30, 50, and
70) by adding Gaussian complex noise at varying levels.
6. Quantitative T2* and R2* maps were calculated by fitting the signal on a pixel-by-pixel basis
to a monoexponential decay by using a nonlinear least-squares fit method, which accounts
for bias due to Rician noise.125, 168
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Figure 7-2. Digital liver phantoms. The top image is an example of the synthesized referential
R2* map (parenchymal R2* = 200 s-1, vessel R2* = 33 s-1) where the white indicates the
parenchyma and the gray vessels. The following three rows are magnitude images simulated at
TEs of 1.1, 5.6, and 9.2 ms (from left to right), and images sequentially added with partial
volume effect (PVE) and noise (SNR = 50).

The vesselness filter was applied on 3 different image inputs: contrast-optimized composite
magnitude image, T2* map and R2* map. The composite image is the average of the images at
the 3 echo times with highest contrast (i.e., maximum difference between signal intensities)
between vessel and parenchyma.200 For different range of R2* values, the first 3 echoes that
produce highest contrast were recorded and used in the patient study.
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7.3.2 Subjects
All consecutive MRI R2* exams performed at our institution for clinical monitoring of hepatic
iron overload between August 2011–June 2016 that were evaluated by an experienced radiologist
were included. The Institutional Review Board approved the retrospective review of the MRI
results with a waiver of informed consent. This study complied with the Health Insurance
Portability and Accountability Act. A total of 565 MRI exams were acquired from 282 patients
with transfusional iron overload (126 male, 156 female; median age at first scan: 13±9 years,
range 1–53 years). Of them, 157 patients received 1 exam, 39 received 2 exams, 37 received 3
exams, 29 received 4 exams, 17 received 5 exams, and 3 received 6 exams. Approximately 50%
of patients underwent multiple MRI exams as annual assessment of R2*-based HIC was part of
their clinical care.

7.3.3 MRI Measurements
All patients were imaged on a 1.5T scanner (Magnetom Avanto, Siemens Healthineers, Malvern,
PA). MRI scans were performed on a single transverse slice of the liver at the location of the
main portal vein, using a multi-echo GRE sequence with the following acquisition parameters:
TR 200 ms, TE1 1.1 ms, ΔTE 0.82-0.92 ms (small variations due to software upgrades), 20
echoes, bipolar readout gradient, matrix size 128×104, slice thickness 10 mm, bandwidth
1950 Hz/px, flip angle 35°, and FOV 210-450 mm, depending on participant’s size. Multi-echo
GRE images were acquired in a single breath-hold of ~21 s in patients who could perform the
breath-hold maneuver. For sedated patients or for those unable to suspend breathing, 3-6
averages were acquired to minimize respiratory motion artifacts.
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7.3.4 Data Analysis
T2*-thresholding technique
As part of the clinical HIC reporting, a single, pediatric radiologist with 16-years of experience
at the beginning of the data collection period, performed the analysis of all 565 exams as
follows: The GRE images were post-processed at a computer workstation, using a customwritten program in MATLAB (MathWorks). Quantitative T2* or R2* (=1/T2*) maps were
calculated by fitting signal intensity on a pixel-by-pixel basis to a monoexponential decay, using
a nonlinear least-squares fit method, which accounts for bias due to Rician noise.125, 168 The T2*thresholding technique consists of 3 steps:152 1) drawing an ROI to outline the entire hepatic
cross-sectional area in the acquired transverse slice (magnitude image or T2* map), 2) excluding
blood vessels based on T2* histogram analysis by rejecting T2* values over the chosen
threshold, and 3) using an image overlay to confirm that exclusion of vessel pixels for the chosen
T2* threshold. Steps 2 and 3 are repeated by re-adjusting the T2* threshold until the radiologist
visually confirms exclusion of all vessel pixels. Mean liver T2* and R2* values are calculated by
taking the pixel-wise mean value of remaining pixels inside the ROI after vessel exclusion.
Cases wherein the number of fitted pixels within the ROI is less than 30% of the total number of
pixels are considered a failed fit and were excluded from any further analysis.152 The
radiologist’s T2*-thresholding results served as a standard reference for evaluation and
comparison against the automated technique.

Automated filter-based technique
An automated method based on multi-scale vessel enhancement filter194 was investigated to
segment hepatic vessels from MRI images without any user interface for R2*-based HIC
assessment. The basic theory of the 2D vesselness filter is given in the Supplement. First, a
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simulation study was performed (in Supplement) to determine appropriate filter parameters and
evaluate the efficiency of the vesselness filter for a wide range of R2* values and SNR scenarios
under known conditions. The vesselness filter was applied to 3 image inputs: contrast-optimized
composite magnitude image, T2* map, and R2* map. For the composite image, a median T2*
value of whole-liver ROI was calculated and the 3 TEs producing the highest contrast between
parenchyma and vessel in the simulation study for that T2* range were used (see Supplement).
Thus, the contrast-optimized composite magnitude image was generated by averaging the images
acquired at the 3 TEs with the highest contrast.200
For all 3 image inputs, the filter was applied to whole-liver ROI drawn by the radiologist
in MATLAB. Appropriate filter parameters β (for suppressing blob-like structures) and c (for
suppressing background noise) determined from the simulation study were as follows: β=0.5 for
all filters and c=15% of the median signal for composite image and T2* map, and 10% for R2*
map. The filter’s spatial scale (σ) was varied between 1 and 2.5 pixels to capture vessels with
different sizes. Filter parameters chosen were similar to those suggested in previous studies.194,
201, 202

The filter also had a Boolean parameter set either to detect bright vessels on a dark

background or dark vessels on a bright background. Vessels appeared bright on the magnitude
images and T2* map, and dark on the R2* map, and filter options were set accordingly.
The filter result is a vesselness response of the pixels containing vessels (defined in
Supplement). The filter output is high for pixels with high probability of containing a vessel and
low for small vessels. The filter might also produce small vesselness values for noise pixels. To
exclude noise pixels, a small threshold value of 0.05 of the maximum vesselness response was
used as recommended previously.197, 198 Thus, pixels with vesselness response greater than or
equal to the threshold value provide the vesselness mask and those less than the threshold value
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provide the extracted parenchyma mask. For each image input, parenchyma and vessel masks
were created and the mean R2* value was calculated by taking the pixel-wise mean of the
extracted parenchyma R2* map. Figure 1 summarizes the processing steps for the automated
parenchyma extraction technique, using the multi-scale vesselness filter for the 3 image inputs.
For both reference and automated analyses, mean liver R2* values were converted into
HIC estimates (abbreviated as R2*-HIC), using a previously published R2* vs. biopsy HIC
calibration curve.11, 152 To investigate the association of the segmentation results of the
automated technique with the reference method, a dice similarity coefficient (DC) was used to
assess agreement of the extracted parenchyma between both methods:200
DC (%) =

2 (A ∩ B)
× 100
A+B

(7.5)

where A and B represent extracted parenchyma masks by the reference and automated methods,
respectively, and ∩ and + represent the intersection and addition between the masks,
respectively. DC values of 0% and 100% indicate no overlap and perfect overlap, respectively,
between extracted masks obtained by both methods.

7.3.5 Statistical Analysis
Statistical analysis was performed using MATLAB. Mean ± standard deviation (SD) and range
of R2* and R2*-HIC values estimated by the reference and automated techniques across the
cohort were determined. Mean R2* values of the extracted liver parenchyma between the
reference and automated methods were compared by linear regression and Bland–Altman
analyses. Further, the coefficient of variation (CV), calculated by dividing the SD with the mean
R2* value, was compared between the reference and automated methods to assess dispersion in
R2* measurements.
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7.4

Results

7.4.1 Simulation Study
The appropriate filter parameters to be used were found: β = 0.5 for suppressing blob-like
structures; c = 10% of the median signal for image-based and T2*-based filter and 20% for R2*based filter; the spatial scale of filter (σ) = 1 – 2.5 pixels, by comparing segmented masks to
ground truth using DC. Figure 7-3 compares the segmentation results and relative error in R2*
measurements of the extracted parenchyma obtained with the filter-based methods to the ground
truth for a wide range of R2* values and SNR levels. For the chosen filter parameters, all filterbased methods consistently produced DC above 93% and relative error in R2* measurements
below 1% for all R2* values ranging from 50 to 1000 s-1 at all clinical SNR levels.

Figure 7-3. Dice similarity coefficient (A-C) and relative-error in R2* measurements (D-F) for
different filter-based methods at varying R2* values and SNR levels in phantoms. The mean dice
similarity coefficient (DC) was 96% and the relative error in R2* measurements was close to 0%
for all filter-based methods across the R2* range of 50 to 1000 s-1 at different SNR conditions.
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7.4.2 In-vivo Study
Of 565 MRI scans, 47 with massive iron overload (HIC > 25 mg Fe/g) for which the number of
T2* fitted pixels was less than 30% of all pixels within the ROI were excluded. Also, 7 exams
for which the radiologist performed only small ROI analysis were excluded. Thus, 511 MRI
exams from 257 patients with transfusional iron overload were analyzed. The median age at first
exam was 13 years (range 1 to 53 years), and 70% of the subjects were children and 30% adults (
Table 7-2).

Table 7-2. Patient Demographics and Disease Characteristics
Characteristic

N (%)

Total MRI exams

565

Evaluable MRI exams

511

Number of patients

257

Adult patients (>18 years old)

79 (30%)

Pediatric patients (≤18 years old)

178 (70%)

Age at first exam (years)
Median (min. – max.)

13 (1–53)

Gender
Male

117 (46%)

Female

140 (54%)

Diagnosis
Sickle cell disease

94 (37%)

β-thalassemia

24 (9%)

Cancer

105 (41%)

Others (Bone marrow failure syndromes, histiocytosis, hereditary
hemochromatosis, pyruvate kinase deficiency)

34 (13%)

Abbreviations: MRI, magnetic resonance imaging.
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Figure 7-4 summarizes the processing steps for the automated parenchyma extraction
technique, using the multi-scale vesselness filter for the 3 image inputs. Figure 7-5 shows
examples of extracted parenchyma masks obtained using reference and filter-based methods in
mild(3 < HIC < 7 mg Fe/g), moderate (7 < HIC < 15 mg Fe/g), and high (HIC > 15 mg Fe/g)
cases of iron overload. For all 3 cases, the reference analysis based on T2*-thresholding did not
completely exclude small vessels and pixels affected by partial volume effects (PVEs) at tissue
and vessel boundaries and yielded lower R2* values than those by filter-based analysis. Further,
compared with filter-based values, the underestimation of R2*/HIC values with T2*thresholding increased with iron overload severity (Figure 7-5). In contrast, visual inspection
revealed that all filter-based methods provided good vessel segmentation by excluding even
small vessels and pixels affected by PVEs while preserving parenchyma pixels.
The mean and range of liver R2* and R2*-HIC values for the reference and automated
parenchyma extraction techniques were summarized in Table 7-3. The mean DCs of parenchyma
masks that were extracted using reference and filter-based methods were 87-88% (Figure 7-6).
Mean liver R2* values estimated by all 3 filter-based methods showed excellent correlation
(R2>0.99, P<0.001) and a slope slightly over 1 (image-based: 1.05, T2*-based: 1.04, and R2*based: 1.05) compared with reference R2* values (Figure 7-7). Bland–Altman analysis showed a
positive R2* bias of 3.93% – 4.51% for all filter-based methods compared with the reference
method (Figure 7-7). Analysis of CV of R2* values measured by radiologist analysis and
different filter-based methods showed a slightly higher mean R2*-CV for the T2* thresholding
technique than that for filter-based methods (Figure 7-8).
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Figure 7-4. Processing diagram for automated parenchyma extraction based on a vesselness
filter for the 3 input data types: contrast-optimized composite image (first column), T2* map
(second column), and R2* map (third column). For all 3 image inputs, the filter was applied to
the whole-liver ROI drawn by the radiologist. The filter output was calculated using optimal
filter parameters derived from the simulation study. Pixels with a vesselness response greater
than or equal to the threshold value (0.05 of the maximum vesselness response) provide the
vesselness mask, and those less than the threshold value provide the extracted parenchyma mask.
ROI, region of interest.
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Figure 7-5. Quantitative T2* maps of the acquired slice (first column) and extracted parenchyma
T2* maps obtained after vessel exclusion using manual, histogram-based T2*-thresholding
performed by a radiologist (second column) and different filter-based methods (last 3 columns)
in cases of mild (top row), moderate (middle row), and high (bottom row) iron overload. Mean
liver R2* and associated R2*-HIC values calculated using the calibration curve11, 152 for the
extracted liver parenchyma for each technique are also given. R2* underestimation seen in T2*thresholding analysis, caused by inclusion of small vessels and pixels affected by partial volume
effects (PVE) (white arrows), can be seen in all 3 cases but is more pronounced in cases of
moderate and high HIC.

Table 7-3. Liver R2* and R2*-HIC Values Obtained with Reference and Automated Parenchyma
Extraction Techniques
Reference

Automated

T2*-thresholding

Image-based

T2*-based

R2*-based

Mean R2*± SD

271 ± 172

283 ± 180

282 ± 178

285 ± 181

Range (s-1)

31–854

31–870

31–868

31–875

Mean R2*-HIC ± SD

7.8 ± 5.3

8.2 ± 5.6

8.2 ± 5.5

8.2 ± 5.6

Range (mg Fe/g)

0.4–25.9

0.4–26.4

0.4–26.3

0.4–26.5

Abbreviation: SD, standard deviation.
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Figure 7-6. Dice similarity coefficients (DCs) for parenchyma masks extracted using T2*thresholding and 3 filter-based methods (A-C). Mean DSCs were 87.3±2.7% for composite
image-based, 88.0±2.9% for T2*-based, and 87.8±2.9 for R2*-based methods.

Figure 7-7. Linear regression (A, C, E) and Bland–Altman (B, D, F) analysis of mean liver R2*
values obtained by conventional T2*-thresholding and 3 filter-based methods. For regression
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plots, solid lines represent regression lines and the dashed line represents the unity line. For
Bland–Altman plots, solid lines represent mean bias and dashed lines represent 95% confidence
intervals (±1.96*SD). Regression equations, correlation coefficients (R2), and mean biases are
also included in the respective plots.

Figure 7-8. Scatter plots showing the coefficient of variation (CV) of R2* values obtained by
conventional T2*-thresholding (A) and 3 filter-based methods (B–D). R2*-CV ranged from
7.8% to 35.1% (mean, 16.4±4.4%) for the conventional method, from 6.5% to 35.5% (mean,
13.7±3.9%) for the image-based filter, from 6.3% to 34.2% (mean, 13.4±3.9%) for the T2*based filter, and from 6.1% to 35.2% (mean, 13.0±3.7%) for the R2*-based filter. The
conventional method based on T2*-thresholding yielded a higher mean CV than the filter-based
methods because of the inclusion of small vessels and pixels affected by PVE at the tissue and
vessel boundaries that led to lower mean R2* value and higher SD.
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7.5

Discussion

Accurate assessment of HIC by R2*-MRI is critical for managing patients with iron overload.
The current approach for R2*-MRI iron quantitation using whole-liver ROI requires manual
steps of excluding blood vessels in the ROI and radiologists take about 3-7 mins per case to
perform the vessel exclusion. Also, this process introduces potential inter-observer variability,
given the need for the subjective reviewer’s visual inspection of vessel pixels to be excluded. In
this study, we tested an automatic vessel segmentation technique that substantially reduces
processing time (< 1 sec per case) and operator dependence, thereby improving the clinical
workflow and diagnostic confidence of R2*-MRI based HIC measurements. This technique was
robust and yielded accurate R2* measurements in patients with a wide range of HICs (0.4 – 26.5
mg Fe/g) when compared with the conventional T2* thresholding technique.
Mean liver R2* values estimated by all 3 filter-based methods and by the reference
method showed excellent agreement (R2 > 0.99) across the wide range of HICs. The reference
analysis based on T2* thresholding, produced on an average ~13% more parenchymal area
compared to filter-based methods (i.e., DC ~87%). This is because the reference analysis
included small vessels and pixels at tissue and vessel boundaries as parenchyma, while filterbased methods did not. This incomplete vessel exclusion by the reference method also led to R2*
underestimation compared with filter-based methods (slope over 1 on linear regression and
positive bias on Bland-Altman analyses), because blood has a lower R2* than iron-overloaded
tissue. Further, R2*/HIC underestimation was higher for cases of high iron overload because of
considerable difference between the R2* of vessels and liver parenchyma with severe iron
overload. Incomplete vessel exclusion also increased SD in R2* values, leading to higher CV for
the reference method than for filter-based methods.

135

Although all filter-based methods performed equally well, irrespective of input data types
used for parenchyma extraction, each has advantages and limitations. The composite image is
calculated by averaging the 3 TE images with highest contrast between vessel and parenchyma.
Thus, the image-based filter output depends on the TEs selected, which should be determined
using simulation studies prior to in-vivo application. Further, the filter output based on
magnitude images is susceptible to signal intensity inhomogeneities, which might affect vessel
segmentation. Applying the filter on quantitative T2*/R2* maps removes the effect of intensity
inhomogeneities. However, filter outputs based on T2*/R2* maps depend on the fitting accuracy
of the signal decay. Fitting is a major concern in cases of high iron overload, as the signal decays
so fast that sampled echoes are predominated by noise that affects accurate T2*/R2*
quantification.203 Applying filters on magnitude images is advantageous for vessel segmentation
in such scenarios but not if the fitting is imprecise, because the goal is to accurately estimate R2*
to assess HIC. Finally, despite subtle differences among different input data types, results
obtained by all 3 filter-based methods compared to reference method were similar. These
findings support the robustness of the automated vesselness filter and offer clinicians the
flexibility to apply it on magnitude images, T2*/R2* maps, or their combination.
Applying the vesselness filter to detect bright vessels on a dark background, as seen in
image-based and T2*-based data types, requires an extra processing step to eliminate liver
boundary outliers, because the filter output also includes a small strip around the liver into the
vessel mask due to the extreme contrast difference at liver boundaries. To avoid this problem,
background signal and T2* values for both image-based and T2*-based methods were made
similar to those in the parenchyma before applying the filter. However, this was not a problem
for R2*-based filters, as they detect dark vessels on a bright background. At liver boundaries, the
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R2*-based filter output will include a small strip from the dark background into the vessel mask,
but this strip can easily be excluded as it is outside the whole-liver ROI. Overall, the R2*-based
filter seems to be the most robust and easiest to implement and apply.
Our study has some limitations. It was a retrospective analysis of liver MRI exams from
patients with different diseases. However, it had a large number of exams, all centrally reviewed
by one single experienced radiologist. The automated technique, although an advance due to the
reduction in user interface and subjectivity, is not fully automated, as the reviewer must still
outline the whole-liver ROI as with T2*-thresholding. Nevertheless, the process of liver
outlining is straightforward and less prone to inter-reviewer variability. A possible future
improvement is to entirely eliminate user interaction by incorporating automatic liver-contouring
techniques based on region-growing methods or using information from additional imaging data
(e.g., fat/water or T1 maps). Second, our patients did not have diffuse or focal liver diseases or
other hepatic pathologies; hence, the usability of filters in such scenarios could not be tested.
Third, automated filter-based methods seem to be over-conservative in vessel segmentation, but
excluding as many vessels as possible is more important than maximizing the extraction of
parenchyma for accurate liver R2* measurement. Fourth, the smallest vessel diameter that can be
detected by the filter is limited by the spatial resolution of the image, which is equally a
limitation for T2*-thresholding. Lastly, R2* was estimated using a mono-exponential signal
model and presence of fat in the liver may confound R2* measurements. However, the majority
of our patients had low body mass index and were primarily iron-overloaded with no prior
evidence of steatosis. Moreover, as the same R2* model is used for both, manual and automated
parenchyma extraction methods, potential fat contamination would not affect comparisons
between the vessel extraction methods.
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In conclusion, our automatic vessel exclusion technique is equivalent to the conventional
technique and can be applied to extract the entire liver parenchyma in the acquired crosssectional image while substantially reducing operator time and input. This method can improve
the radiologist’s workflow while potentially reducing inter-rater variability in HIC measurements
and optimizing management of patients with iron overload.

7.6

Supplement

7.6.1 Implementation of Vesselness Filter on free-breathing radial UTE data
For massive iron cases and sedated or BH non-compliant cases, multiecho UTE imaging could
be potentially superior to multiecho GRE (as demonstrated in Chapter 6).13, 143 So, in this study
the implementation of Frangi filter for automatic vessel exclusion was also tested on freebreathing radial UTE data to obtain an accurate and user independent mean R2* estimation.

Subjects & UTE Data
Multiecho UTE data was collected from 141 patients with hepatic iron overload. Participants had
a history of >12 cumulative packed red blood cell transfusions, and all were consented to
participate in a prospective institutional review board approved study on iron overload
assessment (www.clinicaltrials.gov #NCT01572922).
Multiecho UTE images were acquired axially at the location of the main portal vein
during free breathing. The multiecho UTE sequence was applied with five interleaved echo trains
(shifted by an echo time increment of ∆TEinc = 0.25 ms) following the method description in
Chapter 5.13, 143 Sequence parameters are as follows: TR = 52.5 ms, TE1 = 0.1 ms, echo spacing
ΔTE = 1.8 ms, 12 echoes per interleave, number of radial lines = 192, flip angle = 20°, slice
thickness = 10 mm, pixel bandwidth = 780 Hz/Px, number of averages = 3, and scan time = 5:08
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min. The sequence includes application of two spatial saturation bands placed in parallel to the
imaging slice (gap between saturation band and imaging slice = 10 mm, saturation band
thickness = 100 mm) to eliminate out-of-slice signal contributions, and chemically selective
saturation (CHESS) radiofrequency pulses to reduce radial streaking artifacts.143

Data Analysis
Quantitative T2*/R2* maps were calculated as described in sections 5.2.3 and 7.3.4. Mean liver
R2* values were calculated drawing an ROI encompassing the whole liver and excluding the
blood vessels using T2* thresholding technique as the reference method and an automatic vessel
exclusion technique based on multi-scale vesselness filter as described in 7.3.4. The vesselness
filter was implemented on the UTE data with the same parameters used for the GRE study (see
section 7.3.4). However, the filter was tested only on quantitative T2* and R2* maps and not on
composite magnitude images for the UTE data. This was because the contrast of the blood
vessels on the magnitude images changed over the TEs due to the application of spatial
saturation bands before the RF excitation. The vessels appeared darker than the liver parenchyma
initially as the blood is saturated and later became brighter than the liver tissue towards the end
of the echo train as the effect of the saturation pulse wears off, since unsaturated blood streams
into the slice.

Results & Discussion
Of 141 MRI scans, 2 exams were excluded due to a low number of fitted pixels and
susceptibility artifacts. Measured R2* values in the study cohort ranged from 34 to 1915 s-1
(mean±SD, 440 ± 387 s-1) for T2*-thresholding, 35 to 1978 s-1 (mean±SD, 450 ± 397 s-1) for
T2*-based filter and 34 to 1985 s-1 (mean±SD, 449 ± 398 s-1) for R2*-based filter. Figure 7-9
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shows the extracted parenchyma masks obtained using reference and filter-based methods in
mild (3 < HIC < 7 mg Fe/g), moderate (7 < HIC < 15 mg Fe/g), and massive (HIC > 25 mg Fe/g)
iron overloaded cases. For all 3 cases, the reference analysis based on T2*-thresholding did not
completely exclude small vessels and pixels affected with partial volume effects at the tissue and
vessel boundaries and produced slightly lower R2* values compared to filter-based analysis. On
the other hand, all filter-based methods provided good vessel segmentation by excluding even
small vessels and pixels affected by partial volume effects while preserving parenchyma pixels.

Figure 7-9. Quantitative T2* maps of the acquired slice (first column) and extracted parenchyma
T2* maps obtained after vessel exclusion using manual, histogram-based T2*-thresholding
performed by a radiologist (second column), and T2*-based (third column) and R2*-based (last
column) filter methods in cases of mild (top row), moderate (middle row), and high (bottom row)
iron overload. Mean liver R2* and associated R2*-HIC values calculated using the calibration
curve11, 152 for the extracted liver parenchyma for each technique are also given. Slight R2*
underestimation was observed in T2*-thresholding analysis likely because of inclusion of small
vessels and pixels affected by partial volume effects.
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Figure 7-10 depicts the DC between the parenchyma masks extracted using reference and
filter-based methods. The mean DCs were 90.0 ± 3.2% for T2*-based and 92.4 ± 3.0% for R2*based filters. Figure 7-11 shows the R2* comparisons between the reference and automated
methods using linear regression and Bland-Altman analysis. Mean liver R2* values estimated
from all filter-based methods showed excellent correlation (R2 > 0.99, P < 0.001) and a slope
slightly over 1 (T2*-based: 1.03 and R2*-based: 1.03) compared to reference R2* values. BlandAltman analysis showed a small positive R2* bias (1.63 and 2.01%) for filter-based methods
compared to the reference method (Figure 7-11). Similar to GRE-based vessel segmentation
results, this positive bias exists because incomplete vessel exclusion by the reference method led
to small R2* underestimation compared with filter-based methods.

Figure 7-10. Dice similarity coefficients for parenchyma masks extracted using T2*thresholding and filter-based methods: T2*-based (A), and R2*-based (B). Mean DCs were 90.0
± 3.2% for T2*-based, and 92.4 ± 3.0% for R2*-based methods.
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Figure 7-11. Linear regression (A, C) and Bland–Altman (B, D) analysis of mean liver R2*
values obtained by conventional T2*-thresholding and filter-based methods: T2*-based (A, B)
and R2*-based (C, D). For regression plots, solid lines represent regression lines and the dashed
line represents the unity line. For Bland–Altman plots, solid lines represent mean bias and
dashed lines represent 95% confidence intervals (±1.96*SD). Regression equations, correlation
coefficients (R2), and mean biases are also included in the respective plots.

In summary, the excellent agreement between manual T2*-thresholding and automated
liver parenchyma segmentation demonstrates the applicability, accuracy and robustness of the
vesselness filter even for UTE imaging. Hence, this study validates that vesselness filters can be
applied to quantitative R2*-MRI methods, both GRE and UTE acquisitions, to provide
automated mean liver R2* measurements by reducing operator/radiologist input and will
improve the clinical workflow in R2*-based HIC assessments that guide iron removal therapy.
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Chapter 8
Limitations and Future Work

This chapter discusses the limitations encountered in this dissertation work with respect to the
clinical validation of radial UTE acquisition, ARMA signal model for fat-water and
simultaneous R2* estimation, and automated extraction of liver parenchyma, and discusses the
future work for overcoming these challenges.

8.1

Validation between UTE R2* Measurements and Biopsy HIC

All current R2*-HIC calibration equations were derived between R2* measurements obtained
with Cartesian BH multiecho GRE and HIC measured by liver biopsy. Hence, in order to
translate the R2* measurements obtained with FB multiecho UTE imaging into clinical practice,
it is necessary to demonstrate that there is good agreement between R2* values measured by FB
multiecho UTE with those measured by the reference BH multiecho GRE method. Although our
first study (Chapter 5) showed that mean liver R2* values acquired with both methods were
fairly similar in 16 patients, these findings clearly need to be validated in a larger group of
patients. But previous studies have demonstrated that current GRE techniques lose their
precision in R2* quantification for high HIC (>15 mg Fe/g) and might even fail for massive HIC
(>25 mg Fe/g).10, 11 As GRE is inaccurate for high and massive iron overload assessment, it is
therefore necessary to perform an independent calibration study directly between UTE R2*
values and biopsy HIC values. Such an R2*-HIC calibration curve is currently being developed
under the MIDAS (Massive Iron Deposit Assessment, National Clinical Trials identifier
01572922 on ClinicalTrials.gov) study at our institution - St. Jude Children’s Research Hospital.
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This calibration study will serve 2 major purposes: extend the measurable R2*-based HIC range,
and remove the need for breath-holding for the assessment of hepatic iron overload by R2*-MRI.

8.2

Investigation of Fat-water Models with UTE Imaging

From Chapter 6, our fat-iron phantom study has shown that dual-shot GRE acquisition produced
better R2* and FF results using both NLSQ and ARMA fat-water models compared to singleshot GRE. However, both fat-water models produced inaccurate FFs at 1.5T for the highest iron
concentration even with the dual-shot GRE. In presence of high iron, the signal drops rapidly
before the first TE with the current GRE acquisition, limiting dephasing between water and fat
components and causing fat quantification to become less stable with either of the methods.187 In
these high iron cases (R2* ~ 750 s-1) or even in investigating massive iron cases (R2* > 750 s-1),
we believe that as UTE protocols provide more signal by sampling shorter TEs, they could
benefit fat-water modeling methods to provide both accurate R2* and FF results. Hence, future
work should investigate ARMA and NLSQ models with multiecho UTE imaging.

8.3

Automatic Liver Contouring

Our automated vessel exclusion technique (Chapter 7) – although an advance due to the
reduction in user interface and subjectivity – is not fully automated, as the reviewer must still
outline the whole-liver ROI. A future improvement would be to entirely eliminate user
interaction by incorporating automatic liver-contouring techniques that can extract the wholeliver region from the 2D cross-sectional image. One possible solution is to first generate a liver
probability map by aligning all 565 single-slice liver images analyzed in Chapter 7. Each source
image can then be aligned to the liver probability map and the whole-liver region can be
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extracted using region-growing methods by placing seed points in the pixels with high
probability (> 90%) of belonging to liver. An alternative solution is to use the 565 datasets to
train and develop deep learning algorithms to automatically extract the liver region.204 Other
potential solutions are to obtain additional imaging data such as fat/water images or T1 maps at
the same slice location and FOV of GRE/UTE acquisitions as they might provide better
delineation of the liver region and use these maps to extract the liver region. If automated livercontouring works, all manual post-processing steps can be removed and a fully automated
extraction of liver parenchyma and mean R2*/HIC estimation can be accomplished on the MR
scanner console itself. This process will substantially improve the clinical workflow, as the
radiologist could just review the results on a PACS server and the hematologist can readily use
the mean R2*-based HIC results for deciding on the chelation dose.
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Chapter 9
Conclusions

This dissertation work provided solutions for three limitations in current R2*-based HIC
quantification, which is crucial in guiding the physicians with the iron removal therapy in iron
overloaded patients. These limitations include respiratory motion artifacts affecting the R2*
image acquisition, presence of fat affecting the standard mono-exponential R2* signal model,
and operator dependence in extracting the mean R2* of the liver parenchyma. All these
limitations eventually affect the accuracy, precision and clinical workflow of R2*-based HIC
estimations.
The principal contributions of this dissertation are:
1. Radial UTE imaging removes the need for breath-holding in R2* quantification. Our first
study (Chapter 5) demonstrated the impact of respiratory motion artifacts on R2*
quantification using the standard Cartesian free-breathing GRE sequence and evaluated an
alternative acquisition technique based on radial UTE imaging that improved the image
quality and subsequently the R2* quantification under free-breathing conditions. Such a freebreathing UTE acquisition is essential in young or frail patients who are sedated or incapable
of performing breath-hold scans in determining accurate R2*-based HIC that eventually
guides chelation therapy.
2. ARMA signal model for fat-water separation and simultaneous R2* quantification. Our
second study (Chapter 6) showed the influence of the presence of fat and iron on R2*
quantification using the standard mono-exponential signal model, and evaluated an
alternative signal model based on ARMA that performs multi-spectral fat-water modeling to
simultaneously quantify both R2* and fat fraction. The ARMA based signal model not only
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separates the fat signal from the water and provides accurate R2* quantification for hepatic
iron overload assessment but also provides fat fraction quantification that is important in the
diagnosis of hepatic steatosis.
3. Automated vessel exclusion technique for mean liver R2* estimation. Our third study
(Chapter 7) demonstrated the limitations of the current radiologist’s workflow in extracting
the liver parenchyma and investigated a robust and automated vessel exclusion technique for
mean liver R2*/HIC estimation. Such an automated technique will considerably reduce the
operator dependence and interpretation time and hence, provide an optimized clinical
workflow and remove any potential bias in R2*-based HIC assessments for management of
patients with iron overload.
Each of these 3 studies provides improvements in image acquisition, signal modeling, and
extraction of liver parenchyma and the 3 studies can be cascaded to produce an R2*-MRI based
HIC estimation framework (Chapter 4): Data acquired from a breath-hold multiecho GRE or a
free-breathing multiecho UTE could be processed by fitting either a mono-exponential signal
model in the absence of fat or via ARMA modeling in the presence of fat to produce R2* maps,
and finally the liver parenchyma could be automatically extracted from R2* maps using vessel
exclusion technique to estimate the mean R2*-MRI based HIC.
Hence, efforts made for this dissertation provided solutions to improve the accuracy,
precision and optimize the clinical workflow of R2*-MRI based HIC assessments. With
sufficient continued effort toward implementation, these solutions can help ensure that
appropriate dosing of iron unloading treatment is given to iron overloaded patients to
significantly improve patient care and quality of life.
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